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Almost 2 billion people world-wide are infected with parasitic helminths. These 
complex multicellular eukaryotic organisms are capable of establishing long-term 
infections even in the face of an intact immune response. Typically, in these settings 
regulatory components of the immune response, such as Foxp3+ T regulatory cells 
(Tregs), become dominant, limiting protective effector responses towards the 
parasite. Helminths are thought to have evolved mechanisms, including release of 
immunomodulatory molecules termed excretory-secretory products (ES), to sway the 
balance between the regulatory and effector arms of the immune response to favour 
their persistence. In this thesis both the development of a protective immune 
response toward, and the potential manipulation of the immune response by, the 
rodent gastrointestinal nematode Heligmosomoides polygyrus have been studied.  
Firstly, the effects of H. polygyrus ES (HES) on bone-marrow derived 
dendritic cells (DCs) were analysed. Although HES did not alter the phenotype of the 
DC it was found to be able to suppress the ability of the DC to respond to 
inflammatory stimuli. This activity was lost when HES was heat-inactivated 
(hiHES). After adoptive transfer, HES-pulsed DCs were able to induce a HES-
specific T helper (Th)2-type response even if co-treated with an inflammatory 
stimulus. Th2-type responses are protective against H. polygyrus infection. 
Surprisingly, the ability of HES to generate a Th2-response in a co-treatment 
situation was not related to its anti-inflammatory properties; DCs co-treated with 
hiHES and an inflammatory stimulus were able to drive an equivalent Th2-response 
to HES in this situation. 
Next, making use of mouse strains with different susceptibility phenotypes to 
primary H. polygyrus infection, potential mechanisms of resistance were 
characterised. Development of granulomas in the gut wall were found to be 
associated with reduced worm burdens. Furthermore, in highly susceptible C57BL/6 
mice, production of IL-23 was shown to be counter-regulatory to this process, as 
mice on the same background but deficient in this cytokine have increased numbers 
of granulomas and dramatically enhanced resistance. Susceptibility to H. polygyrus 
was also considered at the level of epigenetic regulation. A protein that binds 
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specifically to methylated DNA, methyl-CpG binding domain protein (MBD)2, was 
found to affect the proportion of Foxp3+ Tregs within the CD4+ T cell population in 
vivo. Additionally, in vitro induction of Foxp3 in response to TGF-β was enhanced 
in MBD2-/- CD4+ T cells. MBD2-/- mice had a trend towards increased worm burdens 
when infected with H. polygyrus, suggesting that the difference in proportion of 
Tregs may limit generation of an effector response. 
  Finally, the ability of HES to directly affect the regulatory arm of the immune 
response was focussed upon. It was found that HES was able to induce Foxp3 
expression in naïve peripheral T cells, and that this was mediated by stimulation of 
the TGF-β pathway. The TGF-β mimic was of parasite origin as a pan-vertebrate 
TGF-β antibody was unable to block its effects but sera from H. polygyrus infected 
animals was competent to do this. Activity of this type was not limited to HES as ES 
from the ovine helminth Haemonchus contortus was found to have the same 
property. These data imply that some helminth parasites have evolved mechanisms to 
support generation of Foxp3+ Tregs, thus favouring the regulatory arm of the 
immune response and hence their own persistence. 
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1.1 Overview of helminth infections. 
 
Estimates suggest that almost 2 billion people worldwide harbour parasitic helminth 
infections. The majority of these individuals live in the developing world where a 
combination of inadequate public sanitation and poor health care provision combine 
to favour parasite transmission. Despite the high prevalence of helminth infections 
less than 1% of global research funding goes towards their study and as such they are 
considered to be neglected tropical diseases. In part this lack of scientific focus is 
reflective of the relatively low rates of mortality associated with these parasites, 
when compared to other global health concerns including malaria, HIV/AIDS and 
tuberculosis (reviewed by (Hotez et al., 2008)). 
 Parasitism by helminths, however, can incur a considerable cost to host 
fitness. Children and adolescents often have heaviest worm burdens and in this age 
group infection can cause growth stunting, decreased physical fitness, and 
impairment of normal cognitive function (reviewed by (Crompton and Nesheim, 
2002). Another group at high risk from these diseases are pregnant women; helminth 
infection is associated with neo-natal prematurity, lower birth weights, and increased 
pregnancy-associated mortality. Moreover, although helminths elicit relatively minor 
symptoms in most individuals, the morbidity they can cause should not be 
underestimated. Onchocerciasis, and lymphatic filariasis are, respectively, leading 
causes of blindness, and limb and genital deformity, in some parts of the world. 
Parasitic worm infections are also frequently co-endemic with malaria, HIV/AIDS, 
and tuberculosis; diseases upon which they are capable of having a negative impact 
(Spiegel et al., 2003; Borkow and Bentwich, 2006; Resende Co et al., 2007). Indeed, 
even though they are not typically considered a major global health concern, it is 
difficult to quantify the immense detrimental effects that these pathogens have on the 
worker productivity, and hence economies of developing countries (reviewed by 
(Hotez et al., 2008).  
Helminth refers to organisms belonging to two phyla: platyhelminths 
(flatworms) and nematodes (roundworms). Platyhelminths, which can be further sub-
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divided into trematodes (flukes) and cestodes (tapeworms), are solely parasitic, 
whilst nematodes additionally include many free-living species. The commonly used 
model organism, Caenorhabditis elegans, is the best-known example of a free-living 
nematode.    
Although a plethora of platyhelminth and parasitic nematode species are 
capable of establishing infection in human populations, a relatively small number are 
responsible for the majority of infections across the globe. The most prevalent 
platyhelminth species are the trematodes Schistosoma haematobium, S. mansoni, and 
S. japonicum, which are collectively estimated to infect 207 million people in the 
developing world. However, these numbers are overshadowed by the intestinal 
nematodes, Ascaris lumbricoides, Trichuris trichuria, and Necator americanus, 
infecting 807 million, 604 million, and 507 million, people, respectively (adapted 
from (Hotez et al., 2008). Other common parasitic helminths include filarial 
nematodes, such as Wuchereria bancrofti, Brugia malayi, and Onchocerca volvulus, 
and the cestode Taenia solium. 
Given the vast numbers of people harbouring helminth infections, it is not 
surprising to learn that a large proportion are host to several different species of 
worm. In order to compete in this world of polyparasitism, helminths have evolved 
to survive in a wide-variety of host niches, including the gut, lymphatic system and 
blood vessels, and to be transmitted in very different, and often highly complex, 
ways. Perhaps the most complex are those parasites whose lifecycles involve an 
intermediate host or vector. Examples of these include: schistosomes, which use 
freshwater snails; the lymphatic filarial nematodes, W. bancrofti and B. malayi, 
which use mosquitoes; and O. volvulus, which uses black flies of the genus 
Simulium.   
Irrespective of their method of transmission or final location within the host, 
a key feature of most helminth infections is their ability to persist for long-periods of 
time in the face of an intact immune system. Moreover, protective immunity towards 
re-infection is frequently only elicited after many years, or even decades, of 
exposure. This is testimony to the highly effective mechanisms of immune evasion 
and immunomodulation used by parasitic worms (reviewed by (Maizels and 
Yazdanbakhsh, 2003). A lack of understanding of these mechanisms, combined with 
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a modest commercial market for anti-helminthics, means that currently tools 
available for control of these infections are limited.  
   
The introduction to this thesis will firstly consider the immune mechanisms by which 
protection against helminth infection is induced, and effected, and then move on to 
assess how these mechanisms are regulated, and how parasites might manipulate host 
immunity through excretion-secretion of immunomodulatory molecules.  
 
1.2 The role of T helper (Th) 2-type responses in helminth 
infections. 
 
1.2.1 Failure to induce Th2-type responses can lead to Th1/Th17-
mediated immune pathology. 
 
In most human infections, and animal models, helminth parasites are associated with 
T helper (Th) 2-type responses classically characterised by production of cytokines 
that include interleukin (IL) -4, IL-5, IL-9, IL-13, and IL-21. Irrespective of infection 
routes and preferred niche occupied by the parasite, common features resulting from 
this type of response include, tissue eosinophilia, mucosal mastocytosis and 
production of immunoglobulin (Ig) E. Where helminth infection does not induce a 
Th2-type response, and subsequently a Th1-type response is favoured, severe 
immune mediated pathology is often found to occur. In human filarial infections, for 
example, Th1-type responses are thought to lead to inflammation of the lymphatic 
system. This causes the failure of drainage and increased susceptibility to 
opportunistic secondary infections that eventually result in elephantiasis. A similar 
situation occurs in schistosome infections where a correlation is observed between 
the presence of Th1-associated cytokines in the peripheral blood and hepatosplenic 
disease (reviewed by (Maizels and Yazdanbakhsh, 2003; Stadecker et al., 2004). 
 Another Th-cell subset that has been implicated in animal models as playing 
a non-redundant role in helminth-associated immune pathology is Th17 (Rutitzky 
and Stadecker, 2006; Rutitzky et al., 2008). Characteristic cytokines produced by 
Th17 cells are IL-17, IL-6, TNF-α (Park et al., 2005) and, in response to 
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environmental toxins, IL-22 (Veldhoen et al., 2008a). These cells are key mediators 
of the chronic inflammation associated with a number of autoimmune diseases, 
including experimental autoimmune encephalomyelitis (EAE) (Cua et al., 2003), 
inflammatory bowel disease (Yen et al., 2006), and collagen-induced arthritis 
(Murphy et al., 2003). 
Optimal induction of both Th1-, and Th17-, type responses are associated 
with production of IL-12-family members by accessory cells, mainly dendritic cells 
(DCs) and macrophages. Acquisition of a Th1 phenotype is dependent on IL-12 itself 
(Szabo et al., 2003), while the, relatively-recently discovered, cytokine IL-23 is 
required for stable expression of IL-17 by Th17-cells (Stritesky et al., 2008). IL-12 
and IL-23 are heterodimeric proteins formed from the combination of a p35 or a p19 
subunit respectively, and a common p40 subunit (Trinchieri et al., 2003). The shared 
usage of this p40 subunit meant that, prior to the discovery of IL-23, studies using 
p40-deficient mice, or mAb depletion of p40, incorrectly implicated Th1-type 
responses as being the sole drivers of inflammation in a variety of settings. 
 In an induced model of high-pathology schistosomiasis, using C57BL/6 mice, 
genetic-deficiency of IL-23(p19), but not IL-12(p35), was found to decrease liver 
granuloma size to background levels (Rutitzky et al., 2008). This reduction in 
pathology correlated with markedly lower lesional, but not local lymph node (LN), 
expression of IL-17. IL-23 is known to have IL-17-independent effects (Izcue et al., 
2008), but in this setting the effects of IL-23 appeared to be predominantly mediated 
by IL-17, since mAb-depletion of this cytokine similarly decreased liver granuloma 
size (Rutitzky and Stadecker, 2006). Furthermore, it was shown that the requirement 
for IL-17 in development of pathology was not limited to the C57BL/6 induced 
model of disease, as mAb-depletion also decreased granuloma size in, naturally high-
pathology, CBA mice. 
 At this time there is no direct evidence linking IL-17 to helminth-associated 
immune pathology in human populations. Indeed, in work focussing on 
hepatosplenic disease in S. mansoni infection, IL-17 was found to be low or not 
detectable in antigen stimulated whole blood cultures from all patients tested (Wilson 
et al., 2008). This data could be explained by local, but not systemic, pathology-
related changes in IL-17, as has been observed in mouse models (Rutitzky et al., 
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2008). As a result, in order to correlate Th17-type responses to helminth infection 
with pathology in human subjects, it may be necessary for future studies to take on 
the challenging task of focussing on Th-cell phenotype at the site of inflammation 
rather than in the periphery. 
 
1.2.2 Induction of Th2-type responses and protection against 
helminth infections. 
 
It is generally assumed that Th2-type responses are protective against all helminth 
infections. However, although this type of response is typically associated with 
protection from re-infection some ambiguities and exceptions still remain. In murine 
models of schistosomiasis, for example, the immune response against the tissue 
migrating larval stage is primarily of a Th1-type, and in vaccination studies this type 
of response can be associated with protection to challenge infection (Smythies et al., 
1992). Similarly Th1-mediated protection has been implicated in experimental 
cysticercosis, where mice were found to be more susceptible to infection by the 
cestode, Taenia crassiceps, under an IFN-γ mAb-depleting regime (Terrazas et al., 
1999), or when IL-12p35 was genetically-deficient (Rodriguez-Sosa et al., 2003). 
Whether Th1-type responses are protective towards certain helminth infections in 
human populations is less clear, but evidence suggests that natural immunity to the 
filarial nematodes, including Wucheraria bancrofti (Dimock et al., 1996) and 
Onchocerca volvulus (Elson et al., 1995), is associated with immune dominance of 
this kind. 
 Surprisingly, the only situation in which an unequivocally protective role for 
Th2-type responses has been substantiated, is for gastrointestinal nematode 
infections of rodents (reviewed by (Lawrence, 2003; Anthony et al., 2007). Perhaps 
the most clear-cut demonstration of this, is observed in respect to the resistance and 
susceptibility phenotypes of different mouse strains infected with T. muris (Cliffe 
and Grencis, 2004). Mice that are resistant to the parasite mount a strong Th2-type 
response in the site-draining mesenteric lymph nodes (MLNs), characterised by the 
presence of IL-4, IL-5 and IL-9 and a relative absence of IFN-γ. In contrast, 
chronically susceptible mice display characteristics of Th1-type polarisation, instead 
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producing large amounts of IFN-γ in the MLNs. Resistant mice can be converted to a 
susceptible phenotype by knocking-out, or mAb depleting, Th2-type cytokines, such 
as IL-4, whilst susceptible mice can be made resistant by administration of the same 
cytokines. This has proved to be an extremely useful tool to identify mechanisms 
involved in driving Th2-type resistance to gut-dwelling helminths, including IL-9 
(Faulkner et al., 1997), IL-13 (Bancroft et al., 1998), and TNF-α (Artis et al., 1999), 
and more recently, IL-25 (Owyang et al., 2006) and IL-33 (Humphreys et al., 2008).    
 Another rodent gastrointestinal nematode, towards which Th2-type responses 
are known to be protective, is Heligmosomides polygyrus. If mAb to IL-4, or IL-4 
receptor, are administered during challenge infections then protection is limited 
(Urban et al., 1991b), and if an IL-4 stabilising antibody is used during primary 
infection then worm expulsion is enhanced (Urban et al., 1995). Like the T. muris 
model there is variation in the susceptibility of different strains of mice to H. 
polygyrus. These variations are apparent in primary infection (Prowse and Mitchell, 
1980; Zhong and Dobson, 1996), but are accentuated in secondary challenge, or 
trickle, infection with the parasite (Behnke et al., 2003; Menge et al., 2003).  In part, 
as for other helminth parasites including T. muris (Else and Wakelin, 1988), 
susceptibility appears to be dependent on genes within the mouse major 
histocompatibility complex (MHC, or H-2 genes). The H-2q and H-2s haplotypes are 
associated with low susceptibility, H-2k and H-2b haplotypes with high susceptibility, 
and H-2d with an intermediate response (Wahid and Behnke, 1993) (reviewed by 
(Monroy and Enriquez, 1992). Additionally, non-H-2 genes also appear to affect this 
parameter, as mice with the same haplotype but crossed onto an alternative strain 
background vary in their responses to H. polygyrus (Wahid and Behnke, 1993). 
Intriguingly, unlike the T. muris model, even susceptible strains generate a Th2-type 
response (Wahid et al., 1994) towards H. polygyrus, suggesting that a simple 
Th1/Th2 dichotomy to explain chronicity of infection is not applicable to all gut-




1.3 Innate cells as initiators of, and effectors in, Th2-type 
responses. 
 
Irrespective of whether Th2-type responses are protective towards all helminth 
parasites, studying the activities of the various immune cell populations during the 
course of these infections has improved understanding of how the immune system is 
driven towards, and then functions in, this polarisation state. This section will 
concentrate on work that has characterised the role of innate immune cell-types in 
favouring generation of Th2-cells, and, when acted upon by Th2-associated 
cytokines, effecting putatively protective mechanisms against invading pathogens.   
 The potential cell-types involved in orchestrating clearance of intestinal 
nematodes will be a particular focus. Much of our knowledge relating to this subject 
has been gained from a small number of murine infection models, namely, H. 
polygyrus, Nippostrongylus brasiliensis, T. muris, and Trichinella spiralis. Although 
adult worms from all these species ultimately come to inhabit the gut, their lifecycles 
prior to colonisation of this site and the precise locations they inhabit within this 
environment vary markedly (Table 1.1). These differences are instrumental in 
distinguishing any common mechanisms invoked by the host to expel multiple 
helminth parasites from those that are effective only against individual species. 
Frequently, however, proposed mechanisms of expulsion have only been studied in 




Table 1.1 – Overview of intestinal nematode models. 
 




H. polygyrus Ingestion free-living larvae. L3 larvae Small intestine 
N. brasiliensis Free-living larvae penetrate skin. L3 larvae Small intestine 
T. muris Ingestion of eggs. Egg Large intestine 
T. spiralis Larvae ingested in muscle of prey eaten by 
carnivore.  
L1 larvae Small intestine 
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One example of a common clearance mechanism is termed ‘weep and 
sweep’; where fluid is increased in the intestinal lumen (weep), and smooth muscle 
contractility is altered (sweep) to literally wash the parasite away. This process is 
highly on dependent on mast cells (Section 1.3.6), goblet cells (Section 1.3.7), and 
direct effects of IL-4 and IL-13 on intestinal epithelial cells (Shea-Donohue et al., 
2001). Since this has been found to be such a ubiquitous response to gut helminth 
infection, where relevant the role of each cell type in mediating this final outcome 
will be described. 
 
1.3.1 Intestinal epithelial cells (IECs). 
 
In order for a Th2-type response to be initiated the host must first recognise that a 
pathogen is invading. A key way in which this can occur is through the recognition 
and uptake of parasite antigens by immune cell populations. However, the essential 
barrier against pathogen attack provided by intestinal epithelial cells (IECs) , also 
create a physical block to this process. Specialised lymphoid structures, including 
Peyer’s patches (PPs), present only in the small intestine, and isolated lymphoid 
follicles, found the entire length of the intestinal tract, are one way that this problem 
is circumvented. Within these structures, M (microfold) cells, which are interspersed 
between the IECs overlying the lymphoid tissue, mediate antigen exposure by 
sampling antigen and delivering it to, amongst other cell types, dendritic cells (DCs) 
situated beneath the epithelial layer (reviewed by (Artis, 2008). When exposed to 
helminth parasite antigen, these DCs are instrumental in activating the adaptive 
immune system and promoting Th2-differentiation of naïve antigen-specific T cells. 
Additionally, it is possible for some subsets of intestinal DCs to access antigen in the 
lumen by extending their dendrites between the tight-junctions connecting IECs 
(Rescigno et al., 2001).  
   Given their location, IECs are often in intimate contact with gut-dwelling 
helminths, and are, therefore, in a prime position to act as sentinels. IECs express a 
broad range of pattern recognition receptors (PRRs) and as a result are often able to 
respond to parasite antigens. When mice with an IEC-lineage specific deficiency in 
IκB kinase β (IKKβ) knockout mice were infected with T. muris this cell-type was 
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found to be integral to the development of a Th2-, rather than a Th1-, type response, 
via NF-κB-induced expression of thymic stromal lymphopoietin (TSLP). Lack of 
TSLP correlated with enhanced production of the Th1/Th17-associated cytokine IL-
12/23p40 by DCs in this setting, suggesting a route by which Th2-type responses 
were no longer favoured (Zaph et al., 2007). Although not considered in this study, 
an additional way in which TSLP may support Th2-type polarisation is by 
stimulating mast cells to produce Th2-associated cytokines, including IL-5, and IL-
13 (Allakhverdi et al., 2007a). 
 Along with TSLP, IECs are also major producers of IL-25, and IL-33, two 
cytokines that bias towards Th2-type responses. Genetic-deficiency in IL-25 leads to 
parasite specific Th1/Th17 polarisation in T. muris infected animals. One explanation 
for this is that IL-25, like TSLP, suppresses IL-23 production, and thus, when not 
present, Th17, rather than Th2-cells, become prominent (Zaph et al., 2008). IL-33, 
also plays a role in resistance to T. muris infection, as susceptible mice can be 
manipulated to expel the parasite by exogenous administration of this cytokine 
(Humphreys et al., 2008). It has been described as a chemoattractant to (Komai-
Koma et al., 2007), and a potent inducer of, Th2-cells (Schmitz et al., 2005), as well 
as working in combination with TSLP to enhance Th2-associated cytokine release by 
mast cells (Allakhverdi et al., 2007b).  
     Aside from release of factors to predispose towards Th2-differentiation, 
IECs can be acted upon by Th2 cytokines to aid in worm expulsion. IL-4, and IL-13, 
in a STAT6-dependent fashion induce IECs to alter cell permeability, absorption, 
and secretion, to favour the intraluminal fluid increases associated with ‘weeping’ to 
flush parasites out of the gut (Madden et al., 2004). Furthermore, some nematodes, 
like T. muris, which reside in IEC syncytia, can be driven out into this fluid-rich 
environment by Th2 cytokine-driven acceleration of epithelial turnover, functioning 




Basophils, which make-up less than 0.3% of leukocytes in the peripheral blood, are a 
poorly understood cell-type in regard to function and development (Min, 2008). In 
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mouse models of helminth infection, including N. brasiliensis, basophil numbers 
increase dramatically in a manner that is thought to be dependent on the Th2-
associated cytokine IL-3 (Sokol et al., 2008).  Ligation of the high affinity IgE 
receptor (FcεRI), or increases in intracellular calcium stores, stimulate significant IL-
4 production by basophils (Seder et al., 1991). Basophils have, therefore, been 
postulated as a potential source of early IL-4, potentiating Th2-cell differentiation in 
response to helminths. Supporting this idea, when ‘G4’ IL-4-reporter mice (in which 
IL-4 is knocked out and GFP is expressed in the cells that would have expressed this 
cytokine) were infected with N. brasiliensis, basophils were found to be a prominent 
source of IL-4 (Min et al., 2004). Moreover, a glycoprotein from S. mansoni soluble 
egg antigen (SEA), IL-4-inducing principle of S. mansoni eggs (IPSE)/alpha-1, binds 
directly to basophils in vitro to trigger release of this cytokine (Haisch et al., 2001; 
Schramm et al., 2007).  
 Recent work has suggested that basophils can also be activated to induce Th2 
differentiation by agents such as papain and bromalein, in a manner that is dependent 
on their cysteine protease activity (Sokol et al., 2008). No genetic-model of basophil 
deficiency is available, but using antibodys specific for FcεRIα it was possible to 
show that depletion of these cells inhibited papain-generated Th2-type responses. It 
was unclear, in this study, whether Th2-polarisation was directly attributable to IL-4 
or another basophil produced cytokine such as TSLP. Given that helminths 
excrete/secrete proteases to gain access to the host, migrate through tissues, and to 
feed (Section 1.7.1), this mechanism of basophil stimulation may in future be found 
to be one route to Th2 differentiation in these infections. However, as the case of 
IPSE shows, other pathways of basophil stimulation may also be evoked by helminth 
parasites. 
   
1.3.3 Macrophages. 
 
Mirroring T cell subset classification, macrophages are described as becoming 
classically or alternatively activated in response to infection. Classically activated 
macrophages (CAMφs) protect against Th1-driving infectious agents, such as 
intracellular bacteria and viruses, in part through pathways that are dependent on 
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nitric oxide (NO) production. CAMφs can be identified by their expression of pro-
inflammatory cytokines, such as IL-12, and IL-23, and inducible nitric oxide 
synthase (iNOS), which is involved in converting L-arginine into NO. In contrast, 
alternatively activated macrophages (AAMφs) are found at sites of inflammation in 
Th2-type settings. In vivo, induction of AAMφs is dependent upon ligation of IL-
4Rα. This receptor forms one half of heterodimeric receptors for both of the Th2-
associated cytokines, IL-4 and IL-13, which in vitro generate AAMφs (LaPorte et al., 
2008). When mice, infected with S. mansoni, are genetically deficient in expression 
of this receptor specifically on Mφs (LysMCreIL-4Rα-/flox), CAMφs develop rather 
than AAMφs in this Th2-type setting (Herbert et al., 2004). Additionally, IL-21 
seems to enhance alternative activation as, in vitro, it augments the activity of IL-4 
and IL-13 on Mφs (Pesce et al., 2006), and, suggesting that this is biologically 
important, in vivo, IL-21R-/- mice have attenuated Th2-type responses towards H. 
polygyrus, N. brasiliensis, and S. mansoni (Pesce et al., 2006; Frohlich et al., 2007).  
Characteristics of AAMφs are their high expression of IL-4 receptor α-chain 
(IL-4Rα), and the mannose receptor CD206, along with, arginase-1 (Arg-1), and low 
expression of iNOS (reviewed by (Reyes and Terrazas, 2007). This abundance of 
Arg-1 favours the metabolism of L-arginine towards prolines, polyamines, and urea 
production, rather than NO. Prolines play an important role in collagen production, 
whilst polyamines stimulate cellular proliferation. Together these metabolites are 
thought to confer a wound healing capacity that has been implicated as an important 
function of AAMφs (Loke et al., 2007). 
 AAMφs have now been identified in all phyla of helminth infections (Reyes 
and Terrazas, 2007), but have been particularly well-phenotyped using a murine 
peritoneal implant model of B. malayi infection. Macrophages isolated from this 
setting, termed nematode elicited macrophages (NeMφs), displayed high Arg-1 
activity, but were found to more dramatically express two other molecules, Ym1, and 
Resistin-like molecule (RELM) α (Loke et al., 2002). The role of these molecules, in 
regard to the function of AAMφs, is still poorly understood. 
Ym1 is a lectin that has an affinity for the abundant natural polymer, chitin, 
which is important to structural support in a wide-range of organisms including 
fungi, insects, and helminths. Approximately 5% of the dry weight of H. polygyrus 
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eggs is chitin (Arnold et al., 1993), and expression of chitin synthase genes is evident 
in the developing embryos of B. malayi (Harris et al., 2000). Despite its ability to 
bind chitin, in contrast to other homologous proteins, Ym1 has no chitinase activity. 
Some studies have implicated Ym1 as having chemotactic properties towards 
eosinophils (Falcone et al., 2001), whilst others have suggested that its ability to also 
bind heparin may be involved in mediating interactions between certain cell-types 
and the extracellular matrix (Chang et al., 2001).  
 RELMα, as its name suggests, bears resemblance, on the basis of an unusual 
C-terminal cysteine-rich domain, to resistin. Resistin itself is an adipocyte-derived 
hormone that antagonises glucose homeostasis, and insulin sensitivity. Alongside 
RELMα, two other family members have been identified, RELM-β, and RELM-γ, 
both of which also have increased expression in helminth infection (reviewed by 
(Artis, 2006; Anthony et al., 2007). Each RELM-protein has a different expression 
pattern: RELMα, aside from its expression in AAMφs, is expressed in a diverse set 
of tissues including the lung, and adipose tissue; RELM-β has a much more 
restricted expression profile, and is most prominently produced by goblet cells in the 
intestinal tract. It has been shown to bind to nematodes (Section 1.3.7); RELM-γ, the 
least well characterised member of the family is found, like RELMα in the lung, but 
additionally in haematopoietic tissue, and the intestine during helminth infection 
(Wang et al., 2005). Although RELMα has multiple functions, including inhibition 
of adipocyte differentiation, its action when released by AAMφs in Th2-type settings 
is unclear. RELMα has been shown to stimulate collagen production by 
myofibroblasts, so one possibility is that, like Arg-1, RELMα plays a role in aiding 
tissue repair in the face of the large amount of damage caused by large extracellular 
parasites (reviewed by (Anthony et al., 2007).  
         AAMφs are essential to the development of resistance in secondary challenge 
infections to H. polygyrus. In primary inoculations, most strains of mice are to some 
extent susceptible to the parasite, with infections lasting between four weeks to eight 
months (reviewed by (Monroy and Enriquez, 1992). However, in secondary 
challenge infection some strains become resistant to re-infection, with clearance 
occurring by 14 days. This resistance is largely dependent on an immune response 
directed against the larval stage of the parasite, which dwells in the intestinal sub-
 13 
mucosa (Patel et al., 2008). A granuloma forms around the parasite, that is dependent 
on memory Th2 cells, made up of neutrophils directly in contact with the invading 
larvae and larger numbers of AAMφs enclosing the parasites and the neutrophils 
(Fig. 1.1) (Anthony et al., 2006). If the host is clodronate depleted of macrophages, 
or the AAMφ-associated enzyme Arg-1 is chemically inhibited, then resistance is 
compromised, implying that AAMφs are mediators in the attack against larvae in the 
tissues. Furthermore, data from N. brasiliensis infection suggests that AAMφs may 
be involved in favouring expulsion of the parasite once it is in the gut lumen. In this 
setting inhibition of Arg-1 blocked smooth muscle contractility, increased smooth 
muscle thickness and partially affected protective immunity of the host, whilst 




Alongside AAMφs, another cell type apparent at sites of tissue invasion by helminth 
parasites is the neutrophil. When gerbils are intradermally inoculated with Brugia 
pahangi L3s, neutrophils are the major cell-type observed surrounding the larvae near 
the injection site by 3 hrs post-injection (Porthouse et al., 2006). Similarly, in 
nodules encasing the adult worms of O. volvulus infected human patients, 
neutrophils are a predominant cell-type (Brattig et al., 2001). Filarial nematodes, like 
these, typically carry symbiotic bacteria and it appears that much of the neutrophilia 
can be attributed, not to recognition of the parasite, but to recognition of the bacteria. 
This is exemplified by the loss of neutrophils from O. volvulus nodules of individuals 
treated with bactericidal antibiotics (Brattig et al., 2001). As discussed previously 
(Section 1.3.3), neutrophils are also evident surrounding H. polygyrus larvae in the 
gut wall. Even in this setting it is possible that neutrophils are responding to resident 
gut bacteria, or potentially pathogenic bacteria carried by the parasite, as opposed to 
the parasite itself. Neutrophil recognition of bacteria, instead of direct recognition of 
the helminth, may still play a key role in favouring parasite clearance. Mice, 
genetically-deficient in CCL2, a chemokine important to neutrophil trafficking, were 
delayed in their ability to expel N. brasiliensis. This was associated with transient 
increases in levels of IFN-γ, implicating a role for neutrophil clearance of Th1-
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driving bacteria in augmenting the Th2-type response to this nematode (Pesce et al., 
2008).  
 The killing of the human threadworm, Strongyloides stercoralis (Galioto et 
al., 2006), by murine neutrophils, argues that there may still be a role in vivo for their 
direct interaction with helminths, albeit in defence against a non permissive 
infection. This could be dependent on release of molecules associated with, like 
macrophages, alternative activation. Alternatively activated neutrophils have not, as 
yet, been reported in helminth infection, but were identified in some strains of mice 
infected with methicillin-resistant Staphylococcus aureus (Tsuda et al., 2004). 
Although much work still needs to be done to better understand their role, it appears 
that neutrophils are an important component of the protective immune response to 
many helminths. However, their importance is clearly context dependent since 
neutrophil-depleted mice, infected with S. mansoni, did not have any discernable 




Dramatic eosinophilopoiesis, followed by eosinophil infiltration into tissue-sites 
local to the parasite, and subsequent release of toxic, eosinophil cationic protein 
(ECP), are a common feature of helminth infections. Despite their highly ubiquitous 
presence, conflicting data from various models has confounded efforts to define 
whether eosinophils are integral to host protection against these organisms (reviewed 
by (Meeusen and Balic, 2000). IL-5, unlike many other cytokines, does not appear to 
have pleiotropic roles but is predominantly involved in inducing eosinophil 
generation from bone-marrow precursors (reviewed by (Ovington and Behm, 1997). 
As a result, one approach to studying the function of eosinophils has been to target 
this cytokine, either by monoclonal mAb depletion or by generating genetically-
deficient mice (reviewed by (Maizels and Balic, 2004). Using this technique it was 
found that IL-5 depletion had no effect on resistance to some helminths, including T. 
muris (Betts and Else, 1999), H. polygyrus (Urban et al., 1991b), and S. mansoni 
(Brunet et al., 1999), but led to greater worm recoveries in S. stercoralis (Rotman et 
al., 1996), and O. volvulus infections (Lange et al., 1994). An alternative method to 
address this issue was to infect transgenic mice that overexpress IL-5, and hence 
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have an overabundance of eosinophils, with various parasites. Once again results 
were wide-ranging; decreased susceptibility was observed in response to N. 
brasiliensis (Dent et al., 1999), but no change in protection was recorded with regard 
to the larvae of the canine roundworm, Toxocara canis (Dent et al., 1999), or T. 
spiralis (Hokibara et al., 1997).       
 One issue with these models is that IL-5 can have affects on other cell types, 
including neutrophils (reviewed by (Maizels and Balic, 2004), so there was a 
possibility that eosinophils were not directly responsible for the phenotypes 
observed. Furthermore, IL-5 depletion was not associated with complete loss of the 
eosinophil compartment. More recent studies have made use of eosinophil deficient 
mice, such as ΔdblGATA mice, which have a deletion within the GATA-1 promoter, 
and TgPHIL mice, which express a diptheria toxin receptor under control of the 
eosinophil peroxidase promoter (Humbles et al., 2004). These mice have 
corroborated some of the earlier data, including the lack of an apparent role for 
eosinophils in protection against schistosome infection (Swartz et al., 2006), and 
furthered understanding of how eosinophils may mediate resistance in other settings 
(Swartz et al., 2006). For example, ΔdblGATA mice had impaired resistance in 
primary and secondary infection with N. brasiliensis, which was found to be due to a 
lack of response in the skin towards the invading larvae, rather than an effect on the 
ability of the mice to expel adult worms from the gut (Knott et al., 2007). In addition 
to this, any protective effects of eosinophils may not be mediated by release of 
cationic proteins, as protection against B. pahangi in mice was not altered by 
genetic-deficiency of these proteins but was affected by total depletion of eosinophils 
(Ramalingam et al., 2005). 
 It is intriguing that eosinophils are recruited to tissue sites in large numbers in 
models of infection, even where they appear not to play a role in protection. For 
example, in the H. polygyrus granuloma, eosinophils are found in surrounding tissue 
but not directly in contact with the parasite (Anthony et al., 2006). Two main 
explanations have been proposed for this. Firstly, eosinophil recruitment has evolved 
as a constitutive response to all helminth infections, because in some settings it does 
favour parasite killing and host fitness. Secondly, eosinophils have an alternative 
non-protective role to play in some responses, perhaps in tissue remodelling or 
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resolution of damage associated with pathogen challenge. Future work will need to 
focus on identifying whether this second option is the case. 
  
1.3.6 Mast cells. 
 
A classic feature associated with helminth infections is mucosal mastocytosis, the 
peak of which is often correlative with worm expulsion. One example of this is in T. 
spiralis infection, where maximal mastocytosis occurs at day 14 of infection, the 
time at which adult parasites are rejected, returning to low levels, typically observed 
in uninfected mice, by 8 weeks post infection (Friend et al., 1996). It has been shown 
that stem cell factor (SCF), another protein secreted by IECs in the small intestine, is 
necessary for this process in response to T. spiralis infection (Donaldson et al., 
1996). Other cytokines, identified from in vivo studies, which favour increases in the 
mucosal mast cell (MMC) population are the Th2-type cytokines IL-3 (Abe et al., 
1988), IL-4 (Madden et al., 1991), and IL-9 (Faulkner et al., 1997). IL-9-transgenic 
mice that constitutively overexpress IL-9, have enhanced MMC hyperplasia 
(Faulkner et al., 1997). When infected with T. spiralis (Faulkner et al., 1997), or T. 
muris (Faulkner et al., 1998), increased resistance was noted.  
 MMC secrete many active mediators that are associated with increased fluid 
accumulation in the gut, some of which can be accounted for by the effects of 
prostaglandins and histamines on the IECs. There is also a suggestion that MMC 
serine proteases may be important in increasing this fluid accumulation. One such 
group are chymases, which are associated with epithelial paracellular permeability 
(reviewed by (Knight et al., 2008).  If rats are infected with N. brasiliensis during 
infection macro-molecular leakage occurs due to mast cell chymase II (Scudamore et 
al., 1995). Mice lacking the mast cell protease Mcpt-1, were significantly delayed in 
their ability to expel T. spiralis despite normal numbers MMCs (Knight et al., 2008). 
These MMC proteases were not relevant to all infections though, as genetic-
deficiency in Mcpt-1 has no effect on expulsion of N. brasiliensis (Knight et al., 
2000). 
 The importance of mast cells in protection against a particular helminth may 
be dependent on its niche. T. spiralis and T. muris, both live in epithelial-cell 
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syncytia and as a result may be more susceptible to expulsion due to changes in 
vascular permeability at this site. 
1.3.7 Goblet cells. 
 
In response to gut nematode infection goblet cell hyperplasia is apparent. Enlarged 
goblet cells primarily release mucins, which cross-link to form a viscoelastic mucous 
gel that protects mucosal surfaces (reviewed by (Knight et al., 2008). The stimulation 
of goblet cells is dependent on IL-4 and IL-13, as shown in T. spiralis infection 
(Khan et al., 2001). As well as mucins IL-4 and IL-13 stimulate goblet cells to 
produce other effector molecules including RELM-β (Knight et al., 2004) (Section 
1.3.3), and intelectin-2 (Pemberton et al., 2004). 
 RELM-β is increased in the gut when resistance is observed towards N. 
brasiliensis, T. spiralis, or T. muris (Artis et al., 2004). This protein may promote 
expulsion of the worm by directly binding to its lateral alae. These chemosensory 
organs are integral to the worm being able to target its movement. When S. 
stercoralis was treated in vitro with RELM-β it became disorientated and was no 
longer able to move towards host tissue extract (Artis et al., 2004). It is possible that 
intelectin-2, a lectin (sugar binding protein), may also play a similar role to RELM-β. 
Intelectins can bind to certain sugar-moieties in bacterial cell walls and it is a 
possibility that they may also bind directly to the nematode and influence its feeding 
or attachment to the gut wall. Alternatively, intelectins could raise the viscosity of 
the mucus in the gut by affecting cross-linking between mucins. This is observed 
with Xenopus egg lectin, XL35, which is responsible for egg hardening (Nishihara et 
al., 1986) (reviewed by (Artis, 2006). In this way it is possible that a sort of 
‘glycoprotein cement’ forms around the nematode promoting its expulsion 
(suggested by (Artis, 2006). 
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1.4 Adaptive immune cells in Th2-type responses to 
helminth infection. 
 
Although innate cells are important in initiating an appropriate response to an 
invading pathogen, it is only their action in concert with the adaptive immune system 
that can ultimately lead to parasite clearance. Of particular importance is the 
differentiation of Th2-cells, which expand to become a major source of the cytokines 
IL-4, IL-5, IL-9, IL-13, and IL-21, which, as discussed in the previous section 
(Section 1.3), mediate Th2-type effector mechanisms. 
 The importance of CD4 cells in generating protective responses to helminths 
is evidenced by the fact that their depletion, in either primary or memory responses, 
in a number of models, such as H. polgyrus and T. muris, favours worm persistence 
and increases fecundity (Urban et al., 1991a; Koyama et al., 1995). 
 
1.4.1 Generation of Th2 cells. 
 
Until recently, the prototypic Th2-type cytokine, IL-4, secreted by T and non-T cell 
sources over the course of a helminth infection was considered to be key to the 
generation of Th2-cells. This idea was propagated by in vitro studies in which IL-4, 
acting via STAT6-signalling, was an absolute requirement for Th2 differentiation 
(Le Gros et al., 1990; Kaplan et al., 1996). In vivo, however, there does not appear to 
be a necessity for IL-4 to induce and expand Th2-cells. This was shown by infecting 
homozygous IL-4G4/G4 transgenic mice, which express GFP as a surrogate for IL-4, 
with N. brasiliensis, and comparing their ability to polarise Th2-cells with mice 
heterozygous for the G4-gene (IL-4+/G4) (van Panhuys et al., 2008). Little difference 
was observed in initial appearance of IL-4/GFP expression between these groups, or 
additionally STAT6-/-IL-4G4/G4 mice. 
 Aside from IL-4, various co-stimulatory molecules on non-T cells have been 
implicated as playing a role in Th2-cell generation. These cell-surface proteins, 
which include members of the tumour necrosis factor (TNF), integrin, and 
immunoglobulin superfamilies, act in concert with TCR-ligation to modulate effector 
cell development. CD40, OX40L, and B7 (CD80/86), are the molecules currently 
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thought to be most important in mediating Th2-cell differentiation in helminth 
infections.  
The role of CD40 begins at the very onset of the response. When CD40 
deficient, bone-marrow derived, DCs are pulsed with SEA, in vitro, and then 
adoptively transferred into WT mice (Section 3.1) they fail to induce Th2-cells, 
unlike their WT counterparts (MacDonald et al., 2002). Not only is CD40 directly 
required to interact with its ligand CD154 on T cells, but it also mediates interactions 
with innate populations (Jenkins et al., 2008). The importance of this relationship in 
vivo is demonstrated by the failure of CD154-/- animals to induce a Th2-type 
response when injected with S. mansoni eggs (MacDonald et al., 2002).  
OX40L, unlike CD40, has only small effects on primary T cell responses to 
helminths, including N. brasiliensis (Pippig et al., 1999) and H. polygyrus (Ekkens et 
al., 2003). A more important role for this molecule appears to be in the memory Th2-
response. This is exemplified by the fact that OX40L-/- mice, given a secondary 
challenge infection of H. polygyrus have reduced IL-4 production and are not 
protected against the parasite (Ekkens et al., 2003). The role of CD80/86 (or B7) 
molecules, in driving Th2-induction, is interesting in that the necessity for their 
expression is context dependent even between different helminth infections. 
CD80/86 deficient animals are unable to make normal IL-4 responses to H. 
polygyrus, whereas when infected with N. brasiliensis production of this cytokine is 
unimpaired (Lu et al., 1994; Greenwald et al., 1997; Liu et al., 2002).  
Another level of control, rarely considered in infection settings, which is 
integral to establishment of a specific Th-cell differentiation state, is epigenetic 
regulation. Current models suggest that all naïve T cells have the potential to become 
Th1, or Th2, cells. At this stage the accessibility of DNA to transcription factors at 
both the Th1-effector cytokine gene Ifng, and the Th2-effector cytokine gene IL4, is 
limited (reviewed by (Reiner, 2005). This lack of accessibility is associated with a 
condensed chromatin (heterochromatin) structure.  
Chromatin is the term used to describe the combination of DNA, RNA, and 
protein, making up chromosomes. A major component of chromatin are histones; 
complexes of which, DNA wraps around to create a ‘beads on a string’ like 
arrangement. By making post-translational modifications to histones the packaging 
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of DNA can be altered to modulate access to, and ultimately transcription of, 
expressed genes. Certain modifications, such as acetylation are associated with 
loosening of chromatin and hence transcription activation, whilst others, such as 
methylation, are associated with compacted chromatin and transcription repression 
(reviewed by (Turner, 2000) . 
Although histone modifications affect chromatin organisation, epigenetic 
changes to the DNA itself are important in directing this process. DNA can be 
methylated, by DNA methyltransferases (DNMTs), on cytosine nucleotides, 
typically in a CpG dinucleotide context. Proteins known as methyl-CpG binding 
domain proteins (MBDs) associate with these sites and recruit histone-modifying 
enzymes, including histone deacetylases, that alter histone modifications such that a 
compacted chromatin structure is favoured. In this manner MBDs act as 
transcriptional repressors (Fig. 1.2) (reviewed by (Klose and Bird, 2006).  
 Returning to the situation in naïve T cells, although the chromatin 
organisation at the Il4 and Ifng loci is repressive, they are not entirely 
transcriptionally silent. Early after their activation, transcriptional activity is 
measurable at both of these sites (Grogan et al., 2001) along with histone acetylation 
(Avni et al., 2002). As cells continue to proliferate in an appropriate setting 
transcription patterns become more restricted, eventually leading to mature 
expression of one or other of these genes in the progeny of the original cell.  
 Integral to the polarisation of a naïve T cell are the master transcriptional 
activators, T-bet (for Th1-cells), and GATA-3 (for Th2-cells). These proteins have 
been described as having a role in chromatin remodelling at two of their target genes, 
Ifng, and Il-4 (reviewed by (Reiner, 2005). This is demonstrated by experiments 
showing that if Gata3 is deleted at the onset of Th2-development, transcriptional 
induction of IL-4 is lost, but if Gata3 is deleted in mature Th2-cells it does not 
impair continued expression of IL-4 (Pai et al., 2004; Zhu et al., 2004). Thus, it 
seems that during T cell differentiation some genes, including Ifng and IL-4, become 
fixed in an open state that is independent of their original activator. 
 DNA-methylation was found to be a modification important to this process. T 
cells from mice lacking DNMT1, which are unable to maintain methylation, and T 
cells from MBD2-deficient animals, which are unable to normally translate DNA-
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methylation into a repressive signal, have derepression of cytokine expression when 
polarised towards a Th1, or Th2, lineage (Hutchins et al., 2002; Makar et al., 2003). 
In particular misexpression of typically non-overlapping cytokines is observed, for 
example IFN-γ, and IL-4. Thus, epigenetic control of gene expression, at the level of 
DNA-methylation, is essential for generation of Th1, or Th2-cells. 
 
1.4.2 B cells and antibody production. 
 
The role of B cells in helminth infections, are much less well understood than for T 
cells. B cells may act to aid in parasite clearance through production of antibodies, 
but they also can have antibody independent effects. In order to induce T cell 
expansion, interactions first occur between the TCR on these cells and their cognate 
MHC class II-peptide complexes presented on DCs. This process takes place in the T 
cell zone of peripheral lymphoid tissues (reviewed by (Steinman et al., 1997). After 
becoming activated the CD4+ T cells head towards the B cell zone where they 
interact with B cells at the border between T and B cell regions (Garside et al., 
1998). B cells are capable of acting as APCs, and can express cytokines and co-
stimulatory molecules. At this point it is thought they may be necessary to support 
the continued expansion of T cells, required to get appropriate effector and memory 
function (Linton et al., 2000). Additionally, it has been suggested that B cells may 
favour Th2 responses by downregulating the levels of IL-12 released by DCs, thus 
inhibiting IFN-γ production (Moulin et al., 2000). 
 When B cell deficient mice were infected with T. muris, the protective Th2-
type response was inhibited and a Th1-type response was apparent (Blackwell and 
Else, 2001). Additionally, in an N. brasiliensis model it was shown that B cells, 
although not required for the initial activation of T cells were required for subsequent 
proliferation and differentiation of Th2-cells (Liu et al., 2007). 
 Production of IL-4 in a Th2-type setting stimulates B cell class switching to 
an IgE isotype. IgE is taken up by FcRεI on mast cells and basophils and in the 
presence of antigen is cross-linked. This stimulates the release of basophil and mast 
cell derived factors that ultimately favour weeping and sweeping. 
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 Antibody isotypes other than IgE are important in helminth infections. IgG1 
dramatically increases in Th2-type settings and recent work has shown that transfer 
of this isotype of antibody correlates with protection in H. polygyrus infections 
(McCoy et al., 2008). Moreover, IgM is protective against the larval stage of filarial 
nematodes (Rajan et al., 2005).  
 
1.5 Regulatory mechanisms in helminth infection. 
 
In order for the host to survive a parasite infection, without significant morbidity, not 
only the type, i.e. Th1 vs. Th2, but also the strength of the immune response must be 
carefully regulated. This is exemplified in murine models of schistosome infection 
where, as discussed previously (Section 1.2.1), Th1/Th17 rather than Th2 
polarisation is associated with immunopathology, but where, additionally, failure to 
control the voracity of the Th2-type response can lead to a similar outcome (Taylor 
et al., 2006). The balance between Th1 and Th2-cells could be described as a form of 
regulation, since these cell-types have been shown in many settings to counter the 
activity of each other. However, what is more commonly defined as “regulation” 
within the immune system are the cells and cytokines that limit the effector response, 
irrespective of its Th-type  
 As will be discussed in the next section, the most well-studied cell-types 
involved in this arm of the immune response are Regulatory T cells (Tregs) whilst 
the characteristic cytokines are IL-10 and TGF-β. 
 
1.5.1 Natural Foxp3+ Tregs. 
 
Broadly speaking regulatory T cells can be separated into two main subsets: ‘natural’ 
Foxp3+CD4+CD25+ Tregs, and inducible Tregs. Natural Foxp3+ Tregs arise in the 
thymus and have bias, within the pool, towards self-antigen. Their main role is to 
maintain peripheral tolerance by limiting proliferation of self-reactive T cells that 
have escaped thymic selection (reviewed by (Sakaguchi, 2005). This is particularly 
important when damage occurs to tissues, mediating self-ligand release, for example 
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during infection. The importance of FOXP3 in maintaining peripheral tolerance is 
apparent when considering the pleiotropic features associated with human IPEX 
(immune dysregulation, polyendocrinopathy, X-linked) syndrome. Patients with this 
syndrome often have deleterious mutations in the FOXP3 locus, and can present with 
a wide-variety of conditions including: eczema, autoimmune enteropathy, thyroiditis, 
autoimmune haemolytic anaemia, and membranous nephropathy (reviewed by (van 
der Vliet and Nieuwenhuis, 2007)). A comparable phenotype, including dermal 
thickening, anaemia and lymphadenomegaly, is observed in scurfy mice (Brunkow et 
al., 2001), which have a mutation in Foxp3, and Foxp3-deficient animals (Lin et al., 
2007). 
Many different mechanisms by which Foxp3+CD4+CD25+ Tregs mediate 
suppression of effector immune responses have been reported. These can be split into 
three main categories: Tregs directly influencing other T cells; Tregs changing 
APCs; Tregs releasing suppressor molecules (reviewed by (Tang and Bluestone, 
2008). 
 
Tregs directly influencing other T cells 
The proliferation, and cytokine production, of T effector (Teff) cells in vitro, and in 
vivo, can be limited by Tregs. Moreover, Tregs are also able to inhibit cytolytic 
activity of CD8+ T cells in vivo (Mempel et al., 2006). When in vitro systems are 
considered Tregs are able to act in the absence of APCs, suggesting that they are 
capable of directly affecting the Teff. One mechanism by which this may occur is by 
the release of molecules such as granzyme B, and perforin, killing the Teff cells 
(Grossman et al., 2004; Gondek et al., 2005). An alternative way that Tregs can 
function in vitro is by starving Teff cells of cytokines. A cytokine important in this 
regard is IL-2, which is consumed by Tregs due to their constitutive expression of 
CD25 (IL-2Rα). As a result availability of IL-2 for Teff proliferation and 
differentiation is reduced and eventually apoptosis occurs (Pandiyan et al., 2007). 
 
Tregs changing APCs 
In vivo it has been observed that Tregs, after transfer, can rapidly interact with DCs. 
The ability of these DCs to subsequently interact with other T cells is altered either 
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by inhibiting their ability to present antigen or by stimulating them to release 
suppressive factors. Tregs are able to upregulate production by DCs of indoleamine 
2,3-dioxygenase (IDO), which converts tryptophan to kynurenine, affecting Teff 
proliferation by reducing availability of this important amino acid (reviewed by 
(Puccetti and Grohmann, 2007).  
CTLA-4 on Tregs is known to be important in these interactions with DCs. 
Mice genetically deficient in CTLA-4 develop severe inflammatory disease 
demonstrating the importance of this molecule in negatively regulating Teff activity 
(Waterhouse et al., 1995). In a recent study, mice with a Foxp3-cre specific deletion 
of CTLA-4 were found to develop similarly severe inflammatory disease to CTLA-4-
/- animals implying that this molecule is essential for Treg function (Wing et al., 
2008). In this system CTLA-4 was found to mediate down-regulation of the 
costimulatory molecule CD86 on DCs, suggesting that limiting expression of this 
molecule is prevented activation of Teff cells. 
 
Tregs releasing suppressor molecules 
Many different molecules have been suggested to be important in the function of 
Tregs, including IFN-γ, IL-9, cAMP, galectins, and IL-35, but only two have been 
well-characterised in vivo, IL-10 and TGF-β. When these cytokines are blocked in a 
number mouse models including IBD, type 1 diabetes, and Leishmania, it has been 
shown that Treg suppression is ablated (reviewed by (Tang and Bluestone, 2008). 
Most recently, a mechanism of infectious tolerance has been described by which 
activated CD4+Foxp3+ Tregs are able to induce Foxp3 expression in naïve T cells 
and convert them into new regulatory phenotype cells. This occurs via a TGF-β 
dependent mechanism that does not require APCs (Andersson et al., 2008). 
Interestingly, induction is associated with Foxp3+ cells that express latency-
associated peptide (LAP), a peptide product of TGF-β processing. 
 
Beyond the in vitro setting, molecules that effect the localisation of Tregs are 
extremely important to their function in suppressing proliferation of Teff cells in 
vivo. One such molecule, expressed on Tregs is CD103, an αe integrin that is known, 
in combination with β7, to bind to E-cadherin (Agace et al., 2000). This affinity may 
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aid in the retention of Tregs at specific tissue sites, for example sites of infection. 
Upregulation of CD103 is associated with a number of parasites including H. 
polygyrus (Finney et al., 2007). The role of CD103 during infection has perhaps been 
best demonstrated in response to Leishmania major, where CD103+ cells accumulate 
at the host parasite interface. When CD103 is genetically deficient there is no 
accumulation of Tregs at the site of infection, and animals on a susceptible genetic 
background now become resistant to this infection (Suffia et al., 2005). Induction of 
CD103 is dependent on TGF-β (Robinson et al., 2001) and is, therefore, 
predominantly expressed in the mucosal tissues of naïve animals. 
 
 
1.5.2 Induced Tregs. 
 
As stated above, Tregs can also be generated in the periphery when naïve 
conventional CD4+ T cells differentiate in an appropriate cytokine milieu. These 
Tregs, termed inducible Tregs, were initially characterised as T regulatory 1 (Tr1), or 
Th3 cells. More recently, it has also been discovered that Foxp3+ Tregs can also be 
induced in the periphery. 
 
Tr1 cells  
Human and murine Tr1 cells can be induced in vitro by, chronic activation of CD4+ 
T cells in the presence of IL-10 (Groux et al., 1997), co-culture with tolerogenic DCs 
(Enk et al., 1993; Steinbrink et al., 1997), or with a combination of the 
immunosuppressive drugs vitamin D3 and dexamethasone (Barrat et al., 2002). 
These cells are characterised by their limited proliferative capacity, high levels of IL-
10 and TGF-β production, low levels of IL-2 production, and lack of IL-4 
production. The ability of Tr1 cells to act as Tregs, in vivo, is demonstrated by the 
prevention of colitis development, in a murine model, when they are adoptively 
transferred (Groux et al., 1997).  
Tr1 cells have now been identified in human studies in a number of settings, 
such as bacterial infection of the respiratory tract (McGuirk et al., 2002) malaria 
infection (Jangpatarapongsa et al., 2008), and during periods of high dose bee venom 
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exposure amongst beekeepers (Meiler et al., 2008). Moreover, it has been shown that 
steroid resistance in some asthmatics is associated with a failure of Tr1 cells to 
secrete IL-10 in response to dexamethasone treatment (Xystrakis et al., 2006).  
Although not formally identified, given that elevated IL-10 production, 
chronic antigen exposure, and the presence of DCs with a tolerogenic phenotype, are 
all associated with helminth infection, it seems likely that some of the T cell derived 




Th3 cells are the least well understood of the induced Treg subsets. They can be 
generated in vitro in the presence of TGF-β, and IL-4, and are classified by 
production of high-levels of TGF-β but, unlike Tr1 cells, no IL-10 (reviewed by 
(Weiner, 2001). Their generation has been described at mucosal sites during oral 
tolerance regimes where it is hypothesised that clonal deletion, via apoptosis, leads to 
release of TGF-β from dying T cells, and perhaps DCs and macrophages (reviewed 
by (Faria and Weiner, 2005). Transfer of these cells, in vivo, can rescue IL-2 
deficient animals from autoimmunity by a mechanism that involves induction of 
Foxp3+ T cells (Carrier et al., 2007). It is currently unclear whether some Th3 cells 
may also represent peripherally induced Foxp3+ Tregs. 
 
Induced Foxp3+ T cells 
As mentioned previously, Foxp3 expression can be switched on in naïve CD4+ T 
cells when they are stimulated to proliferate, in vitro, in the presence of TGF-β 
(Chen et al., 2003). This process can be augmented if, exogenous IL-2 (Davidson et 
al., 2007), or the vitamin A metabolite, retinoic acid (RA) is included in these 
cultures (Coombes et al., 2007; Sun et al., 2007). Foxp3 induction has now been 
demonstrated in several models, in vivo, including, antigen delivery under 
subimmunogenic conditions (Apostolou and von Boehmer, 2004), targeting of 
antigen to DEC205+ DC subsets (Kretschmer et al., 2005), and adoptive transfer of 
TCR transgenic cells followed by antigen feeding at mucosal sites (Sun et al., 2007). 
RA may be especially important to induction in this final situation, as a subset of 
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CD103+ DCs in the lamina propria (LP) have been shown to favour vitamin A 
metabolism into RA (Sun et al., 2007). Interestingly, RA does not act directly on the 
naïve T cell to induce Foxp3 but indirectly modulates this process by limiting 
production of cytokines including IL-4, IL-9, IL-21, and IFN-γ, from a subset of Teff 
cells (Hill et al., 2008). Again as is the case for Tr1 cells, although Foxp3 induction 
has not been explicitly observed in helminth infection, it is probable that a 
combination of chronic low level antigen exposure, and high TGF-β expression, 
would support this process. It is as yet unclear whether induced Tregs are as stable as 
natural Tregs. In vitro, at least, induced Foxp3+ Tregs lose their expression of this 
marker when restimulated (Polansky et al., 2008). Furthermore, TGF-β in 
combination with IL-6 has been shown to generate Th17 cells (Bettelli et al., 2006). 
This may provide a mechanism in vivo of switching from a regulatory to an effector 
phenotype. 
 
Foxp3+ T cells have been shown to expand in H. polygyrus (Wilson et al., 2005), B. 
malayi (McSorley et al., 2008), and L. sigmodontis infection (Taylor et al., 2008). It 
is not yet known to what extent this represents expansion of natural Foxp3+ Tregs, or 
de novo induction of Foxp3 in naïve T cells. Moreover, it is unclear whether some of 
this expansion represents manipulation by the parasite to favour its persistence. In L. 
sigmodontis infection, resistance to the helminth can be increased by depleting 
Foxp3+ Tregs (Taylor et al., 2005). In addition to increased Foxp3 Treg numbers the 
suppressive ability, in vitro, per unit number of Tregs is increased during H. 
polygyrus infection (Finney et al., 2007). 
 
1.5.3 Other regulatory cell-types. 
 
Despite much of the research regarding immunoregulation being focussed on the role 
of CD4+ Tregs, many other cell-types are capable of limiting effector responses. 
These include DCs, and Mφs, through their production of TGF-β, and IL-10, and 
other adaptive cell populations CD8+ Tregs, and regulatory B cells (Bregs). 
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1.5.4 CD8+ T cells 
 
Although CD8+ Tregs were first described almost 40 years ago (Gershon and Kondo, 
1970) they have been much less studied than CD4+ Tregs, in part because of the lack 
of a characteristic marker. CD8+ Tregs, like CD4+ Tregs, have similar surface 
receptor expression to activated T cells, including upregulation of CD25 and CD122 
(IL-2Rβ). These Tregs have been shown to act via a similar array of mechanisms to 
CD4+ Tregs including direct killing of the target cell, altering the APC population, 
and secreting immunosuppressive cytokines (reviewed by (Smith and Kumar, 2008). 
One subset of CD8+ Tregs that have been examined in a number of models are the 
CD8αα+TCRαβ+ population (reviewed by (Smith and Kumar, 2008). These occur 
naturally in the mouse model of multiple sclerosis, experimental autoimmune 
encephalomyelitis (EAE), and expand during the course of disease (Tang et al., 
2006). In this situation mAb activation of this population can effectively prevent 
development of EAE (Tang et al., 2007).       
 Although CD8αα+TCRαβ+ T cells only make up a small proportion of the 
total T cell population in the lymph nodes and spleen, they make-up a major 
percentage of the intra-epithelial lymphocytes (IELs) in the gut (reviewed by 
(Lefrancois and Lycke, 2001). In a murine colitis model, transfer of these cells was 
able to protect against disease in an IL-10 independent manner (Poussier et al., 
2002). Interestingly then, in respect to this, it has been suggested that during the 
course of H. polygyrus infection a CD8+ Treg population is induced, and that these 
cells are important in the observed ability of this parasite to reduce colitis in IL-10-/- 
mice (Metwali et al., 2006). Given that this helminth dwells in the gut, and that the 
effects of CD8αα+TCRαβ+ are IL-10 independent, it is a distinct possibility that 
these CD8+ Tregs are derived from this subset.  
Generation of CD8+ Tregs have also been implicated as inhibiting immune 
responses to a number of other helminth parasites including, S. mansoni (Pedras-
Vasconcelos and Pearce, 1996), Echinococcus multilocularis (Kizaki et al., 1993), 
and B. pahangi (Owhashi et al., 1990). 




Bregs have been reported to play an important role in a number of mouse models of 
immune-related disorders, in particular EAE, colitis, and diabetes (reviewed by 
(Mauri and Ehrenstein, 2008).   As is the case for CD8+ Tregs, the Breg phenotype is 
also poorly defined. It is clear that certain B cell subsets are responsible for 
production of high levels of the immunosuppressive cytokine IL-10, such as B1 cells 
in the peritoneal cavity (O'Garra et al., 1992), and B2 lineage marginal zone B cells 
(Brummel and Lenert, 2005), and that in situations of chronic intestinal 
inflammation, IL-10 producing CD1d positive B cells are generated (Mizoguchi et 
al., 2002).   
 During S. mansoni infection a population of IL-10 producing B cells is 
evident that are proposed to have a regulatory role, since B cell deficiency in this 
model is associated with increased disease severity (Jankovic et al., 1998). The fact 
that these B cells are regulatory is further testified to, by transfer experiments in 
which they were shown to reduce allergic symptoms in an airway hypersensitivity 
model (Smits et al., 2007), and protect against experimentally induced anaphylaxis 
(Mangan et al., 2004). 
B cells may additionally be important in aiding the peripheral induction or 
maintenance of Foxp3 expression in CD4+ T cells. Delayed emergence of Foxp3+ 
cells in the CNS during the recovery phase of EAE was associated with B cell 
deficiency (Mann et al., 2007), whilst in the resting state B cells have been shown to 
expand the CD4+CD25+Foxp3+ T cell population via a TGF-β3 dependent 
mechanism (Shah and Qiao, 2008). Gut-dwelling helminth infections, including H. 
polygyrus and T. muris, are associated with influx of B cells to the sites of infection, 
as well as MLNs (Parker and Inchley, 1990; Little et al., 2005). An important aspect 









Although first identified in Th2 cells, as a factor that suppressed synthesis of Th1 
cytokines (Fiorentino et al., 1989), IL-10 has since been shown to be produced by a 
number of innate and adaptive cell-types including DCs, macrophages, and various 
B, and T cell subsets. IL-10 is known to regulate the immune response by targeting a 
number of cell populations. It is able to limit activation of DCs, and Mφs, inhibiting, 
MHC class II and costimulatory molecule expression, along with secretion of the 
proinflammatory cytokines, IL-6, IL-12, and TNF-α (reviewed by (Moore et al., 
2001), thus, indirectly affecting T cell priming. Additionally, IL-10 is able to act 
directly on Th1 and Th2 cells to both prevent their proliferation and cytokine 
production, and to induce Tr1 cells (Section 1.5.2). 
 In a number of situations, IL-10 has been reported to act in an autocrine 
manner to mediate its effects. For example, IL-10 released by DCs can further reduce 
their ability to make chemokines, inhibiting trafficking to lymph nodes, and hence 
abolishing productive interactions with T cells (Demangel et al., 2002). Also, the co-
production of IL-10 by Th2 (Del Prete et al., 1993), and as has been more recently 
described, by Th1 cells (Jankovic et al., 2007), is likely to feed back to suppress their 
own effector functions.   
 Testifying to the importance of IL-10 as an immunoregulatory cytokine, 
depletion, or inhibition of activity, early in infection is frequently associated with 
improved parasite killing. This is demonstrated in Mycobacterium avium infection, 
where ablation of IL-10 signalling in BALB/c mice leads to better control of the 
pathogen in this normally susceptible strain (Roque et al., 2007). However, this is not 
the case in all settings, and particularly gut-helminth infection, as early mAb 
inhibition of IL-10R signalling, or genetic deficiency of IL-10, during T. spiralis 
establishment, favours adult worm persistence (Helmby and Grencis, 2003). This 
was associated with increases in Th1 and Th2 cytokine production, suggesting that 
IL-10 controls both of these effector cell subsets at mucosal surfaces. Failure to expel 
T. spiralis was explained by abnormal maturation and development of mast cells, a 
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process that requires IL-10. A similar situation is observed when IL-10-/- animals are 
infected with T. muris, where Th2 responses are ultimately inhibited and worm 
clearance does not occur, leading to severe Th1-mediated immune pathology (Schopf 
et al., 2002). Interestingly, in the case of T. spiralis the effects of IL-10 were tissue 
specific, as although adult worm burden was enhanced, tissue-dwelling larval load 
was decreased. 
 Targeting of IL-10 mediated effects, typically at later time points in 
infection, rather than aiding in resolution of infection can also enhance immune 
mediated pathology. This is exemplified in murine models of schistosome infection 
where Th1 or Th2 mediated pathology is significantly accentuated in the absence of 
IL-10 (Hoffmann et al., 2000). IL-10 production must, therefore, be temporally and 
spatially controlled to initially allow proinflammatory mechanisms to clear the 





TGF-β plays an important role in many different biological processes, including 
development, apoptosis, wound repair, and regulation of immune responses. In the 
immune system this importance is demonstrated by the severe autoimmune 
conditions developed by TGF-β1 knock-out mice (Kulkarni et al., 1993). TGF-β is 
produced by a wide variety of haematopoietic and non-haematopoietic cell types, 
such as DCs, macrophages, T cells, thymic epithelial cells, and smooth muscle cells. 
It is a member of a large superfamily of TGF-β-like molecules that include, bone 
morphogenetic proteins (BMPs), inhibins, and activins. TGF-β is originally 
translated as a pre-pro-protein that must undergo a number of different steps to 
become an active cytokine (Annes et al., 2003). These include removal of a signal 
peptide in the Golgi apparatus and subsequent cleavage at a tetrabasic protease site 
by furin. Although the pro- and active domains are cleaved separate units, the pro-
domain (termed latency-associated peptide (LAP)), remains non-covalently 
associated with the TGF-β. 
 32 
 For TGF-β to be able to bind to its receptor, the LAP must be either 
degraded, or dissociated. In vitro, this is routinely achieved by heat, or acid 
treatment. However, in vivo, a number of enzymes, often those also associated with 
tissue damage, have been shown to mediate this process. These include, plasmin, 
matrix metalloprotease -2 and -9, and thrombospondin-1 (Lawler et al., 1998; Annes 
et al., 2003). Furthermore, activation of this latent TGF-β to its active form also 
requires integrin binding in vivo. Of particular relevance to the immune response is 
the integrin αvβ8, which, when specifically knocked-out on DCs, leads mice to 
develop a phenotype indistinguishable from TGF-βR deficiency (Travis et al., 2007). 
 Another interesting feature of TGF-β processing is that TGF-β isoforms (of 
which there are three in mammals) are able while in their latent form to homo- or 
hetero- dimerise and associate with latent TGF-β binding proteins, whilst in the 
Golgi. The resulting large latent complex (LLC) attaches to the extracellular matrix, 
sequestering latent TGF-β in tissues ready to be rapidly activated when needed 
(Annes et al., 2003). Once activated TGF-β binds to its heterodimeric receptor 
composed of TGF-βRI/ALK-5 and TGF-βRII to initiate a well-characterised 
signalling cascade (ten Dijke and Hill, 2004). 
 Aside from playing a role in generating Foxp3+ Tregs in both the thymus and 
periphery, and hence suppressing effector responses, TGF-β can modulate the 
responses of many different immune cell types. Like IL-10, it is able to inhibit the 
ability of DCs (Fainaru et al., 2007), and macrophages (reviewed by (Ashcroft, 1999) 
to become activated, as well as limiting mast cell function by down-regulating FcεRI 
expression (Gomez et al., 2005). 
 In vivo during schistosome infection TGF-β and IL-10 may act redundantly 
to establish the balance point between parasite clearance and unwanted 
immunopathology. When mice were treated with mAb to TGF-β alone only marginal 
effects on hepatic inflammation were observed, but in tandem with mAb to IL-10R, 
severe pathology was apparent, which was far greater than that observed with IL-




1.7 Immunomodulation by helminth-derived products. 
 
In order to favour their persistence helminths are thought to release a variety of 
products that modulate the immune response generated by the host. A common 
feature of chronic helminth infection is a skewing of the immune response towards 
its regulatory arm, suppressing the Th2-type response, and thus preventing expulsion 
of the parasite (reviewed by (Maizels and Yazdanbakhsh, 2003; Dzik, 2006). One 
group of helminth-derived products that are likely to be important in mediating this 
suppression are products released by the parasite at the host:pathogen interface 
termed Excretory-Secretory products (ES). Studies have, typically, focussed on 
either characterising the gross immunomodulatory effects of ES, or pin-pointing 
specific proteins present in ES and elucidating their function. This process has been 
aided recently by the burgeoning amount of helminth sequence data, making it 
possible for proteomic techniques to be used to rapidly identify the major ES 
components of many organisms.  
 Functional analysis of helminth-derived products has been undertaken in a 
wide-range of settings, and from this body of work, amongst other cell-types, 
specific modulation of DCs, basophils, macrophages, neutrophils, and mast cells, is 
apparent. One interesting, but rarely discussed issue, arising from phenotyping 
helminth-derived products in this manner, is whether the modulation of cellular 
activity observed represents a suppression of the effector response, supporting 
parasite persistence (as is usually assumed) or bias towards a Th2-type response, 
aiding in host expulsion. This concept is perhaps best exemplified by considering a 
common feature of helminth-derived products on DCs; inhibition of normal cytokine 
production in response to inflammatory stimuli. When BMDCs are stimulated with 
Th1/17-driving bacterial components in combination with helminth-derived products 
that include SEA (Cervi et al., 2004), H. polygyrus 24 hr ES (Segura et al., 2007), or 
N. brasiliensis ES (NES) (Balic et al., 2004) suppression of cytokine release, in 
particular IL-12p70, towards the bacterial components is apparent. This inhibition 
could be predictive of the parasite products pushing the DC into a hyporesponsive 
state, in which its ability to induce any type of response, including Th2-type 
response, is impaired. Alternatively, impairment in Th1/Th17-associated cytokine 
expression by the DC may be an appropriate host response upon recognition of 
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helminth molecules to decrease production of secreted mediators that oppose 
generation of a protective Th2-type response. A necessity for the latter response 
would seem plausible given that invasion of many helminth parasites is associated 
with simultaneous exposure to bacteria (Section 1.3.4). As yet there is no conclusive 
data to imply which of these possibilities is the case, or indeed whether both are 
concurrently at play.  
 Adding to the conceptual complexity of this situation is the prospect that 
polarisation of a Th2-type response could also be considered an immunomodulatory 
tactic by the worm. As discussed previously, Th2-type responses are not always 
protective to helminth parasites so in some situations products that bias towards this 
immune polarisation status may aid in parasite persistence. Moreover, Th1/17-type 
responses to helminths can be associated with severe immunopathology, modulation 
towards a Th2-type response may, therefore, improve host fitness providing a better 
long-term reservoir for parasite transmission. If considered from this perspective 
then the mixture of products generated by the helminth must integrate to strike a 
delicate balance between polarising a Th2-type response, whilst simultaneously 
inducing regulation such that expulsion does not occur.   
In the next section the effects of numerous helminth-derived products, but 
particularly ES, in modulating the immune response will be discussed. Attention will 
be paid to the issue of which products are most likely to aid in host recognition and 
Th2 induction, to limit the Th2-type response directly, or to bias toward a dominant 
regulatory component.         
 
1.7.1 Proteases and protease inhibitors. 
 
Proteases hydrolyse peptide bonds to catalyse a broad spectrum of biological 
reactions, playing important roles in a diverse array of processes, including blood 
coagulation, fibrinolysis and tissue remodelling. Depending on the chemical group in 
their active site proteases can be separated into four major classes: metallo, aspartic, 
serine, and cysteine. Although proteases are integral to the development of free-
living nematodes, for instance in digesting the cuticle during moulting, parasitic 
 35 
helminths appear to have evolved to secrete proteases that aid in their establishment 
and persistence in the host (reviewed by (McKerrow et al., 2006). 
 A stage of helminth lifecycles during which proteases are commonly 
excreted-secreted is during invasion of the host. All major classes of protease are 
present in the ES of the infective L1 larvae of T. spiralis (Moczon and Wranicz, 
1999; Lun et al., 2003). These may aid larval penetration of epithelial cells in the 
absence of any obvious mechanical means of doing so, such as oral appendages or a 
stylet. In particular, metalloendoproteases, that can hydrolyse components of the 
extracellular matrix e.g. collagen, make-up a substantial proportion of the protease 
pool of this ES (Lun et al., 2003). Similarly, the L3 larvae of O. volvulus that migrate 
through cutaneous tissue after entry through the blackfly bite site, and the 
microfilariae that travel from subcutaneous nodules to the skin, have protease 
activity in their ES (Haffner et al., 1998). This ES contains both serine and 
metalloproteases that are capable of degrading components of the dermal 
extracellular matrix, which can be predicted to help in migration of these different 
lifecycle stages to their target destinations. 
 Aside from invasion, another important process to parasitic helminth 
survival, which requires proteases, is feeding. The human hookworm, N. americanus, 
and the ruminant nematode Haemonchus contortus, are known to feed on blood, and 
tissue exudates. The adult ES from N. americanus and H. contortus contain a number 
of proteases, some of which are thought to degrade host tissue whilst others have 
anti-coagulent properties (Karanu et al., 1993; Brown et al., 1995).  Interestingly, H. 
contortus adult ES cysteine proteases may play an additional role in feeding of this 
parasite; extra corporeal digestion of the blood meal. This was implicated from in 
vitro experiments in which cysteine protease inhibitors were shown to block 
degradation but not uptake of radiolabelled haemoglobin by adult H. contortus 
(Fetterer and Rhoads, 1997).  
 In concert with proteases, parasitic helminths also release protease inhibitors. 
A probable explanation for this is that, although proteases often have a high degree 
of substrate specificity, their activity needs to be tightly regulated in order to prevent 
collateral damage to both the host and worm. The potential harm that uncontrolled 
protease activity can cause to the helminth is evidenced by the efficacy of plant-
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derived cysteine proteases in destroying the cuticle of H. polygyrus in vitro, (Stepek 
et al., 2005) and bringing about its expulsion in vivo (Stepek et al., 2007). It seems, 
however, that parasitic helminths may release protease inhibitors as method to 
modulate aspects of the host environment that may be detrimental to their survival. 
Some of the earliest data suggesting this comes from extracts of the human parasitic 
nematode, Ascaris lumbricoides, which dwells in the intestinal tract, that were found 
to contain inhibitors of the common digestive proteases, pepsin and trypsin 
(reviewed by (Knox, 2007). Other protease inhibitors are thought to have effects on 
the immune response, such as cysteine protease inhibitors (CPIs), termed cystatins. A 
cystatin from B. malayi, Bm-CPI-2, was found to inhibit protease-dependent 
processing of antigen in the MHC class II presentation pathway, limiting the ability 
of APCs to present T cell epitopes (Manoury et al., 2001). Altering the presentation 
capability of APCs in this manner would presumably prevent worm antigens being 
displayed in an infection setting, thus favouring persistence by preventing a T cell 
response being generated against the parasite. Since basophil initiation of Th2-type 
responses can be activated in a manner that is dependent on cysteine protease activity 
(Sokol et al., 2008) an as yet untested mechanism by which cystatins could function 
is by blocking activation of this pathway. This could potentially not only inhibit 
parasite cysteine proteases, which has been suggested as a method used by the host 
to detect and respond to worms, but also inhibit host proteases that might further 
contribute to basophil activation.   
 Alongside cystatins, serine proteases known as serpins (SPNs) have also been 
described as having effects on immune cells. Again identified in B. malayi, Bm-
SPN-2, which is secreted by the microfilarial stage of the parasite, inhibits two 
human neutrophil-derived serine proteases, cathepsin G, and elastase (Zang et al., 
1999). Cathepsin G is a chemoattractant for T cells and monocytes (Chertov et al., 
1997), whilst elastase may be able to break down parasite membrane proteins. 
Consequently, by producing an inhibitor of these proteases the helminth may limit 
immune cell recruitment to the host:parasite interface and prevent neutrophil- 
mediated parasite killing. 
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1.7.2 Chitin and chitinases. 
 
Chitin, is an abundant polymer found in various fungi, bacteria, arthropods and 
helminths. It has been shown that intranasal administration of chitin leads to 
accumulation of eosinophils and basophils in the lung, as well as rapid alternative 
activation of macrophages, suggesting that detection of chitin may itself drive Th2-
type polarisation (Reese et al., 2007).   
Throughout development of the helminth parasite chitinases are reported to 
play important roles in breakdown of various structures, such as the egg-shell 
(Arnold et al., 1993). Whilst in the intermediate host L3 filarial helminths stockpile 
chitinases, which are expelled upon entry into the vertebrate host (Adam et al., 
1996). Previously, an implied function for these chitinases was to aid movement of 
the parasite through the tissues by breaking down the extracellular matrix. However, 
given the ability of chitin to induce the Th2-type response in vivo, an alternative 
possibility is that the helminth releases chitinases to break down residual chitin that 




Acetylcholine is a neurotransmitter associated with the neuromuscular system of 
helminths. In order to terminate neuronal signals hydrolysis of acetylcholine is 
mediated by acetylcholinesterase (AchE). AchE has been identified in the ES of 
many gut-dwelling nematodes, including H. polygyrus (Lawrence and Pritchard, 
1993), N. brasiliensis (Grigg et al., 1997), and H. contortus (Sutherland and Lee, 
1993). It has been proposed that their secretion may hydrolyse acetylcholine from the 
host’s enteric nervous system. Since acetylcholine mediated signalling is required to 
stimulate chloride secretion and mucus secretion in the intestine this production of 
AchEs may inhibit fluid increases in the gut that are detrimental to parasite 
persistence.   
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1.7.4 Metabolic enzymes and metabolite binding proteins. 
 
Obviously, helminth parasites express a variety of enzymes involved in metabolic 
processes necessary for their growth and survival. Some metabolic enzymes seem to 
be selectively released into the ES, raising the question as to whether they may have 
immunomodulatory activity. One such enzyme is triose phosphate isomerase (TPI), 
which is a major component of B. malayi adult ES (Hewitson et al., 2008), and has 
also been idenitified in ES from schistosome larvae (Coustau et al., 2003).  
 Another glycolytic enzyme found in ES is enolase, and it has been suggested 
that this too may have immunomodulatory activity. Enolase from the trematode 
Fasciola hepatica is able to bind to human plasminogen in vitro, implying that a 
function of this enzyme, aside from glycolysis may be as a receptor for this molecule 
(Bernal et al., 2004). This has been suggested to enhance the activity of plasminogen 
and increased plasminogen-mediated proteolysis would favour breakdown of host 
extracellular matrix thereby aiding in establishment of the parasite. 
 Retinol appears to be an important vitamin for a variety of developmental 
processes in helminths. Several in vitro studies have demonstrated uptake of 
radiolabelled retinoic acid (RA), by helminths, including B. malayi (Wolff and Scott, 
1995). Furthermore, in vivo depletion of vitamin A led to retarded development of 
Mfs in L. sigmodontis infected cotton rats (Storey, 1982). Interestingly, inside the 
onchocercal nodule the concentration of retinol is estimated to be around eight-fold 
higher than in the surrounding tissue environment. A way in which this differential 
may be achieved is by secretion of retinoid-binding proteins (RBP), in O. volvulus 
known as Ov-fatty acid receptor (FAR)-1. As well as sequestering retinol for the 
parasite these type of molecule could play another role in immunomodulation. As 
described (Section 1.5.2), RA can synergise with TGF-β to induce Foxp3+ Tregs. It 
is an as yet unexplored possibility that RBPs could enhance vitamin A uptake by host 
tissues to favour conversion to RA and thus enhance Foxp3+ Treg induction.  
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1.7.5 Glycans, lectins and lipids. 
 
The ES from helminth parasites is rich in glycoproteins and lipids. These products 
have been described in a number of settings as interacting with PRRs, such as Toll-
like receptors (TLRs), as well as C-type lectins in the case of glycoproteins. One 
well-characterised example of these is lacto-N-fucopentaose III (LNFPIII) a glycan 
found in SEA that is also present in milk (reviewed by (Thomas and Harn, 2004). 
LNFPIII interacts with TLR4 and specifically activates the mitogen-activated protein 
kinase (MAPK) protein, extracellular signal-related kinase (ERK) (Thomas et al., 
2003). DCs stimulated in this way favour Th2 polarisation of naïve T cells. This 
interaction could be a method by which host recognition of parasite invasion occurs, 
biasing towards a Th2 response. Helminth glycans can also bind to C-TLs, in a 
calcium-dependent fashion. DC-specific ICAM-3 grabbing non-integrin (DC-SIGN) 
is one such CT-L that interacts with T. canis (Schabussova et al., 2007) and 
schistosome sugar motifs (Meyer et al., 2007). Although binding to DC-SIGN by the 
peanut glycan allergen Ara h 1can favour differentiation of naïve T cells to a Th2-
phenotype by the DC it is not clear whether this occurs in response to these helminth 
products (Shreffler et al., 2006). 
 As well as helminth glycans binding to host CT-Ls, parasite CT-Ls, and S-
type lectins, also known as galectins, have been identified in helminth ES. T. canis 
L2 larvae produce the CT-Ls, TES-32 and TES-70 (Page et al., 1992), whilst adult B. 
malayi ES contains galectins (Hewitson et al., 2008). Whether lectins are important 
in immune evasion is still unclear but many hypotheses have been put forward as to 
their function. These include: inhibiting binding of leukocytes to selectin ligands that 
are upregulated when tissue is damaged; limiting glycan-recognition dependent 
infiltration of immune cells into sites of inflammation (Loukas et al., 2000); altering 
the nature of the highly glycosylated mucin barrier in the gut; and tissue recognition 
allowing the helminth to establish itself at a particular site. Another intriguing 
possibility is that galectins may be able to directly affect T cells to drive toward a 
specific type of response. This is indicated by work on mouse T cells, in which 
galectin-1 was shown to selectively induce apoptosis of Th1-differentiated cells, but 
not Th2-cells, via its interaction with specific surface glycoproteins (Motran et al., 
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2008). Whether helminth galectins are capable of mediating similar functions is still 
unknown. 
 Helminth-derived lipids, like glycoproteins, have also been demonstrated to 
interact with TLRs. Schistosome lysophosphatidyl-PS (lyso-PS), interacts with 
TLR2, and induces DCs to polarise IL-4/IL-10 producing T cells (van der Kleij et al., 
2002). Surprisingly, if the number of acyl chains was increased then DCs could be 
conditioned to induce IL-10 secreting Treg cells rather than Th2 cells, thus swaying 




A further modification that can occur to protein and carbohydrate molecules is 
addition of phosphorylcholine (PC). This occurs in both prokaryotes and eukaryotes, 
and frequently it is found on the cuticles of nematodes. Helminths also secrete 
molecules that have exposed PC moieties. The best-characterised molecule of this 
kind is ES-62, a glycoprotein from the filarial nematode Acanthocheilonema viteae 
(Harnett et al., 1989). Homologues of this protein have been found in other filarial 
nematodes including B. pahangi (Stepek et al., 2004) and B. malayi (Hewitson et al., 
2008). However, in B. malayi ES-62 was not found to be PC-rich suggesting that 
heavy use of the PC modification is not always associated with this molecule. 
 Recognition of PC by DCs and macrophages seems to be associated the 
adoption of a Th2 phenotype. Macrophages, for example, when pre-exposed to ES-
62, are impaired in their ability to produce IL-12, IL-6 and TNF-α when 
subsequently exposed to IFN-γ and LPS (Goodridge et al., 2004). To some extent 
these changes seemed to occur via interaction with TLR4 (Goodridge et al., 2005). 
However, there is also some suggestion that ES-62 may be able to impair Th2-type 
responses. It has been shown to make lymphocytes less able to proliferate in 
response to ligation of their antigen receptor (Marshall et al., 2005). Furthermore, 
ES-62-TLR4 complexes when internalised by mast cells inhibit their ability to 
degranulate in response to FcεRI ligation (Melendez et al., 2007). Interestingly, there 
is specific inhibition of TNF-α, IL-3 and IL-6, but not IL-5 and IL-13 perhaps 
suggesting they are favouring some kind of modified response. 
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1.7.7 Venom-allergen like proteins (VAL). 
 
Another group of proteins that are present in the ES of several nematodes are the 
venom-allergen like proteins (VAL). They are related to proteins first described in 
Ancylostoma caninum, Ancylostoma secreted protein (ASP), and recently they were 
described as the most highly represented protein family in the ES of A. caninum 
(Mulvenna et al., 2008). Many of these appeared to be highly glycosylated. It is 
currently unclear as to the role of VALs in the parasitic lifecycle of the helminth, 
although some possible activities have been described.  VAL proteins from O. 
volvulus have been reported to have angiogenic activity (Tawe et al., 2000), whilst N. 
americanus ASP-2 was found to induce neutrophil recruitment (Bower et al., 2008). 
Analysis of the structure of these proteins has revealed that they may have a wide-
variety of functions. They consist of a cysteine-bonded structural framework but can 
have great variability in regions outside of the core, allowing for evolution of diverse 
activities.    
 
1.7.8 Cytokine homologues. 
 
There have been a number of reports of helminths secreting homologues of host 
cytokines. One example is from T. muris, which secretes a protein that is able to bind 
to the IFN-γ receptor on lymphocytes, inducing cellular changes similar to IFN-γ 
(Grencis and Entwistle, 1997). Favouring a Th1-type response could be a method of 
preventing expulsion of the parasite by Th2-type mechanisms. 
 Homologues of macrophage migration inhibitory factor (MIF) have been 
identified in the ES of a number of helminth parasites (reviewed by (Vermeire et al., 
2008), and in many other groups of parasites. When primary structures of MIF from 
T. spiralis was compared to mouse and human MIF it was found to have (Tan et al., 
2001) 44% and 42% amino-acid identity, including many of the conserved residues. 
Moreover, B. malayi MIF despite only having a 28% primary sequence identity had 
a crystal structure that was superimposable with human MIF (Zang et al., 2002). It is 
possible that MIF may favour parasite persistence by inhibiting moncyte migration 
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local to the parasite. MIF, however, has been shown to have a wide-variety of 
functions in vivo and the main purpose of excreting this molecule could not be 
associated with this its monocyte migration inhibiting capability. Most recently it has 
been shown that parasite MIF in the presence of IL-4 can enhance alternative 
activation of Mφs (Prieto-Lafuente et al., in press). 
 The excretion of a TGF-β homologue has also been reported by B. malayi 
(Gomez-Escobar et al., 2000). Two homologues of this protein were identified 
although only one was found to be present in ES. This molecule was capable of 
activating a TGF-β responsive cell line suggesting that it would have 
immunomodulatory properties in vivo, although none were investigated. As 
discussed (Section 1.6.2), TGF-β has many effects on suppressing immune responses 




Figure 1.1 – Organisation of a Th2-type granuloma around H. polygyrus larvae 
at day 4 of a secondary challenge infection.   
 
Adapted from (Patel et al., 2009). 
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Figure 1.2 – Control of gene accessibility by MBD proteins.  
 
(A) CpG islands are not methylated and histone tails are acetylated. As a result DNA 
is loosely bound to histones and is accessible to transcription factors. 
 
(B) CpG islands are methylated, resulting in MBD binding. MBDs recruit histone 
deacetylases (HDACs) that remove acetyl groups on histone tails. 
 
 
(C) Loss of acetylation on histone tails leads to tight binding of the DNA around the 
histones  and DNA becomes inaccessible to transcription factors. 
 












CBA, C57BL/6, BALB/c, and SJL, mice used for all experiments in this thesis, were 
aged 6-12 weeks, and either purchased from Harlan (UK), or bred in-house. IL-
12/23p40-/-, IL-23p19-/-, IFN-γ-/-, TGF-βRII-/-, MeCP2-/-, and Foxp3-GFP knock-in, 
mice on a C57BL/6 background, and MBD2-/- mice on a BALB/c background, were 
also bred in-house. Mice were housed in individually ventilated cages (IVCs) during 
experiments. All experiments complied with UK Home Office guidelines. 
 
 
2.2 General Reagents. 
 
2.2.1 Complete RPMI. 
 
RPMI medium, containing HEPES (Gibco), was supplemented with 2 mM L-
glutamine (Gibco), 100 U/ml penicillin (Gibco) and 100 µg/ml streptomycin 
(Gibco), 10% heat-inactivated foetal calf serum (FCS) (Gibco), and 50 nM 2-
mercaptoethanol (Gibco). 
 
2.2.2 Serum free parasite culture media. 
 
RPMI medium, containing HEPES (Gibco), was supplemented with 1% glucose 




2.2.3 X-Vivo media. 
 
X-Vivo 15 serum free media (BioWhittaker) was supplemented with 2 mM L-
glutamine (Gibco). 
 
2.2.4 Gut wash buffer. 
 
Hanks’ balanced salt solution (HBSS) (Sigma) was supplemented with 2 mM L-
glutamine (Gibco), 100 U/ml penicillin (Gibco) and 100 µg/ml streptomycin 
(Gibco), and 5% heat-inactivated foetal calf serum (FCS) (Gibco).   
 
2.2.5 Strip Buffer 
 
Hanks’ balanced salt solution (HBSS) (Sigma) was supplemented with 5 mM EDTA 
(Gibco), 1 mM dithiothreitol (DTT) (Sigma), 2 mM L-glutamine (Gibco), 100 U/ml 
penicillin (Gibco) and 100 µg/ml streptomycin (Gibco), and 5% heat-inactivated 
foetal calf serum (FCS) (Gibco).  
 
2.2.6 DMEM/F12 media for MFB-F11 cell culture. 
 
DMEM/F12+GLUTAMAX medium (Gibco) was supplemented with 2 mM L-
glutamine (Gibco), 100 U/ml penicillin (Gibco) and 100 µg/ml streptomycin 
(Gibco), 15 µg/ml  Hygromycin B (Invitrogen), and 10% heat-inactivated foetal calf 
serum (FCS) (Gibco) for MFB-F11 cell culture. For assaying TGF-β activity 10% 
FCS was replaced with 1% FCS. 
 
2.2.7 Carbonate buffer for ELISA. 
 
Solutions of Na2CO3 (Sigma) (1 M) and Na2HCO3 (Sigma) (1 M) were made up in 
distilled water. To make 0.06 M carbonate buffer, 45.3 ml of 1 M Na2CO3 and 18.2 
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ml of 1 M Na2HCO3 were added to 936.5 ml of distilled water and the solution was 
adjusted to pH 9.6. 
  
2.2.8 FACS buffer. 
 
FACS analyses were performed with PBS containing, 0.5% bovine serum albumin 
(BSA) (Sigma), and 0.05% sodium azide (Sigma).  
 
2.2.9 ALK-5 inhibitor SB 431542. 
The ALK5 inhibitor, SB 431542, was purchased from Tocris Bioscience, dissolved 
at 10 mM in DMSO, and used at a final concentration of 5 µM. 
 
2.2.10 Lipopolysaccharide (LPS). 
 
Escherichia coli LPS (Sigma) strain 0111:B4 was made up at 1 mg/ml in sterile PBS 
(Sigma) and used at a final concentration of 1 µg/ml. 
 
 
2.3 H. polygyrus life cycle and excretory-secretory products 
(ES). 
 
2.3.1 H. polygyrus lifecycle maintenance. 
 
To maintain the H. polygyrus life cycle, CBA x C57BL/6 F1 mice were orally 
gavaged with 600 L3 larvae. From day 14 post-infection faecal pellets were collected 
from these mice, and a slurry made by mixing with distilled water and charcoal. The 
faecal slurry was then thinly smeared on moist filter paper, which was placed in a 
Petri dish. Cultures were then left for 7 days in the dark, at room temperature, after 
which time L3 larvae were collected by rinsing the filter paper with distilled water. 
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L3 larvae were then stored at 4ºC for up to two months prior to use. Before use larvae 
were washed at least three times in distilled water.  
 
2.3.2 Isolation of adult H. polygyrus. 
 
The small intestine of day 14 H. polygyrus infected animals was removed and 
opened longitudinally using scissors. The opened small intestines were then gently 
scraped using the edge of a microscope slide to loosen worms tightly associated with 
the gut wall. Intestines were subsequently placed onto the upper surface of a coarse 
nylon mesh in a Baermann apparatus (Section 3.1), filled with HBSS (Sigma). The 
Baermann was incubated at 37ºC for 3 hrs after which time most of the motile 
parasites had become separated from the gut material and collected at the bottom of 
the apparatus. Typically, adults from 20 mice were then washed 12-times under unit 
gravity in 50 ml of RPMI (this is approx. 10x the packed volume of adult worms) 
(Gibco) supplemented with 100 U/ml penicillin, and 100 µg/ml streptomycin 
(Sigma), and then incubated at room temperature for 20 min in RPMI supplemented 
with 1 mg/ml gentamycin (Gibco). After this time, parasites were washed a further 
12-times in RPMI and were then cultured to generate H. polygyrus excretory-
secretory product (HES). 
 
2.3.4 H. polygyrus excretory-secretory product (HES). 
 
Adult H. polygyrus worms were cultured in serum free parasite culture medium, at 
approximately 50 worms/ml for 21 days. After 24 hrs, and subsequently every 2-3 
days, the supernatant was removed from the parasites and replaced with fresh media. 
After this period supernatants were pooled, excluding the first 24 hrs of supernatant, 
and concentrated and diafiltrated into PBS over a 3,000 MW filter (Millipore) in an 
Amicon stirred ultrafiltration device (Millipore). Routinely, 1 l of supernatant was 
diafiltrated to 5 ml of final product. 
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2.3.5 Other parasite products. 
 
Propionibacterium acnes extract, Salmonella typhimurium extract, and Schistosoma 
mansoni soluble egg antigen were all kind gifts from Dr. A. MacDonald (University 
of Edinburgh). Nippostrongylus brasiliensis ES (NES) was produced in a similar 
fashion to H. polygyrus ES by Y. Harcus (University of Edinburgh). Live 
Teladorsagia circumcinta and Haemonchus contortus L4 stage larvae, were supplied 
by Prof. D. Knox (Moredun Research Institute, Edinburgh) and subsequently 
cultured under the same conditions as H. polygyrus adults to obtain ES. 
 
 
2.4 Cell isolation and culture. 
 
2.4.4 Bone marrow derived DC culture and adoptive transfer. 
 
Dendritic cells were derived by culturing bone marrow in the presence of GM-CSF. 
Briefly, PBS was used to flush the bone marrow from femurs and tibias and then 
homogenised by repeatedly passing through a 1.1 mm needle. Cells were plated at 
2x106 total cells in bacteriological petri dishes in 10 ml of complete RPMI 
supplemented with 20 ng/ml rGM-CSF (Peprotech). Media was replaced on days 3, 6 
and 8 of culture. On day 10 cells were harvested by gently washing with media, thus 
removing contaminating cells that were stuck on the plates. Cells were then 
incubated for 18 h in the presence of antigen, in media containing 5 ng/ml GM-CSF. 
After this time supernatants were removed, cells washed once and 5x105 cells 
transferred intraperitoneally (ip) into mice. Seven days later spleens were removed 
and 2x106 splenocytes per well, in a 96-well plate, were cultured in X-vivo media 
(Cambrex), supplemented with 2 mM L-glutamine, in the presence of HES (10 
µg/ml), SEA (10 µg/ml) or Pa (1 µg/ml) for 72 h (Section 3.2). Cytokine levels in 18 
h DC supernatants or 72 h splenocyte cultures were measured by ELISA. 
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2.4.2 Mesenteric LN and splenocyte recovery. 
 
MLNs, or spleens were mashed through 70 µm nylon filters (BD) to generate single 
cell suspensions in complete RPMI. Where necessary, red blood cells were lysed in 
suspensions using red blood cell lysis buffer (Sigma). Cells were then either used for 
FACS staining, or restimulated in complete RPMI with HES (1 µg/ml) or medium 
alone for 72 hrs at 37ºC, and antigen specific cytokine production measured by 
ELISA. 
   
2.4.3 Peyer’s patch, intraepithelial, and lamina propria, 
lymphocyte isolation 
 
The small intestine was removed from naïve or H. polygyrus infected C57BL/6 mice 
and immediately placed into a Petri dish containing pre-warmed (37ºC) sterile PBS 
(Sigma). Peyer’s patches were excised and stored in PBS on ice, until ready to 
process. Intestines were cut open longitudinally and washed with PBS to remove gut 
contents before being transferred into gut wash. Next intestines were sliced into 
approx. 1 cm pieces, which were then sucked up into a 25 ml stripette (Corning) in 
approx. 10 ml of gut wash using a Pipette aid. Media was bubbled through for 30 s, 
gut pieces decanted back into Petri dish and media disposed of. Process was repeated 
several times with fresh media until gut pieces were clean. 
 
Peyer’s patch lymphocyte isolation. 
Peyer’s patches were transferred into 15 ml of strip buffer, incubated for 20 min with 
shaking (300 rpm shaking incubator) to remove epithelial cells, and then washed in 
complete RPMI. Single cell suspensions of Peyer’s patches were made by passing 
through a 70 µm filter (BD). Cells were resuspended in Percoll 30 (GE Healthcare) 
and then carefully layered on to a Percoll gradient in a universal tube (Sterilin) with 
an upper 5 ml Percoll 40 layer and a lower 2 ml Percoll 80 layer. Gradients were 
centrifuged for 20 min at room temperature, 400 g with the brake off. After this time 
cells were recovered at the 40/80 interface and washed twice in 20 ml complete  




Intraepithelial lymphocyte (IEL) isolation. 
Cleaned gut tissue was transferred into 15 ml of Strip Buffer in a 50 ml tube 
(Corning) and incubated for 15 min at 37ºC with vigorous shaking (300 rpm in 
shaking incubator). The supernatant was decanted and stored on ice. The process was 
repeated twice more, supernatants pooled and centrifuged at 200 g to pellet. 
Recovered cells were resuspended in 20 ml of complete RPMI and passed through a 
100 µm cell strainer (BD) and then a 70 µm cell strainer (BD). IELs were then 
stained for flow cytometric analysis.  
 
Lamina propria lymphocytes (LPL). 
After stripping IELs, remaining gut tissue was washed in complete RPMI and then 
incubated for 20 min at 37ºC in 8 ml of compete RPMI containing 0.2 mg/ml 
liberase CI (Roche), again with shaking (300 rpm shaking incubator). Supernatants 
and remaining tissue pieces were then passed through a cell strainer (70 µm, BD) and 
then centrifuged at 200 g to pellet cells. Cells were resuspended in Percoll 30, and 
purified over a Percoll gradient as for Peyer’s patches.  
 
2.4.4 CD4+ T cell isolation. 
 
To purify CD4+ T cells, typically 5x107 red blood cell lysed splenocytes were 
incubated in 450 µl of complete RPMI with 25 µl of anti-CD4 (L3T4) microbeads 
(Miltenyi Biotech). Cells were then incubated at 4ºC for 15 min before being washed 
twice in 15 ml of complete media. Separation of cells that had bound beads then took 
place using a midi-MACS magnet in combination with a MACS LS separation 
column (Miltenyi Biotech). Positively selected cells were subsequently eluted from 
the column in complete RPMI, and cultured. Samples were also taken for surface 
staining to assess purity of sort by flow cytometry. 
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2.4.5 CFSE and CMTMR labelling. 
 
MACS purified CD4+ cells were washed and resuspended in PBS with 0.1% BSA 
(Sigma) at a concentration of 1x107 cells/ml. CFSE (carboxyfluorescein diacetate 
succinimidyl ester) (Invitrogen) was then added to a final concentration of 5 µM, or 
CMTMR (5-(and-6)(4-chloromethyl-benzoyl-amino-tetramethyl-rhodamine)) 
(Invitrogen) to a final concentration of 20 µM, in the cell solution and thoroughly 
mixed. Cells were incubated for 15 min at 37ºC, and then washed once in complete 
RPMI before being resuspended in 5 ml of complete RPMI and incubated for a 
further 30 min at 37ºC to allow the labels to completely incorporate. Following this 
cells were washed twice more and then used for in vitro culture.     
 
 
2.5 SDS-PAGE and silver staining. 
 
For SDS-PAGE, 5 µl of 4x NuPAGE LDS sample buffer (Invitrogen) with 5% 2-
mercaptoethanol (Sigma) was added to a 5 µg sample of HES made up to 15 µl with 
distilled water. Samples were heated for 5 min at 95ºC and then separated on a 
NuPAGE 4-12% Bis-Tris gel (Invitrogen). Gels were run in NuPAGE MES SDS 
running buffer (Invitrogen) at 200 V for 35 min. 
After running, gels were fixed (40% ethanol (Fisher Scientific), 10% glacial 
acetic acid, Fisher Scientific, in distilled water) for 30 min, and then sensitised (30% 
ethanol, 5% w/v Na2S2O3 (Sigma), 0.8 M sodium acetate (Sigma), in distilled water) 
for 30 min. Next the gel was washed with distilled water, and then incubated in silver 
reaction solution (2.5% w/v AgNO3 (Sigma) in distilled water) for 30 min before 
being washed again. Gels were allowed to develop (200 mM Na2CO3 (Sigma), 0.01% 
formalin (Sigma), in distilled water) and then stopped (40 mM EDTA-Na2 (Sigma) in 




2.6 FITC-dextran uptake. 
 
After treating with antigen for 18 hrs, DCs were harvested, washed and replated. A 
final concentration of 1 mg/ml of FITC-dextran (Sigma) was added to the cultures 
and cells incubated at either 4ºC, or 37ºC for 20 min. After this time cells were 
harvested and washed 3x in ice cold FACS buffer before surface marker staining. 
 
 
2.7 Foxp3+ Treg induction assay. 
 
CD4+ cells were first MACS-purified from splenocytes, or if an initially Foxp3-
GFP- population was required, stained for CD4-PerCP and sorted for GFP– 
population on a BD FACS Aria. Sorted cells were 5x105 cells per well in 24-well 
plates in complete RPMI. Cells were stimulated with plate-bound anti-CD3 (clone 
145-2C11, 2 µg/ml), anti-CD28 (clone 37.51, 2 µg/ml) and recombinant murine IL-2 
(20 µg/ml) (R+D, 402-ML-20) and either varying concentrations of rhTGF-β1 or 10 
µg/ml HES. After 72 h cells were removed and stained for flow cytometric analysis.  
 
 
2.8 Treg suppression assay. 
 
Following culture under Treg inducing conditions,  Foxp3-GFP positive and 
negative populations were FACS sorted; 5x104 of either population were cultured 
with the same number of FACS-sorted CD4+Foxp3–GFP– effector cells with 1x105 
irradiated APCs and 2 µg/ml anti-CD3. Responder cells were stained with 1 ml of 
20 µM CMTMR. Cells were then washed and cultured.  After 90 h, cells were 




2.9 MFB-F11 bioassay. 
 
MFB-F11 cells (Tesseur et al., 2006) are a mouse TGF-β1-/- fibroblast cell-line that 
have been stably transfected with a plasmid containing a TGF-β-responsive secreted 
alkaline phosphatase reporter construct. For the bioassay, cells were allowed to 
adhere to a 96-well flat-bottomed tissue culture plate at 4x104 cells/well for 4 hrs in 
complete DMEM/F12.  After the 4 hr period complete DMEM was removed, cells 
washed with PBS, and 50 µl samples added to each well, made-up in DMEM/F12 
assay media (1% FCS. MFB-F11 cells were then incubated for 21 hrs with samples 
and after this time 10 µl of each supernatant removed to detect SEAP activity. SEAP 
was detected using the Great EscAPe SEAP chemiluminescence kit 2.0 (ClonTech) 
as per manufacturer’s instructions and read on a LUMIstar luminometer (BMG 
Biotechnologies).  
 
2.10 Detection of cytokines by ELISA. 
 
Cytokine levels were detected in culture supernatants by enzyme-linked 
immunosorbent assay (ELISA). Plates were first coated with monoclonal capture 
antibodies by adding 50 µl of carbonate buffer containing antibody at concentration 
stated (Table 2.1) to each well of an ELISA plate (NUNC, Immunoplate MaxiSorp, 
NUNC) and incubating overnight at 4ºC. The next day carbonate buffer was flicked 
off and plates blocked for 2 hrs at 37ºC with 200 µl/well of TBS with 0.05% Tween 
and 10% FCS. 
 After blocking, plates were washed 5x in TBS with 0.05% Tween and then 
50 µl of sample or standard was added to each well. The standard was a twelve-point 
standard of doubling dilutions starting at the concentrations stated (Table 2.1), made 
up in the same media that had been used for cell culture. Plates were then left to 
incubate overnight at 4ºC. 
 Following incubation, samples were flicked off and plates washed 5x with 
TBS with 0.05% Tween. Biotinylated detection antibodies were then added, 50 µl 
per well, and plates incubated at 37ºC for 1 hr (Table 2.1). After this time plates were 
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washed as previously, 50 µl of streptavidin-alkaline phosphatase (1:10,000)(Sigma) 
added to each well, and incubated for a further 45 min. 
 Finally, plates were washed 3x with TBS with 0.05% Tween, and 2x with 
distilled water, before adding 100 µl of p-nitrophenyl phosphate (pNPP) substrate to 
each well. After colour had developed optical densities were measured using an 
Emax precision microplate reader (Molecular Devices).    
 
 
















IFN-γ  50 ng/ml R46A2, in house 2 µg/ml BVD6-24G2, BD 5 µg/ml 
IL-4  10 ng/ml 1B11, in house 2 µg/ml TRFK4, BD 2 µg/ml 
IL-6 100 ng/ml MP5-20F3, BD 2 µg/ml MP5-32C11, BD 0.5 µg/ml 
IL-10  20 ng/ml JES5-2A5, BD 4 µg/ml SXC-1, BD 2 µg/ml 
IL-12p40 100 ng/ml C15.6, BD 2 µg/ml C17.8, BD 0.5 µg/ml 
IL-12p70  20 ng/ml 9A5, BD 4 µg/ml C17.8, BD 0.5 µg/ml 
IL-13 20 ng/ml 38213, R&D 2 µg/ml Rabbit polyclonal, 
Peprotech 
0.5 µg/ml 




2.11 Flow cytometric analysis. 
 
2.11.1 Staining surface markers. 
 
Cells were stained in 96-well round-bottomed plates. For DCs, typically 1x105 cells 
were stained per sample, and for MLNs, or splenocytes typically 1.5x106 cells. Prior 
to FACS antibody staining of cells, Fc receptors were blocked in 40 µl of FACS 
buffer containing 100 µg/ml of naïve rat IgG (Sigma) for 20 min at 4ºC. Samples 
were then washed in 200 µl of FACS buffer and stained for 20 min in 20 µl of FACS 
buffer containing antibodies at concentrations listed (Table 2.2), or appropriate 
isotype controls. After staining cells were washed twice in 200 µl of FACS buffer 
before acquisition on the LSR II flow cytometer (BD Bioscience), and subsequently 
being analysed using FlowJo (Tree Star). 
 
Table 2.2 – FACS antibodies. 
 
Antibodies Clone and Supplier Dilution Isotype Fluorochrome 
B220 RA3-6B2, BD 1/200 Rat IgG2a PerCP 
CD4 RM4-5, BD, Biolegend 1/200 Rat IgG2a FITC/PE/PerCP 
CD8 53-6.7, Biolegend 1/200 Rat IgG2a PE 
CD11c N418, Biolegend 1/200 Hamster IgG1 APC 
CD25 PC61, Caltag 1/200 Rat IgG1 PE 
CD40 3/23, BD 1/100 Rat IgG2a PE 
CD80 16-10A1, BD 1/100 Rat IgG2a PE 
CD86 GL1, BD 1/100 Rat IgG2a PE 
CD103 M290, BD 1/200 Rat IgG2a Biotin 




2.11.2 Intracellular cytokine staining. 
 
To measure intracellular cytokines, cells were first stimulated for 4 hrs at 37ºC in the 
presence of PMA (50 ng/ml) (Sigma), Ionomycin (1 µg/ml) (Sigma), and Brefeldin 
A (20 µg/ml) (Sigma). Samples were then stained for surface markers. Following 
surface staining, cells were permeabilised for 30 min at 4ºC in fix/perm solution (BD 
Biosciences), and then washed twice in 200 µl of perm/wash (BD Biosciences). Cells 
were blocked and stained for intracellular cytokine expression (Table 2.3) in the 
same manner as for surface markers but substituting perm/wash for FACS buffer. 
 
Table 2.3 – Intracellular cytokine antibodies. 
 
Antibodies Clone and Supplier Dilution Isotype Fluorochrome 
IFN-γ XM6-1.2, Biolegend 1/200 IgG1 FITC/APC 
IL-4 1B11, Biolegend 1/200 IgG1 PE 
IL-10 JES5-16E3, BD 1/200 IgG1 APC 
IL-17 TC11-18H10, BD 1/200 IgG1 PE 
   
2.11.3 Foxp3 staining. 
 
Samples were stained for surface markers. Following surface staining, cells were 
permeabilised for 18 hrs at 4ºC in fix/perm solution (eBioscience Foxp3 staining set), 
and then washed twice in 200 µl of perm/wash (eBioscience Foxp3 staining set). 
Cells were blocked and stained for Foxp3 expression (FJK-16s, isotype rat IgG2a, 
ebiosciences, 1/200 dilution) in the same manner as for surface markers but 
substituting perm/wash for FACS buffer.   
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2.12 Gene expression analysis by mRNA. 
 
2.12.1 Gut mRNA extraction. 
 
 
After removal, the small intestine of naïve or H. polygyrus infected mice was flushed 
with pre-warmed PBS (37ºC). Approximately 0.5 cm of gut (uppermost part of the 
duodenum) was removed, placed into 1 ml of Trizol (Invitrogen), and immediately 
stored at -80ºC. RNA was later extracted according to the manufacturer’s protocol 
Briefly, tissue was disrupted using a TissueLyser (Qiagen). Samples were then 
centrifuged at 12,000 g for 15 min at 4ºC, and the upper aqueous layer removed. This 
was added to 500 µl of isopropanol, mixed, and left to incubate at room temperature 
for 10 min. After this time the sample was centrifuged again at 12,000 g for 10 min 
at 4ºC to pellet the RNA. RNA was washed once in 70% ethanol, and the pellet then 
allowed to air dry before being dissolved in 50 µl of DEPC-treated water. A DNA-
free kit (Ambion) was used to degrade any remaining DNA. To do this, 2 µl of 
DNase with 2.4 µl of DNase buffer was added to 20 µl of dissolved RNA and 
incubated at 37ºC for 30 min. Subsequently, 5 µl of DNase inactivation reagent was 
added, and incubated at room temperature for 2 min before sample was spun down 
briefly and supernatant recovered. RNA concentration was determined using the 
Nanodrop 1000 (Thermo Scientific). 
 
2.12.2 Reverse transcription 
 
Reverse transcription was performed using 1-2 µg of RNA, 2 µl 10 reverse 
transcriptase buffer, 2 µl 25 mM dNTP mix, 1 µl of 50 U/µl MMLV reverse 
transcriptase, 0.5 µl of 40 U/µl RNAsin, 1 µl of 0.4 µg/ml Oligo dT primer, and 
made up to 20 µl with DEPC treated water. A PCR block (Peltier Thermal Cycler, 
MJ Research) was used for the transcription reaction, 20ºC for 10 min, 37ºC for 60 
min, and 99ºC for 5 min. 
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2.12.3 Light cycler. 
 
Relative quantification of the genes of interest were measured by real-time PCR 
using the Lightcycler 480 II (Roche). PCR amplifications were carried out in 10 µl 
total volume made up of 1 µl cDNA, 5 µl SYBR Green (Roche), 0.3 µl of each 
primer (10 µM) (Table 2.3), and 3.4 µl DEPC treated water (Ambion). The 
amplifications were performed using the following protocol: 30 s denaturation at 
95ºC, 5 s for primers to anneal at 55ºC, 12 s elongation at 72ºC, for 40 cycles.   
 
Gene Forward Primer Reverse Primer Amplicon 
Length 
Arg-1 CAGAAGAATGGAAGAGTCAG CAGATATGCAGGGAGTCACC 249 
HPRT TCCTCCTCAGACCGCTTTT CCTGGTTCATCATCGCTAATC 90 
RELMα TATGAACAGATGGGCCTCCT GGCAGTTGCAAGTATCTCCAC 107 




2.13 Statistical analysis. 
 
All statistical analyses were performed using Prism 4.0b (Graphpad Software Inc.). 
For comparisons of two groups Student’s t test was used. When three or more groups 
were analysed then a one-way ANOVA was used with a Tukey’s multiple 








Dendritic cells (DCs) provide a key link between the innate and adaptive immune 
system. This cell-type acquires antigen in the peripheral tissues and then migrates to 
the draining LNs where it can initiate antigen-specific helper T cell expansion, and 
drive these cells towards a specific helper lineage. In response to Th1-driving 
pathogens, including bacteria, and protozoa, DCs take on what is termed a ‘mature’ 
or ‘classically’ activated phenotype, characterised by upregulation of major 
histocompatibility complex (MHC) II, and costimulatory molecules CD80, CD86, 
and CD40 (reviewed by (Pulendran, 2005)). These phenotypic changes are triggered 
by both release of inflammatory cytokines such as tumour necrosis factor (TNF)-α, 
and ligation of pattern recognition receptors (PRRs) by pathogen-associated 
molecular patterns (PAMPs), for example lippopolysaccharide (LPS) detection by 
toll-like receptors (TLRs) (Fitzgerald et al., 2004). 
 When DCs are stimulated with helminth-derived products, including SEA 
(MacDonald et al., 2001), ES-62 (Whelan et al., 2000), and NES (Balic et al., 2004), 
in vitro, they become competent to stimulate Th2-polarisation. Unlike Th1-type 
pathogen products, no distinct Th2-favouring DC phenotype has been found. SEA-
pulsed DCs have a phenotype that is almost indistinguishable from an unstimulated 
DC (MacDonald et al., 2001; Kane et al., 2004), whilst NES pulsed DCs upregulate 
expression of only a limited subset of the proteins typically associated with responses 
to Th1-driving pathogens (Balic et al., 2004). 
Although DCs treated with helminth-derived products do not acquire a 
characteristic phenotype upon initial stimulation, they may be compromised in their 
ability to concurrently, or subsequently, respond to Th1-type PAMPs (Balic et al., 
2004; Cervi et al., 2004; Kane et al., 2004; Goodridge et al., 2005). This was first 
demonstrated by co-pulsing bone-marrow derived (BM) DCs with SEA, and a 
preparation derived from the heat-killed gram-positive bacterium, 
Propionobacterium acnes (Pa). Production of the Th1-driving cytokine IL-12p70 
was suppressed when DCs were co-pulsed with SEA/Pa compared to Pa alone, but 
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the anti-inflammatory cytokine IL-10 was enhanced (Cervi et al., 2004). This, and 
other similar work (Balic et al., 2004), suggested that helmith-derived products 
function by actively modulating the DC to drive a Th2-type response (Cervi et al., 
2004). Given this, it is surprising that there have been no studies addressing whether 
suppression of DC activation towards Th1-driving stimuli correlates with the potency 
of the eventual helminth-specific Th2-type response. More recently, and in 
opposition to the idea of helminth-derived products actively driving Th2 polarisation, 
it was shown that 24 hr ES from H. polygyrus suppresses antigen-specific Th2-type 
induction by DCs, possibly as an immunomodulatory tactic to prevent its recognition 
(Segura et al., 2007). 
Here the phenotype of BMDCs exposed, in vitro, to H. polygyrus ES (HES), 
and in co-treatments with inflammatory stimuli, are characterised. Subsequently, 
BMDCs are adoptively transferred, in vivo, and their ability to favour Th1, or Th2, 
polarisation assessed. Making use of a heat-inactivated form of HES (hiHES), the 
association between inhibition of phenotypic maturation and T cell differentiation is 








3.2.1 Production of HES 
 
Although there is published information on the ES from various lifecycle stages of 
several nematodes, including B. malayi (Hewitson et al., 2008), T. canis (Loukas et 
al., 2000) and N. brasiliensis (Holland et al., 2000), prior to the commencement of 
this project no work had been undertaken using the ES from adult H. polygyrus. 
Initially, therefore, methods had to be developed to both obtain adult worms in large 
enough numbers, and to maintain them for prolonged periods, to make sufficient 
quantities of H. polygyrus ES (HES) to be able to analyse its potential immune 
functions.  
 C57BL/6 x CBA F1 mice were used as hosts, since their large size and lack 
of resistance to primary infection (Chapter 4) meant that each animal could be 
infected with 600 H. polygyrus L3 larvae by oral inoculation. Fourteen days post 
infection, when the worms are fecund and have been dwelling in the gut lumen for 5-
7 days, mice were sacrificed and adult H. polygyrus isolated from the intestine using 
a modified Baermann technique (Fig. 3.1). After removal from the host, the worms 
were cultured in serum free media under similar conditions to N. brasiliensis (Balic 
et al., 2004). Typically, N. brasiliensis adults are cultured for 7 days. However, when 
assessed by microscopy, H. polygyrus were found to be viable and laying eggs up to 
day 28 of culture. 
Every 2-3 days the supernatant from the worms was collected and replaced 
with fresh media. This was then diafiltrated and concentrated over a 3,000 MW filter, 
generating what will be referred to as H. polygyrus ES (HES). To assess whether the 
HES produced was broadly similar across the entire 4-week period, pooled 
supernatant taken at each week was visualised by silver-staining on a 1D gel (Fig. 
3.1). Despite being a relatively crude way of comparing ES components, no dramatic 
differences in protein expression were noted between the various samples. On this 
basis, all subsequent batches of HES were made by concentrating pooled 
supernatants from several weeks of culture. Two further refinements were made to 
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the protocol: worms were only maintained for 3 weeks, to further ensure that 
products expelled by dying worms did not contaminate the cultures; and the first 24 
hrs of supernatant was excluded, as in the case of N. brasiliensis some carry-over of 
host proteins has been noted (Healer et al., 1991). Samples of HES were 
subsequently run on 2D gels and the protein components were found to be very 
different to those present in 2D gels of adult worm homogenate (H. polygyrus extract 
(HEx)). Implying that the HES did represent proteins selectively secreted by the 
parasite (K. Filbey, unpublished observation). 
 
 
3.2.2 HES does not induce classical DC activation 
 
The ability of HES to induce inflammatory cytokine production from, and alter 
surface phenotype of, BMDCs was first investigated. BMDCs were stimulated, in 
vitro, for 18 hrs (Fig 3.2) with either PBS, HES, heat-inactivated HES (hiHES – heat 
inactivation of HES was carried out for 30 min at 100ºC), or the TLR-4 ligand LPS, 
as a positive control. After this time, production of cytokines associated with 
classical DC activation (Fig. 3.3), and expression of surface markers (Fig. 3.4), were 
analysed. LPS, as anticipated, stimulated release of the pro-inflammatory cytokines 
IL-6, IL-12p40 and IL-12p70, and the regulatory cytokine IL-10. HES, in contrast, 
did not induce production of any of these cytokines (Fig. 3.3). Additionally, LPS 
triggered strong upregulation of the co-stimulatory molecules CD40, CD80 and 
CD86 as well as MHC class II. In comparison to LPS, HES treatment made very 
little difference to surface marker expression, although a small positive shift in MHC 
class II was apparent (Fig. 3.4). 
hiHES allows any effects of heat-stable components in the HES, (possibly 
including LPS) to be identified, by relieving potential inhibition of inflammatory 
responses that may be caused by heat-labile parasite proteins. There are unlikely to 
be major inflammatory contaminants in HES, as no cytokine production was evident 
in response to hiHES (Fig. 3.3). Moreover, although greater differences in surface 
marker expression were apparent than with HES, these where marginal when 




3.2.3 Treatment of DCs with HES does not affect antigen uptake.  
 
Even though HES did not appear to classically activate the DC it was still possible 
that an alternative form of activation had occurred. If this was the case then one 
parameter that may be altered is the ability of the DC to subsequently take up 
antigen. This was quantified, in vitro, by assessing acquisition of fluorescently 
labelled dextran (FITC-dextran) as a measure of endocytic activity (Fig. 3.5). After 1 
hr incubation at 37ºC, approx. 50% of the PBS-treated DCs had taken up FITC-
dextran. This was unaltered in cells that had been pre-incubated with HES, or hiHES, 
for 18 hrs prior to addition of the fluorescent marker. LPS, however, markedly 
inhibited uptake, with only 19.6 % of DCs found to be FITC-dextran positive. Thus, 
HES does not inhibit endocytic uptake by DCs. 
 
 
3.2.4 HES limits LPS induced DC cytokine release. 
 
There was no evidence of HES activating the DC, in terms of classical activation 
phenotype. As discussed previously, this has been described for several helminth 
products including SEA, ES-62, and NES (Section 3.1). These helminth products 
did, however, affect the ability of the DC to respond to inflammatory stimuli. It was 
possible that HES would have a similar effect. DCs were co-treated with LPS and 
increasing amounts of HES for 18 hrs. Levels of the IL-12p70, and IL-10, were then 
measured in the supernatants. HES dramatically inhibited release of the Th1-driving 
cytokine IL-12p70, in a concentration dependent manner (Fig. 3.6 A, right panel). 
This was not a general suppression of cytokine production from the DC, little effect 
on IL-10 was detected, even with high concentrations of HES (Fig. 3.6 B, right 
panel). The inhibition was dependent on heat-labile components in the HES since 
hiHES, at the same concentration as the HES maximum, did not alter LPS stimulated 




3.2.5 HES modulates LPS stimulated changes to surface 
phenotype. 
 
In concert with cytokine production, the ability of HES to alter LPS triggered surface 
marker upregulation on the DC was also analysed (Fig. 3.7). Although effects were 
not as striking as those observed for cytokine production, HES did limit, to some 
extent, upregulation of all surface markers in response to LPS (Fig. 3.8). Particularly 
affected were the co-stimulatory molecules CD40 (CD40+ DCs, LPS mean 67.7%, 
HES/LPS mean 48.6%), and CD86 (CD86 high DCs, LPS mean 89.7%, HES/LPS 
mean 76.0%). Once again, the suppressive capabilities of HES were largely 
abrogated by heat-inactivation.   
 
 
3.2.6 Inflammatory cytokine inhibition by HES is short-lived. 
 
HES suppression of cytokine release could represent a long-term change to the DC 
phenotype, or a relatively transient effect. To distinguish between these two 
possibilities, DCs were pre-incubated for 18 hrs with HES, or hiHES, washed and 
then restimulated with LPS, again for 18 hrs, at various time points (Fig. 3.9 A). 
Interestingly, at day 0, when cells were pre-incubated with HES before addition of 
LPS, rather than co-pulsed, inhibition of IL-10, as well as IL-12p70 was observed 
(Fig. 3.9 B, C). Furthermore, pre-incubation with hiHES had some suppressive 
capacity, although not as great as that of HES. 
 The ability of HES to limit LPS stimulated IL-12p70 release was short-lived. 
At day 0 (LPS added after the initial 18 hrs pre-incubation with HES) a greater than 
two-fold reduction in IL-12p70 levels was recorded, however, by d1 IL-12p70 
concentration was not different to the PBS control DCs (Fig. 3.9 B). Similar effects 
were apparent on IL-10 secretion, but some degree of suppression was still apparent 
at day 3 (Fig. 3.9 C). Surprisingly, IL-12p70 release was greater in HES treated DCs 
on day 3 than the PBS, or hiHES groups. This is possibly related to differential 
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protein expression as a result of previously being in an inhibited state. By day 5 
cytokine levels were reduced in all groups, probably as a result of cell death. 
 
 
3.2.7 HES inhibits DC activation by P. acnes extract.  
 
It has been reported, that DCs are able to segregate both Th1 and Th2 antigens into 
separate compartments and thus simultaneously induce both Th1 and Th2 responses 
(Cervi et al., 2004). These studies were performed using P. acnes extract (Pa), and 
SEA. 
To assess whether DCs were able to process HES, and a Th1-type antigen in 
a similar manner, adoptive transfer experiments were undertaken with BMDCs 
pulsed with HES, or hiHES, in combination with Pa. Groups of recipient mice were 
given intraperitoneally PBS BMDCs (A), HES pulsed BMDCs (B), hiHES pulsed 
BMDCs (C), Pa pulsed BMDCs (D), HES/Pa co-pulsed BMDCs (E), or hiHES/Pa 
co-pulsed BMDCs.  
Prior to transfer, the cytokine production from (Fig. 3.10), and surface 
phenotype of (Fig. 3.11), the DCs were assessed to confirm that HES had anti-
inflammatory properties when co-pulsed in the presence of Pa, as had been observed 
with LPS. It was possible that there would be differences in this situation since Pa is 
a complex mixture of PAMPs rather than a specific TLR-ligand. As previously HES 
and hiHES pulsed DCs showed no secretion of cytokines or upregulation of surface 
markers (data not shown).  
Pa led to increases in IL-6, IL-10, and IL-12p70, levels, along with CD40, 
CD80, CD86, and MHC class II, expression. HES inhibition of Pa induced activation 
was phenotypically almost indistinguishable from LPS. In terms of cytokine 
secretion IL-12p70, and IL-6, were limited, but IL-10 was unaffected (Fig. 3.10), 
whilst downregulation was observed for all surface markers, particularly CD40, and 




3.2.8 HES/Pa co-pulsed DCs are able to maintain segregation of 
Th1, and Th2, but not Th17 antigen specific responses. 
 
Having assessed that HES was able to alter the DC response to Pa, cells were 
adoptively transferred into recipient animals (Fig. 3.2). Seven days later, splenocytes 
from these mice were re-stimulated with HES or Pa and the production of cytokines 
associated with Th1, Th2 and Th17 polarisation measured (Fig. 3.12). Pa-pulsed DCs 
induced a Th1/Th17 response, as previously reported, whilst HES induced a Th2 
response. DCs co-pulsed with HES and Pa developed a Pa-specific Th1 response and 
a HES-specific Th2 response. No evidence of HES-specific Th1 responses or Pa-
specific Th2 responses could be observed. However, the strength of both the Th1 and 
the Th2 responses with co-pulsed DCs were reduced compared to those pulsed with 
each antigen alone.  
Interestingly, Th17 cytokines did not follow the same pattern as those 
observed for Th1 and Th2. In comparison to Pa, DCs pulsed with HES had weak Ag-
specific IL-17 production. However, in DCs co-pulsed with both Ags, HES-specific 
IL-17 responses developed that were of a similar intensity to the Pa-specific 
responses in DCs pulsed with this antigen alone. Additionally, unlike Pa-specific 
IFN-γ, Pa-specific IL-17 was not significantly reduced in co-pulsed DCs. 
Antigen-specific secretion of IL-10, a cytokine associated with regulation in 
both Th1 and Th2 settings, was also measured in the restimulated supernatants. IL-10 
was found to be produced at comparable levels in response to both HES-pulsed DCs 
and Pa-pulsed DCs. Surprisingly, given the strong IL-10 responses in the single Ag-
pulse setting, HES-specific and Pa-specific IL-10 were both dramatically decreased 
when DCs were co-pulsed with these antigens. 
 
 
3.2.9 SEA/Pa co-pulsed DCs are also unable to maintain 
segregation of Th17 antigen specific responses. 
 
The cross-induction of IL-17 production towards HES could be a general feature of 
antigen co-pulse, or be specific to HES/Pa. The same experiment was, therefore, 
performed using PBS, SEA, Pa, or SEA/Pa co-pulsed DCs (Fig. 3.13). There was no 
evidence of Th1 polarisation towards SEA, nor Th2 polarisation towards Pa in any of 
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the groups. However, an IL-17 response developed towards SEA when products 
were co-pulsed together, as was found for HES/Pa.  
 
 
3.2.10 Anti-inflammatory and Th2 driving properties of HES are 
separable. 
 
Previously, it has been suggested that suppression of the ability of DCs to make 
inflammatory cytokines by helminth products is linked to their ability to drive a Th2 
response (Cervi et al., 2004). hiHES is unable to suppress inflammatory cytokine 
production in response to Pa or LPS, and as a result it would be hypothesised to have 
reduced Th2 polarising potential. However, DCs pulsed with hiHES were able to 
drive IL-4 and IL-13 production to the same extent as HES. Moreover, there was no 
evidence of a deviation towards Th1 or Th17 polarisation and they stimulated a 
similar level of IL-10 production as HES (Fig. 3.12). 
Although hiHES induces a comparable Th2 response to HES in a single pulse 
setting it is possible that the anti-inflammatory properties are important in generating 
a Th2 response in the face of a concurrent inflammatory stimulus. The effects of 
hiHES were studied when co-pulsed with Pa. hiHES/Pa co-pulsing of DCs, like 
HES/Pa, led to induction of HES-specific Th2 responses and Pa-specific Th1 
responses. There was no discernable difference in levels of Th2 cytokines or IL-10. 
Additionally, there was no evidence of a significant Th1-specific HES response 
occurring in the hiHES/Pa co-pulsed DCs. There was, however, evidence of the 
emergence of a HES specific Th17 response that had been previously observed in 
HES/Pa co-pulsed DCs (Fig. 3.12). It appears, therefore, that the anti-inflammatory 














Figure 3.1 – Collecting H. polygyrus ES (HES). 
 
(I) CBA (M) x C57BL/6 (F) mice were inoculated with 600 Hp L3s. (II) Fourteen 
days later mice were sacrificed and worms separated from gut material using a 
modified Baermann technique. (III) Worms were thoroughly washed and cultured at 
approx 50 worms/ml in vented flasks. Every 2-3 days supernatant was collected and 
replaced with fresh media. (IV) Worms were cultured for 21 days, after which time 
supernatant was concentrated down over a 3,000 MW filter. Concentration of HES 
was measured by Bradford assay. (V) One-dimensional silver stained gel showing 







Figure 3.2 – BMDC transfer model.  
 
(I) BMDCs were generated by culturing bone-marrow cells from C57BL/6 mice for 
10 days in the presence of granulocyte macrophage colony stimulating factor (GM-
CSF). (II) DCs were then stimulated with antigens, such as HES, or Pa, for 18 hrs, 
after which time supernatants were removed for cytokine ELISAs, and cells were 
washed and intraperitoneally transferred in recipient animals. (III) 7 days later mice 
were sacrificed and splenocyte cultures restimulated with antigens. After 72 hrs of 






Figure 3.3 – HES does not induce inflammatory cytokine production by DCs. 
 
DCs were stimulated, in vitro, with PBS, HES (25 µg/ml), hiHES (25 µg/ml), or LPS 
(1 µg/ml). After 18 hrs supernatants were removed and cytokines measured by 
ELISA, IL-6, IL-10, IL-12/23p40, and IL-12p70. Detection limits: IL-6, 400 pg/ml, 
IL-10, 20 pg/ml; IL-12p70, 400 pg/ml, IL-12p40, 40 pg/ml. Error bars represent 
SEM of triplicate wells plated from the same BMDC cultures in a single experiment. 







Figure 3.4 – HES does not upregulate surface expression of DC activation 
markers. 
 
DCs were stimulated, in vitro, with PBS, HES (25 µg/ml), hiHES (25 µg/ml), or LPS 
(1 µg/ml). After 18 hrs cells were collected and their surface expression of CD40, 
CD80, CD86, and MHC class II, assessed by flow-cytometry. Black line, positive 






Figure 3.5 – HES does not alter endocytic activity of the DC. 
 
DCs were stimulated, in vitro, with PBS, HES (25 µg/ml), hiHES (25 µg/ml), or LPS 
(1 µg/ml). After 18 hrs cells were washed and then incubated at 37ºC (Black line) 
with FITC-dextran, or at 4ºC as a negative control (Solid grey), for 1 hr. Uptake of 







Figure 3.6 – HES inhibits LPS-induced inflammatory cytokine production from 
DCs. 
 
DCs were stimulated, in vitro, with PBS, LPS (1 µg/ml), LPS (1 µg/ml)/hiHES (31.6 
µg/ml) (A, B, left panels), or LPS (1 µg/ml) with increasing concentrations of HES 
(A, B right panels). IL-10, and IL-12p70, were measured by ELISA. Line on right 
panels represents cytokine released by LPS alone treated DCs. Error bars represent 
SEM of triplicate wells of DCs plated from the same original cultures. This is 






Figure 3.7 – HES inhibits upregulation of DC surface activation markers in 
response to LPS. 
 
DCs were stimulated, in vitro, with PBS, LPS (1 µg/ml), HES (25 µg/ml)/LPS (1 
µg/ml), or hiHES (25 µg/ml)/LPS (1 µg/ml). After 18 hrs cells were collected and 
CD40, CD80, CD86, and MHC class II, expression analysed by flow-cytometry. 









Figure 3.8 – HES inhibits upregulation of DC surface activation markers in 
response to LPS. 
 
Flow-cytometry data (shown in Fig. 3.7), compiled from three separate wells, plated 
from the same DC cultures. Error bars represent the SEM. This is representative of at 
least two similar experiments. Results of one-way ANOVA and Tukey’s test: n.s. = 




Figure 3.9 – HES inhibition of inflammatory cytokine production is short-lived. 
 
(A) DCs were stimulated, in vitro, with PBS, HES (25 µg/ml), or hiHES (25 µg/ml) 
in 6 well plates. After 18 hrs cells were washed and replated in triplicate wells of a 
96 well round-bottom plate. Cells were then stimulated with LPS (1 µg/ml) for 18 
hrs at various time points, beginning straight after plating (day 0), and continuing up 
to day 5. (B) IL-12p70, and (C) IL-10, were then measured in the supernatant by 
ELISA. To ensure that cells remained viable fresh media was added to non-LPS 
treated wells daily. Error bars represent SEM of triplicate wells. Results of one-way 







Figure 3.10 – HES inhibits Pa induced inflammatory cytokine production by 
DCs. 
 
DCs were stimulated, in vitro, with PBS, Pa (10 µg/ml), HES (25 µg/ml)/Pa (10 
µg/ml), or hiHES (25 µg/ml)/Pa (10 µg/ml). After 18 hrs supernatants were removed 
and cytokines measured by ELISA, IL-6, IL-10, and IL-12p70. n.d. = not detected. 
Detection limits: IL-6, 400 pg/ml, IL-10, 20 pg/ml; IL-12p70, 40 pg/ml. Data are 







Figure 3.11 – HES limits DC activation associated surface marker upregulation 
by Pa. 
 
DCs were stimulated, in vitro, with PBS, Pa (10 µg/ml), HES (25 µg/ml)/Pa (10 
µg/ml), or hiHES (25 µg/ml)/Pa (10 µg/ml). After 18 hrs cells were collected and 
CD40, CD80, CD86, and MHC class II, expression analysed by flow-cytometry. 






Figure 3.12 – Antigen specific responses driven by adoptively transferred HES, 
hiHES, Pa, and co-pulsed DCs. 
 
Seven days after DC transfer (Fig. 3.2), splenocytes were restimulated with media 
alone, HES (1 µg/ml), or Pa (1 µg/ml). 72 hrs later supernatants were harvested and, 
the Th1-associated cytokine IFN-γ, the Th2-associated cytokines IL-4, IL-13, the 
Th17-associated cytokine IL-17, and the immunoregulatory cytokine IL-10, 
measured by ELISA. Error bars represent SD of splenocytes from five separate 






Figure 3.13 – Antigen specific responses driven by adoptively transferred SEA, 
Pa, and co-pulsed DCs. 
 
Seven days after DC transfer (Fig. 3.2), splenocytes were restimulated with media 
alone, SEA (10 µg/ml), or Pa (1 µg/ml). 72 hrs later supernatants were harvested 
and, the Th1-associated cytokine IFN-γ, the Th2-associated cytokines IL-4, IL-13, 
the Th17-associated cytokine IL-17, and the immunoregulatory cytokine IL-10, 
measured by ELISA. Error bars represent SEM of splenocytes from five separate 





Treatment of DCs with helminth-derived products, and subsequent analysis of the 
type of immune response they induce, has proved a useful tool to study their 
immunomodulatory properties. Here, it has been shown that HES, as with other 
helminth-derived products, does not induce classical maturation of the DC. 
Corroborating data that have recently been published using ES released in the first 24 
hrs of H. polygyrus culture (Segura et al., 2007), DCs pulsed, in vitro, with HES 
maintained an immature phenotype in regard to the surface markers analysed and 
cytokines measured. Additionally, HES pre-treatment did not alter the ability of the 
DC to uptake antigen, unlike inflammatory stimuli such as LPS. Despite this 
apparent lack of phenotypic alteration it remains a possibility that the effects of HES 
are subtle and an as yet un-described parameter is changed. This is evidenced by 
microarray studies of SEA-pulsed DCs in which only 29 genes were altered 
compared to unstimulated controls (Kane et al., 2004).  
Although apparently inactivated, HES-pulsed DCs adoptively transferred in 
vivo, induced a Th2 response; characterised by production of antigen-specific IL-4 
and IL-13. This is consistent with the phenotype of SEA-pulsed DCs, which are also 
maintained in an immature state and strongly polarise a Th2 response (MacDonald et 
al., 2001).  
The lack of a signature phenotype for DCs that are capable of polarising Th2 
responses has lead to the proposal of a ‘default’ hypothesis for their mode of action. 
In essence, the hypothesis suggests that Th2-type conditioning of the DC is not 
associated with a specific gene expression profile but rather on the absence of a 
classical maturation profile. This fits particularly well with data from H. polygyrus 
infections where DCs from the spleen exhibit an immature phenotype whilst a strong 
Th2 response is generated (Su et al., 2005). However, a number of studies have also 
been published which do not support this hypothesis. Perhaps the best example is 
that of DCs pulsed with N. brasiliensis ES (NES), which are able to polarise a Th2 
response despite evident maturation (Section 3.1) (Balic et al., 2004). When 
phenotyped these DCs were described as being partially mature since they 
upregulated CD86 and OX40L, but not CD80, and secreted IL-6 and IL-12p40, but 
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not IL-12p70. The selective upregulation of genes associated with generation of Th2 
immunity in vivo was suggested to be the mechanism by which these DCs were able 
to prime a response.  
Other evidence that argues against the default hypothesis comes from co-
pulse experiments using SEA and Pa. In this situation, transferred DCs are able to 
concurrently polarise Th1 responses towards Pa and Th2 responses towards SEA. 
Interestingly, these DCs, prior to transfer, shared some phenotypic similarity to NES-
pulsed DCs, particularly in respect to the strong inhibition of Pa induced secretion of 
the inflammatory cytokine IL-12p70.  
It was found that HES specifically inhibited production of the inflammatory 
cytokines IL-6, and IL-12p70, when co-administered with LPS, or Pa, whilst the 
immunoregulatory cytokine IL-10 was unaffected. HES also had inhibitory effects 
on LPS/Pa induced expression of the co-stimulatory receptors CD40, CD80 and 
CD86, as well as MHC class II. According to the default hypothesis of DC 
polarisation potential, this shift away from a classically activated DC phenotype 
towards a more immature state should favour Th2 responses.  
Unlike previous studies, we were able to directly assess whether this was the 
case by comparing the effects of HES with its heat-inactivated form. Upon heating, 
HES lost its ability to modulate DC activation in the presence of LPS. However, 
hiHES-pulsed DCs adoptively transferred in vivo were still able to induce a robust 
Th2 response. This suggests that, in an immature DC, the factors that are required to 
modulate the phenotype of the DC towards inflammatory stimuli are not the same as 
those required to polarise a Th2 response.  
Surprisingly, we found that these two effects of HES on DCs were also 
separable in the presence of a strong inflammatory stimulus. When HES/Pa, or 
hiHES/Pa, co-pulsed DCs were used in transfer experiments both induced 
comparable antigen-specific Th2 responses, even though hiHES was unable to 
significantly modulate DC maturation. This demonstrates, that at least for HES 
stimulated DCs, the default hypothesis does not hold true. DCs pulsed with 
components of HES are able to induce Th2 responses irrespective of their maturation 
status. It would seem, therefore, most likely that DC induced Th2-responses driven 
by HES, and possibly other helminth-derived products, are not dependent on the 
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attainment of a specific DC phenotype but are due to an inherent property of the 
antigen.  
One possible mechanism by which this could occur is differential processing 
of the two antigens. This was observed previously in SEA/Pa co-pulsed DCs where, 
using fluorescently labelled antigens, SEA and Pa were found to traffic to different 
compartments after uptake. By studying the phenotype of these compartments it was 
suggested that Pa was more heavily processed than SEA and hence Pa-derived 
peptides could be displayed at a higher density on the surface of the DC. Since 
peptide concentration can affect T cell polarisation, this may explain how the DC is 
able to initiate appropriate responses to each antigen in a co-pulse setting. 
Although this idea fits well for DCs co-pulsed with SEA/Pa, subtle 
differences in the ability of HES/Pa and hiHES/Pa co-pulsed DCs to induce T cell 
responses suggest that there may be an alternative explanation in this setting. Unlike 
SEA/Pa co-pulsed DCs, whilst there is no switching in type of response, HES/Pa and 
hiHES/Pa co-pulsed DCs polarise muted Pa-specific IFN-γ responses as well as 
muted HES-specific Th2 responses. Suppression is most clearly observed when 
considering antigen-specific IL-10 production. Although both antigens polarise 
similar IL-10 responses, when DCs are co-pulsed with HES/Pa or hiHES/Pa, IL-10 
secretion stimulated by either antigen is dramatically suppressed. 
Unexpectedly, the maintenance of polarisation phenotype in a DC co-pulse 
was not observed for Th17 generation. In HES/Pa and hiHES/Pa co-pulsed DC 
transfers a strong HES specific IL-17 response was observed, comparable to that of 
Pa alone. A possible explanation for this is that Th17 polarisation has little to do with 
the nature of the antigen and is more to with the local cytokine milieu. 
If the suppression of DC activation by HES is unrelated to eventual T cell 
polarisation then, what is the purpose of this activity? One possibility is that 
modulation is important to limit inflammation at the site of infection. During an H. 
polygyrus infection damage caused to the gut wall is likely to mediate exposure of 
DCs to ligands from commensal bacteria or bacteria carried in by the helminth 
(Section 1.3.4). In this situation limiting production of cytokines such as IL-12/23 
and allowing production of IL-10 would prevent inflammation at the site of 
infection. This concept is further backed-up by the short-period of time for which 
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HES inhibits the ability of the DC to make cytokine. As discussed (Section 1.7), this 
inhibition has been suggested as a form of parasite immunomodulation. However, it 
is equally possible that this represents an appropriate host response to recognition of 
parasite antigens. Down-regulation of inflammatory cytokines would favour Th2-
type effector mechanisms local to the helminth, aiding in pathogen clearance. 
Should this prove to be the case then there is little point in searching for a 
signature profile of a Th1 or Th2 phenotype in DCs. Indeed, our data suggests that 
the phenotype of the DC after pulsing tells you little about its polarisation potential 
but might be relevant to the kind of inflammation that will be induced at the site.  
 Future work to support the data in this chapter could focus on gaining a better 
understanding of the mechanism by which HES is able to suppress DC activation in 
response to inflammatory stimuli. Initially, the molecular pathways that HES is 
acting upon when co-pulsed with LPS could be characterised. Western blotting could 
be used to look for the stage at which inflammatory signalling is inhibited, for 
example mitogen-activated protein kinase (MAPK) phosphorylation. Once these 
pathways are identified it may be possible to predict receptors that HES may be 
binding to. Isolating molecules, perhaps using ion-exchange chromatography, from 
the HES, that are specifically responsible for the suppression could be another 
powerful tool for better understanding the process. Additionally, all the work 
presented here is looking at BM-derived DCs, it would be interesting to see whether 
different populations of DCs from the gut, such as lamina propia, or Peyer’s patch, 
DCs respond in similar manner to HES.  
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4 Mechanisms of resistance to primary infection 




H. polygyrus is reported to be capable of establishing a chronic primary infection (>4 
weeks) in almost all strains of mice tested (Section 1.2.2). In contrast to this, a 
striking variation has been shown in response phenotypes of different strains to 
secondary challenge, or trickle infections (Section 1.2.2). This is exemplified by one 
study in which the final worm burdens, following a repeated weekly inoculation 
protocol, were in excess of 300 worms per animal in CBA mice at week 8 of 
infection, compared to a mean of 1.2 worms per animal in SWR mice (Behnke et al., 
2003). As a result of the perceived minor strain distinctions in respect to resistance to 
primary infection, in relation to secondary or trickle infection, much of the work in 
this area has focussed on the latter setting. This has resulted in a clear mechanism 
being described by which secondary protection against H. polygyrus is mediated 
against the larval stage of the parasite, dwelling in the sub-mucosa of the small 
intestine. Memory Th2-cells induce rapid recruitment of AAMφs that are involved in 
formation of granulomas around the invading pathogen, favouring its killing (Section 
1.3.3). 
 For the reasons described above, little focus has been placed on exploring the 
well-documented disparities between rates of response in primary infection. 
Moreover, key aspects of the initial immune response to infection remain poorly 
understood. Correlations have been observed between helminth expulsion and a 
number of immunological parameters including levels, and type, of cytokine 
production (Behnke et al., 1993; Wahid et al., 1994), serum and luminal antibody 
concentrations (Ben-Smith et al., 1999), and mast cell metalloprotease concentrations 
(Behnke et al., 1993; Wahid et al., 1994). These studies did not analyse the early 
stages of H. polygyrus interaction with the host making it difficult to ascertain 
whether variation in any particular feature of the immune response was causative, or 
a result, of differential worm burdens.   
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 One possible explanation for variation in resistance to primary infection is the 
balance between Th1 and Th2 responses, as strong Th2 polarisation is fundamental 
to the strain specific expulsion of T. muris (Section 1.2.2) (reviewed by (Cliffe and 
Grencis, 2004). The prospect of a similar balance existing in H. polygyrus infection, 
where some degree of Th2 polarisation occurs in both resistant and susceptible 
strains, has not been widely considered. If it is relevant then the relative strengths of 
Th1 and Th2 could be important in determining the response phenotype to this 
helminth too, or additional subtypes may be involved. For example, given its 
establishment in the gut, where Th17-cells are prevalent, there could be an as yet 
undescribed counter-regulatory relationship between this newly described subset and 
the Th2-cells required to aid in worm expulsion. 
 In this chapter, responses of slow and fast responder mice to H. polygyrus are 
studied in different strains of mice with particular focus on the very early responses, 
both in the LN and the gut tissue. Subsequently, the role of Th1, and Th17, counter-
regulation in mediating any strain-specific differences is considered. 






4.2.1 Fecundity and worm burden is affected in different strains of 
mice, early in infection. 
 
Based on the published literature, four different mouse strains were compared for 
susceptibility to primary infection. These strains were the slow responder strains, 
CBA, and C57BL/6, the intermediate responder strain, BALB/c, and the fast 
responder strain, SJL. Faecal egg counts were measured at day 14, day 21, and day 
28, of infection to address how rapidly differences in worm fecundity were evident in 
primary H. polygyrus infections of different strains of mice. Reductions in eggs/g of 
faeces were apparent as early as day 14 of infection in BALB/c and SJL mice (Figure 
4.1 A). At later time points egg counts continued to fall in these strains whilst 
remaining relatively constant in CBA and C57BL/6 mice. The reduced egg burden at 
day 14 represented a reduction in worm fecundity, as the total number of adult 
worms in the gut lumen were not significantly different between groups at this time 
point (Figure 4.1 B). By day 28 of infection, however, dramatic differences in worm 
burden were observed between the strains with, as expected, SJL, and BALB/c mice 
having the lowest worm burdens, while CBA and C57BL/6 mice carried the highest. 
 
 
4.2.2 Phenotyping lymphocyte populations in different strains of 
mice. 
 
It is possible that the increased rate of expulsion of H. polygyrus in different strains 
of mice is related to variation in the lymphocyte populations present in the MLNs. In 
the naïve state it was observed that, baseline cell numbers within MLNs were greater 
in the faster responding strains (Fig. 4.2 A, B). In order to broadly assess the cell 
types making up the lymphocyte pool, MLNs were isolated and stained for the helper 
T cell marker CD4, the cytotoxic T cell marker CD8, and the B cell marker B220. 
Initial percentages of CD4+, CD8+, and B220+, cells were found to be different 
between strains.  C57BL/6 mice in particular had low CD4 percentages but as a 
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result high CD8, and B220 percentages (Fig. 4.2 C). At day 7 of H. polygyrus 
infection there was no significant increase in the cellularity of MLNs, but there were 
changes in the lymphocyte populations (Fig. 4.2 C). Percentages of B220+ cells, as 
has been previously reported for some strains of mice (Parker and Inchley, 1990), 
were increased in all groups. Increases were most striking in CBA mice, where 
B220+ cell increased over four-fold, and in BALB/c mice where they increased two-
fold. These B220+ percentage increases were accompanied by decreases in CD4, but 
particularly CD8 percentages.  
By day 14 post-inoculation, the MLNs of all mouse strains had expanded 
dramatically in response to infection. BALB/c mice had the largest overall cellularity 
rising from a mean of 2.5x107 cells, to 1.3x108 cells, whilst CBA, C57BL/6, and SJL 
mice (despite their different response phenotypes) all had similarly sized MLNs at 
this time point (Fig. 4.2 B). Percentages of lymphocyte populations, as defined by 
CD4, CD8, and B220 expression, were similar to those at day 7 (data not shown), 
although absolute numbers were greater due to the increases in MLN size.  
 
 
4.2.3 CD4+ T cell Foxp3 expression levels increase in different 
strains of mice at day 7 of H. polygyrus infection. 
 
Previously it has been reported that early in H. polygyrus infection of BALB/c mice 
increased percentages of Foxp3+ cells are present in the MLNs (Finney et al., 2007). 
These are most apparent at day 7, and reduced by day 14. Whether these changes 
also occur in the MLNs of mice with different responder phenotypes has not been 
investigated.  
As for different lymphocyte populations, CD4+ T cell expression of Foxp3 
was also assessed at day 7 and day 14 of infection (Fig. 4.3). Differences were 
apparent in the percentage of Foxp3+ cells in naïve animals from each strain. CBA 
mice had lowest Foxp3 expression, C57BL/6 had highest, whilst similar levels were 
evident in BALB/c, and SJL. Despite these baseline variations, all strains were found 
to have significantly upregulated proportions of CD4+ Foxp3+ T cells at day 7 of 
parasite infection (Fig. 4.3 A). The percentage-increase over naïve was markedly 
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different between strains and negatively correlated with susceptibility. CBA, and 
C57BL/6 had small mean percentage-increases, 5%, and 4%, but BALB/c, and SJL, 
had larger percentage-increases, 9%, and 11%. A similar effect was discernable if 
fold-change was calculated, to take into account the variations in the starting 
proportions of Foxp3+ cells (Fig. 4.3 B). 
 By day 14 of infection the situation was very different (Fig. 4.3 C). The 
increases in percentage of CD4+ Foxp3+ T cells had fallen back to baseline levels in 
CBA and C57BL/6 mice, whilst BALB/c mice had only a slight mean elevation of 
4%. In contrast, SJL mice maintained an almost identically enhanced population to 
that observed at day 7 of infection (mean percentage change – 13%). As might be 
anticipated from the day 7 data, fold-change analysis at day 14 told a similar story to 
the percentage change (Fig. 4.3 D).     
 
 
4.2.3 Cytokine production in different strains of mice. 
 
Another factor that could affect the ability of a mouse strain to respond to primary 
infection with H. polygyrus is the strength, and type, of CD4+ T cell response. At 
days 7 and 14 of H. polygyrus infection, MLNs were isolated, polyclonally 
stimulated, and intracellularly stained for, the Th2-type cytokine IL-4, the Th1-type 
cytokine IFN-γ, and the Th17-type cytokine IL-17. First, the different Th-types were 
considered as a percentage of the total CD4+ T cell population. IL-4 producing CD4+ 
cells were enhanced in all strains at both day 7, and day 14, of infection (Fig. 4.4 A). 
The smallest percentage was in the susceptible CBA strain. However, the highest 
percentage was in the C57BL/6 strain, which is also susceptible. The two resistant 
strains, BALB/c and SJL, had intermediate percentages of CD4+ IL-4+ cells. 
Although Th1-type and Th2-type responses are considered to be in a counter-
regulatory relationship at these early time-points trends in CD4+ IFN-γ production 
were similar to those observed with IL-4 (Fig. 4.4 B). CBA mice had the lowest 
percentage of IFN-γ producing cells, whilst C57BL/6 had the highest. No such 
pattern was apparent with IL-17-staining (Fig. 4.4 C). Indeed, only SJL mice 
displayed a clear increase in IL-17 over naïve at day 7 and day 14 of infection. 
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Interestingly, C57BL/6 mice appeared to have highest constitutive expression of IL-
17, although this was unchanged in response to H. polygyrus. 
 Due to the variation in MLN cellularity (Fig. 4.2 A, B), and CD4 percentages 
(Fig. 4.2 C), of the various strains, when Th-cell responses were considered as 
absolute cell numbers a different relationship between groups was apparent (Fig. 4.5 
A, B, C). BALB/c mice had the highest total number of Th2-type cells, 5-fold greater 
than CBAs, which had the lowest total number (Fig. 4.5 A). C57BL/6, and SJL, mice 
that have very different susceptibilities had comparable total Th2-type cell numbers. 
Once again, although there were smaller numbers of cells, the IFN-γ-producing (Fig. 
4.5 B), and IL-17 producing (Fig. 4.5 C), CD4+ populations followed a similar trend. 
  
 
4.2.4 Resistance to primary infection is associated with 
granuloma formation. 
 
As discussed (Section 1.3.3), in secondary infection, resistance to H. polygyrus is 
associated with granuloma formation around the tissue-dwelling larvae in the wall of 
the gut (Anthony et al., 2006). It was possible that susceptibility to primary infection 
was also dependent on this mechanism. Granuloma-like structures can be identified 
by eye, or using a light-microscope, in the wall of the gut at day 14 of primary H. 
polygyrus infection (Fig. 4.6 A). Even at this time-point parasites are evident in some 
of these structures (Fig. 4.6 B). These granuloma-like structures were counted under 
a light-microscope. Marked differences in their numbers were apparent between the 
slow and fast responding strains (Fig. 4.6 C). BALB/c and SJL mice had an over 5-
fold greater mean granuloma count than CBA and C57BL/6 mice.  
 In secondary infection, alternative-activation of Mφs within the granulomas 
was implicated in larval killing (Anthony et al., 2006). mRNA levels of genes 
associated with AAMφ generation, Arginase-1, RELMα, and Ym1, were measured 
in the duodenal wall by real-time RT-PCR at day 7 of infection (Fig. 4.7). 
Expression of these genes varied between strains. In particular, BALB/c mice, 
despite having increased numbers of granulomas did not have enhanced expression 
of any of these AAMφ genes. CBA, and C57BL/6, mice had > 10-fold increased 
 94 
expression of Arginase-1, and RELMα, but no significant change in Ym1. SJLs, in 




4.2.5 IL-12/23p40-/- C57BL/6 mice have increased resistance to H. 
polygyrus infection. 
 
Although it was unclear from these data whether AAMφs were associated with 
enhanced primary resistance to H. polygyrus it was possible that non-Th2-type 
cytokines such as IL-12, IFN-γ, IL-23, or IL-17, acting on this cell-type, may have a 
negative impact on the protective response to the parasite in some of the strains. To 
assess whether this was the case WT C57BL/6, or IL-12/23p40-/- animals on the 
same background were infected with H. polygyrus and their responses to the parasite 
characterised. At day 28 worm burdens were counted, and MLN cells isolated and 
re-stimulated with HES. A trend towards decreased infection intensity was evident at 
this time point (Fig. 4.8 A), which did not appear to be associated with increased 
cellularity of the MLNs (Fig. 4.8 B). 
 Enhanced clearance might be predicted to correlate with upregulation of IL-4 
production and downregulation of IFN-γ production in response to parasite antigens. 
Little change was observed in the levels of either of these cytokines in supernatants 
when MLNs were restimulated with HES (Fig. 4.8 C). IL-10, which, as discussed 
(Section 1.6.1), may play a regulatory role in H. polygyrus infections, was also 
unaltered. There was, however, an over 2-fold decrease in IL-17 release, implicating 





4.2.6 IL-23p19-/- mice have increased resistance to H. polygyrus, 
associated with granuloma development. 
 
In order to ascertain whether the resistance to H. polygyrus observed in  
IL-12/23p40-/- animals might be associated with IL-17 production, mice with a 
specific deficiency in IL-23 (IL-23p19-/-) were infected. This deficiency led to 
reduced fecundity at day 14 of infection (Fig. 4.9 A, left panel), and a comparable 
increase in resistance to the parasite as IL-12/23p40-/- at day 28 of infection (Fig. 4.9 
A, right panel). In a repeat experiment, the lower egg count was associated with a 
reduced worm burden at day 14 of infection (Fig. 4.9 B). Interestingly, an increased 
presence of granuloma-like structures was observed in the gut wall of IL-23p19-/- 
animals, as was observed for naturally resistant BALB/c and SJL mice (Fig. 4.6).  
 
  
4.2.7 IFN-γ-deficiency does not enhance resistance to H. 
polygyrus infection. 
 
Since IL-17-/- animals were not available for use in this project, experiments were 
performed using IFN-γ-/- mice to assess whether resistance to H. polygyrus infection 
was dependent on Th1/Th2 dichotomy as is the case for T. muris (Section 1.2.2). At 
day 14 of infection, unlike IL-23p19-/- animals, there was no change in worm burden 
(Fig. 4.10 A) or fecundity of the parasites (Fig. 4.10 B). There was also no alteration 
in granuloma numbers in the wall of the gut (Fig. 4.10 C).  Intracellular levels of the 
cytokines IL-4, IFN-γ, IL-17, and IL-10, were measured in response to polyclonal 
stimulation of the MLNs (Fig. 4.10 D). As expected, IFN-γ was not present, whilst 
the percentages of cells producing the other cytokines were not different between 
groups. These data again suggested that IL-23, perhaps acting via IL-17 induction, 




4.2.8 H. polygyrus infection leads to increases in IL-17 production 
that are abrogated in IL-23p19-/- animals. 
 
H. polygyrus has been reported to inhibit IL-17 production in the MLNs at day 14 of 
infection in C57BL/6 mice (Elliott et al., 2008), however, it is possible that earlier in 
infection this cytokine is upregulated. This seems probable as damage mediated by 
the larval stage of the parasite is likely to expose the gut-associated lymphoid tissue 
(GALT ) to antigens from commensal bacteria. 
 Polyclonal restimulation, followed by intracellular cytokine staining for IL-
17, as well as IL-4, IFN-γ, and IL-10, was therefore performed on populations of 
lymphocytes extracted from the small intestinal tissue, the lamina-propria 
lymphocytes (LPLs), and Peyer’s patches. These were isolated from naïve and day 7 
H. polygyrus infected animals. Additionally, MLNs were restimulated and compared 
to the other lymphocyte populations. Isolation of the same populations was attempted 
from naïve and infected IL-23p19-/- mice. LPLs, could not be phenotyped from these 
genetically-deficient animals when infected with H. polygyrus due to the large 
amount of cell-death. 
 In the MLN at day 7 of infection a similar increase in CD4+ IL-17+ cells 
occurs in WT and IL-23p19-/- mice when compared to the naïve level of IL-17 
production (Fig. 4.11). There are also increases in IL-4, IFN-γ, and IL-10, and again 
these are unchanged between the two groups. This situation is very different in sites 
closer to the parasite. The percentage of cells producing IL-17 in the Peyer’s patches 
in the naïve state is around 60-fold higher than in the MLNs (Fig. 4.11). IL-17 does 
not increase at this site during infection, but IL-23p19-/- animals have approximately 
2-fold less IL-17+ cells than WT. IFN-γ, and IL-10, production are similar between 
WT and IL-23p19-/- mice in the Peyer’s patches, whilst IL-4 is significantly increased 
in the knock outs.  
 LPLs contained a greater percentage of CD4+ IL-17+ cells than the Peyer’s 
patches (Fig. 4.11). Here also, IL-23p19-/- animals had decreased naïve IL-17 
expression levels, but additionally were found to have increased levels of IL-10.  
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Figure 4.1 – Variation in susceptibility to primary infection with H. polygyrus is 
associated with early differences in parasite fecundity. 
 
Female, 7 week-old, age-matched, CBA, C57BL/6, BALB/c, or SJL mice were 
infected with 200 H. polygyrus L3 larvae by gavage. (A) Faecal egg counts were 
performed at day 14, 21, and 28 after infection. Data are representative of two 
separate experiments. (B) Mice were sacrificed at day 14, or day 28 after infection, 
and adult parasites in the lumen of the gut counted. Tables show results of one-way 




Figure 4.2 – B cell increases are apparent in MLNs early during H. polygyrus 
infection in all mouse strains studied. 
 
MLNs were isolated from naïve, day 7, or day 14, H. polygyrus infected, female, 
CBA, C57BL/6, BALB/c, or SJL mice. (A) Total MLN cell counts were calculated 
at day 7 and (B) day 14. Results of one-way ANOVA and Tukey’s test comparing 
infected groups: *, P < 0.05; **, P<0.01; ***, P<0.001. (C) Composition of the 
MLNs were analysed by flow-cytometry. Percentages of CD4+, CD8+, and B220+ 
cells, were measured within the lymphocyte gate. Day 7 data are shown but similar 





Figure 4.3 – Early stages of H. polygyrus infection are associated with 
percentage increases of Foxp3+ cells, within the CD4+ T cell population, in all 
mouse strains tested, irrespective of susceptibility phenotype. 
 
Mesenteric lymph node (MLN) cells were isolated from naïve, or H. polgyrus 
infected, 7 week-old age-matched, female, CBA, C57BL/6, BALB/c, or SJL mice. 
The percentage of Foxp3+ cells, within the CD4+ T cell population, was assessed by 
flow-cytometry. (A, C) Percentage of CD4+ Foxp3+ T cells identified in naïve, and 
day 7, or day 14, infected mice for each strain. Both naïve and infected animals were 
sacrificed at the same time point. Error bars represent SD of at least four individual 
naïve, or five individual infected mice. Results of Student’s t test: *, P < 0.05; ***, 
P<0.001. (B, D) Fold-change in Foxp3 expression at day 7, or day 14, for each 
infected animal, as compared to mean naïve Foxp3 percentage. Error bars represent 
SD of at least five individual infected mice. Table shows results of one-way ANOVA 





Figure 4.4 – Changes in CD4+ T cell cytokine expression early during H. 
polygyrus infection. 
 
After isolation MLNs from naïve, day 7, or day 14 H. polygyrus infected, female, 
CBA, C57BL/6, BALB/c, or SJL mice, were polyclonally stimulated and stained for 
intracellular cytokines. (A) Percentage IL-4+ CD4+ T cells at day 7, and day 14. (B) 
Percentage IFN-γ+ CD4+ T cells at day 7, and day 14. (C) Percentage IL-17+ CD4+ T 
cells. (D) Tables show results of one-way ANOVA and Tukey’s test for infected 





Figure 4.5 – Changes in total number of CD4+ cytokine expressing T cells early 
during H. polygyrus infection. 
 
After isolation MLNs from naïve, day 7, or day 14 H. polygyrus infected, female, 
CBA, C57BL/6, BALB/c, or SJL mice, were polyclonally stimulated and stained for 
intracellular cytokines. Total number of cells was calculated based on MLN cell 
count, percentage of CD4+ T cells, and percentage of cells producing each cytokine. 
(A) Total number of IL-4+ CD4+ T cells at day 7, and day 14. (B) Total number of 
IFN-γ+ CD4+ T cells at day 7, and day 14. (C) Total number of IL-17+ CD4+ T cells. 
(D) Tables show results of one-way ANOVA and Tukey’s test for infected groups. 





Figure 4.6 – Primary resistance to H. polygyrus infection is associated with 
granuloma-like formation in the gut wall. 
 
(A) Image showing granuloma-like structures apparent in gut wall of SJL, and 
BALB/c, but not C57BL/6, or CBA mice, at day 14 post infection. (B) Larvae are 
apparent in granuloma-like structures from SJL mice (white box). (C) Number of 
surface granuloma-like structures identified along entire small intestine in different 





Figure 4.7 – Quantification by real time RT-PCR of AAMφ  associated genes in 
the gut wall.   
 
cDNA was isolated from the duodenum of naïve, and day 7 H. polygyrus infected 
animals. Expression of Arginase-1, RELMα, and Ym1 were calculated relative to the 
housekeeping gene, hypoxanthine-guanine phosphoribosyl transferase (HPRT). Error 
bars represent SD of four individual mice in the naïve, and six individual mice in the 
infected group. Results of Student’s t test comparing naïve to infected groups for 





Figure 4.8 – IL-12/23p40-/- C57BL/6 mice have increased resistance to H. 
polygyrus infection.  
 
C57BL/6 mice, or IL-12/23p40-/- animals were infected for 28 days with H. 
polygyrus. (A) Adult worms counts in lumen of the gut at day 28 of infection. (B) 
MLN were isolated and total cell numbers calculated. (C) Antigen specific IL-4, IL-
10, IFN-γ, and IL-17, were measured in supernatants from 5x105 MLN cells 
restimulated, in vitro, with 1 µg/ml of HES for 72 hrs, or medium alone. Error bars 
represent SD of cytokines measured in cultures from five individual mice in the WT, 





Figure 4.9 – IL-23p19-/- C57BL/6 mice are resistant to H. polygyrus and show 
increases in granuloma-like structures. 
 
(A) C57BL/6 mice, IL-12/23p40-/-, or IL-23p19-/-, mice were infected for 28 days 
with H. polygyrus. Faecal egg counts were performed at day 14 of infection. Mice 
were sacrificed on day 28 of infection and luminal worms counted. (B) C57BL/6 
mice, or IL-23p19-/- mice, were sacrificed at day 14 of infection and luminal worms 
counted. Faecal egg counts were also measured at the same time point. (C) Image 
showing granuloma-like structures in the wall of the gut from IL-23p19-/- mice (red 
circles) that are not present in WT mice. Counts of granuloma-like structures from 








Figure 4.10 – IFN-γ -/- C57BL/6 mice do not have enhanced resistance to H. 
polygyrus. 
 
C57BL/6, or IFN-γ-/-, mice were infected with H. polygyrus. At day 14 mice were 
sacrificed and several parameters measured. (A) Luminal worm count. (B) Faecal 
egg counts. (C) Granuloma-like structures in the gut wall. (D) MLNs were 
polyclonally stimulated and stained for intracellular cytokines, IL-4, IFN-γ, IL-17, 





Figure 4.11 – Reduced IL-17 production by IL-23p19-/- mice compared to WT 
animals in the naïve setting, and at day 7 of H. polygyrus infection. 
 
MLNs, Peyer’s patches, or LPLs, were isolated from naïve, or day 7 H. polygyrus 
infected, C57BL/6, and IL-23p19-/- mice. Cells were polyclonally stimulated prior to 
intracellular staining for IL-4, IFN-γ, IL-17, and IL-10. Error bars represent SD of 








The studies in this chapter have addressed the mechanisms of primary resistance to 
H. polygyrus through comparisons of genetically different mouse strains. Although 
many previous studies had characterised SJL and BALB/c mice as being better able 
to control H. polygyrus establishment (Behnke et al., 1993; Lawrence and Pritchard, 
1994; Wahid et al., 1994), it has not previously been shown that resistance is 
expressed at an early stage of infection. Indeed, by day 14 after inoculation dramatic 
differences were apparent in worm fecundity between the strains. Subsequently, 
between d14 and d28, resistant mice expelled the great majority of luminal worms. A 
key question this raises is whether expulsion follows from damage incurred while in 
the intestinal wall (explaining, for example, the poor fecundity), or if a separate and 
second phase of protective immunity is directed at H. polygyrus after it has emerged 
from its tissue dwelling phase. Alternatively, once they have emerged into the lumen, 
adult worms could develop immunomodulatory strategies that allow it them to 
neutralise host immunity.  
Clear differences between strain susceptibility did not correlate with gross 
immunological measures such as total numbers or proportions of lymphocyte subsets 
in the mucosal lymphoid tissues. Thus, MLN cellularity did not correlate with 
susceptibility to primary infection, and indeed the highest and lowest cell counts 
were found in two susceptible strains, BALB/c and CBA. When lymphocyte subsets 
were compared, despite variations in naïve levels, the overall patterns of cell 
expansion were similar irrespective of resistance phenotype. B cell percentages 
increased rapidly, whilst CD4+ and CD8+ T cell populations were reduced, as had 
been previously reported in some strains (Parker and Inchley, 1990). This is of 
particular interest given that natural antibodies may be important in protecting aginst 
H. polygyrus infection (McCoy et al., 2008). A combination of ELISA and Western 
Blotting could be used to look at whether those mice that are less susceptible to 
infection have higher levels of natural antibody towards either HES or HEx. There 
was, however, no clear relationship between increases in B cells and enhanced 
protection. 
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Foxp3+ Tregs were also characterised, early in H. polygyrus infection the 
percentage of CD4+ Foxp3+ T cells rises in the MLNs of all strains of mice tested, 
irrespective of their susceptibility to this parasite. Differences are particularly 
striking at day 7, and only maintained to day 14, in resistant strains, suggesting that 
these increases in Foxp3 are favoured by the host immune system to control the 
burgeoning effector response. This inverse relationship, between response phenotype 
and Foxp3 expression, clearly highlights the problem of separating any parasite-
mediated manipulation of the Foxp3+ Treg compartment from appropriate expansion 
to limit immune-mediated damage to the host (Chapter 6).  
The polarisation of Th cells towards a type-2 phenotype was then tested for 
correlation with resistance. At the simplest level, Th2 responses can be measured as 
a percentage of the CD4 population, or as an absolute number based on MLN 
cellularity.  Using either measure, responses of all mice were dominated by IL-4-
producing Th2 cells, with differences in absolute numbers appearing not to relate to 
susceptibility. For example, BALB/c mice had the greatest number of Th2 cells and 
CBA mice the least, while the absolute number of IL-4+ CD4+ T cells was 
comparabe in susceptible C57BL/6 mice and resistant SJL mice. In particular, 
counter-regulation of Th2-cells by Th1-cells did not appear to be of importance in 
this setting as mice with approximately equal susceptibility (CBA and C57BL/6) 
had, respectively, fewest and most IFN-γ producing CD4+ cells.   
 A novel finding from this work is the development of granuloma-like 
structures, some containing larvae, in the small intestinal gut wall of the more 
resistant BALB/c and SJL mice. Moreover, few of these granulomas were observed 
in the susceptible CBA or C57BL/6 strains. The granulomas appeared to be similar 
to those described in secondary infection, within which it was suggested that AAMφs 
played a key role in mediating parasite killing (Anthony et al., 2006).  
 To evaluate whether AAMφ populations are involved in the gut wall reaction, 
duodenal samples were tested by RT-PCR for three major AAMφ-associated 
transcripts, Arginase-1, RELMα and Ym1.  BALB/c mice, which had many 
granulomas, failed to display upregulation at the mRNA level of any of these 
markers in the wall of the gut. In contrast, although CBA, and C57BL/6 had few 
granulomas, upregulation of the AAMφ markers Arginase-1, and RELMα upon 
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infection were observed in these strains. There was, however, no increase in the 
chitinase-like protein Ym1. SJL mice strongly upregulated Ym1, and also RELMα, 
but not Arginase-1. This raises the possibility that perhaps Ym1, but not other 
AAMφ products, might be important in conferring resistance to H. polygyrus, and/or 
that it is not the presence of AAMφs per se that is important, but their mobilisation 
into granulomas around the tissue-phase larvae. 
 Further work will be required to investigate the granulomas in more detail. In 
particular histological examination can be used to ascertain the localisation of 
AAMφs within the granulomas as well as in the gut wall generally. Furthermore, the 
involvement of neutrophils, and the microscopic state of the encapsulated larvae, will 
be important to determine. 
 If AAMφs are responsible for resistance to H. polygyrus, at least in some 
strains of mice, they are likely to require IL-4 and/or IL-13, as it is known that AAM 
development is ablated in IL-4R-/- mice (Herbert et al., 2004). There may also be a 
requirement for certain counteracting factors, such as IFN-γ or IL-12. Release of 
these, along with IL-17, seems likely early in H. polygyrus infection where the gut 
wall is compromised perhaps leading to the GALT being exposed to antigens and 
PAMPs from commensal bacteria. Interestingly, resistance to H. polygyrus was 
enhanced in C57BL/6 mice genetically deficient in IL-23p19. No reports have as yet 
considered the effects of IL-23, or IL-17, on induction of the alternatively activated 
phenotype in Mφs, but these data indicate that a component of the IL-23/IL-17 axis 
may directly inhibit AAM development. One way in which this could be tested is by 
adding IL-23, and IL-17, into BM-derived Mφ cultures that contain factors to 
encourage alternative activation, and assessing whether they inhibit this process. 
Surprisingly, an absence of IFN-γ did not alter the resistance of C57BL/6 mice, 
in acute infection, to H. polygyrus. This implies that the typically considered 
counter-regulatory balance of Th1/Th2 in gut helminth infection is not relevant to 
establishment of infection in this model. It contrasts sharply with work on T. muris, 
where a lack of IFN-γ drives parasite expulsion (Else et al., 1994). These data also 
indicate that the failure of susceptible mice to attack tissue phase larvae is not due to 
IFN-γ-mediated classical activation of macrophages, which could deplete the host’s 
ability to generate AAMφs. 
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The different roles of IFN-γ in H. polygyrus and T. muris may be explained by 
the variation in the load, and types of bacteria, that the host is exposed to when the 
small versus the large intestine is invaded by a helminth. Indeed, the data presented 
in this chapter strongly suggests that initial resistance to H. polygyrus is dependent 
on the Th2/IL-23 balance directly, or via the effects of IL-23 to enhance Th17, or a 
combination of both. To address the importance of IL-17 it will be necessary to 
either mAb deplete IL-17 during infection, or infect IL-17-/- animals. The latter idea 
seems preferable since in S. mansoni infection mAb depletion was only partially 
effective (Rutitzky and Stadecker, 2006). If IL-17 is found to affect response of the 
host to H. polygyrus then it will be tempting to speculate that neutrophils could be 
playing a negative role in parasite killing. Neutrophils are recruited by IL-17 and 
could disfavour alternative activation of Mφs by responding in a pro-inflammatory 
fashion to commensal bacteria at the infection site. As mentioned, histological 
analysis of the granuloma-like structures could be used to look for neutrophil 
localisation. 
Additionally, it would be interesting to see whether, as suggested previously, 
commensal bacteria are important in mediating the increases in IL-17 that are 
observed in the GALT at day 7 of H. polygyrus infection. This could be achieved by 
studying IL-17 responses, and resistance to the parasite, of either germ free mice, or 
antibiotic treated (to remove all commensals) WT mice. Although IL-23, and/or IL-
17, have been defined as integral to the susceptibility status of C57BL/6 mice to H. 
polygyrus, these same cytokines are not necessarily key to the variation between all 
strains.  
It is likely that a combination of different mechanisms, rather than one specific 
component, are at play in each strain to ultimately define their resistance or 
susceptibility to primary infection with H. polygyrus. BALB/c mice, for example, do 
not have enhanced expression of AAMφ markers, despite the apparent presence of 
granulomas. Since killing of the larval stages of the parasite is thought to be driven  
by AAMφs, this suggests that the relative resistance of BALB/c mice to H. polygyrus 
infection is mediated in another fashion. This could be in part directed at the adults 
once they enter the gut lumen, as BALB/c mice generated the largest number of Th2 
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cells by day 14 of infection. Alternatively, a different mechanism of damaging the 
larval stage of the parasite could be at play in the granulomas. 
SJL mice on the other hand upregulated markers of AAMφ induction at the 
mRNA level. Ym1 was particularly strongly increased but unaltered in any of the 
other mouse strains tested. It is a possibility, therefore, that much of the resistance of 
SJL mice is mediated at the tissue dwelling stage of H. polygyrus. At day 14 of 
infection SJL mice did not generate Th2-cells to any greater extent than the relatively 
susceptible C57BL/6 mice. CBA mice, which are most susceptible to the parasite 
were also unable to preferentially target H. polygyrus larvae in the wall of the gut, or 
induce a strong Th2 response in the MLNs.  Much future work will be needed to 
better characterise how each strain of mice responds to H. polygyrus and which 
features of the response are important to resistance. This will require the depletion of 
candidate cell-types and cytokines across the course of infection, as has been 






5 The role of methyl-binding domain (MBD) proteins 




DNA methylation, as discussed in the main introduction (Section 1.4.1), is thought to 
be a key epigenetic mechanism that plays a role in controlling the development of 
naïve T cells into differentiated effector subsets. One group of proteins that have 
been implicated in converting DNA methylation patterns into a phenotypic outcome 
are the methyl-CpG binding domain (MBD) proteins (Klose and Bird, 2006; 
Dhasarathy and Wade, 2008). As their name suggests the five members of this 
family, Methyl-CpG binding protein 2 (MeCP2), MBD1, MBD2, MBD3, and 
MBD4, all contain a conserved motif that directs interactions with methyl-CpG 
containing DNA fragments (Hendrich et al., 1999). It is currently considered that by 
virtue of these interactions and a concurrent ability to recruit histone deacetylases, 
MBD proteins are able to favour repressive chromatin organisation in regions of 
highly methylated DNA. As such they are repressive to gene expression, limiting 
DNA accessibility to transcriptional machinery. 
Although the role of MBD proteins in regulation of the immune response has 
been relatively poorly characterised two studies have implicated MBD2 as playing a 
role in ensuring that T helper subsets maintain appropriate cytokine expression 
(Hutchins et al., 2002; Hutchins et al., 2005). In vitro, MBD2-/- T cells displayed 
disordered differentiation during polarisation towards Th1 or Th2 phenotypes 
(Hutchins et al., 2002). In particular, GATA-3 was found to be dispensable for IL-4 
induction in MBD2-/- T cells leading to inappropriate IL-4 expression in otherwise 
Th1 polarised cells. Loss of MBD2 at GATA-3 binding-sites, resulting in relief of a 
repressive chromatin structure at the il-4 locus and hence GATA-less expression of 
this gene, was implicated as the mechanism by which this misexpression occurred. 
Despite this aberrant IL-4 expression in vitro, unexpectedly in vivo MBD2-/- mice 
had a defect in Th2 polarisation and were susceptible to infection with T. muris 
(Hutchins et al., 2005). The suggested mechanism for this counter intuitive result 
was that MBD2-/- T cells as well as expressing GATA-less IL-4 were also capable of 
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expressing T-bet-less IFN-γ. However this data is reconciled it is clear that MBD2 is 
integral to the stringent control of gene expression patterns required to mount an 
appropriate T helper response.  
Hand in hand with the T helper response the expression of genes associated 
with T regulatory cells must also be kept tightly in check. It is not surprising to learn 
then, that several recent reports have implicated DNA methylation as a key 
mechanism of controlling Foxp3 expression. When human natural killer (NK) T 
cells, a cell-type that do not normally express FOXP3, were treated with the 
demethylating agent 5-aza-2’deoxycytidine (5azaC) expression of this gene was 
observed in response to IL-2 (Zorn et al., 2006). In corroboration of this, bisulphite 
sequencing to determine DNA methylation patterns of murine T cells, revealed 
dramatically reduced levels of this modification at the foxp3 locus in CD4+CD25+ 
cells compared to CD4+CD25- cells (Floess et al., 2007). This reduction correlated 
with increased histone acetylation, a feature of a less condensed more accessible 
chromatin structure suggesting a mechanism by which Foxp3 expression is 
differentially regulated in these populations. Interestingly, in the same study, de novo 
induction of Foxp3 in CD25- T cells by TGF-β was associated with weak 
demethylation of regions of the foxp3 locus.    
Studies using chromatin immunoprecipitation (ChIP) to define binding-sites 
for MBDs have implicated MeCP2 as a candidate MBD family member that provides 
the link between methylation status of the Foxp3 locus and gene expression (Kim 
and Leonard, 2007). In CTLL-2 cells, a murine cytotoxic T cell line, MeCP2 has 
been found to bind to CpG islands in the promoter and also an intronic region of the 
foxp3 gene. MeCP2 is perhaps the best characterised of the MBD proteins due to the 
fact that mutations at this locus are associated with the human autistic spectrum 
disorder Rett syndrome (Amir et al., 1999). However, there have as yet been no 
reports in humans, or animal models, of direct immunological defects associated 
with MeCP2.  
This chapter focuses on the roles of MeCP2 and MBD2 in the control of Foxp3 
expression and the implications of MBD2 deficiency in the development of an 






5.2.1 MeCP2 deficiency does not affect in vitro Foxp3 induction. 
 
Given that MeCP2 binds to the foxp3 locus in CTLL-2 cells it seemed possible that a 
more open chromatin structure would be adopted in CD4+Foxp3- cells from MeCP2-/- 
mice, and hence Foxp3 expression would be more easily induced. Induction of 
Foxp3 in vitro can be achieved by stimulating CD4+ T cells with TGF-β, as 
described previously (Section 1.5.2). Purified WT and MeCP2-/- CD4+ T cells were, 
therefore, stimulated for 72 hrs with increasing concentrations of recombinant human 
(rh)TGF-β1 in the presence of plate-bound anti-CD3/anti-CD28 and exogenous IL-2. 
After this time period, expression of Foxp3 in these cultures was assessed by flow 
cytometry (Fig. 5.1 A). Very little difference was observed in Foxp3 expression 
between the WT and MeCP2-/- T cells across a concentration curve ranging from 0.1 
ng/ml to 10 ng/ml rhTGF-β1 (Fig. 5.1 A, B). Additionally, when stimulated to divide 
in the absence of TGF-β (Fig. 5.1 A, left panel) there was no evidence in MeCP2-/- 
CD4+ T cells of aberrant switch on of Foxp3 expression.  
 
5.2.2 In vivo, MeCP2 deficiency alters Foxp3 expression on a per 
cell basis. 
 
Since there was no apparent change in the ability of TGF-β to induce Foxp3 
expression in CD4+ T cells in vitro, the impact of MeCP2 deficiency on in vivo 
expression of Foxp3 was next studied. To do this analysis of the ex vivo phenotype of 
CD4+Foxp3+ T cells from the MLNs of MeCP2-/- mice, or their MeCP2+/+ 
littermates, was undertaken. MLNs were used, rather than other peripheral LNs, as 
they are a major site for accumulation of converted CD4+Foxp3+ T cells (Sun et al., 
2007), allowing natural and induced Treg populations to be studied simultaneously. 
Prior to phenotyping the T cells, it was apparent that there was a decrease in 
overall size of the MLNs from the MeCP2-/- animals (Fig. 5.2 A). If Foxp3 
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expressing cells are increased in vivo by MeCP2 deficiency, then one explanation for 
this effect would be that suppression of CD4 expansion is enhanced, leading to a 
reduction in LN size. There was, however, no change in the percentage of CD4+ T 
cells in the MLNs of MeCP2-/- compared to MeCP2+/+ animals, suggesting there was 
a concurrent proportional decrease in other lymphocyte populations (Fig. 5.2 B). 
Similarly the percentage of CD4+Foxp3+ cells in the MLNs was not altered (Fig. 5.2 
C). This data is in agreement with the unchanged percentage of Foxp3+ cells induced 
in vitro (Section 5.3.1).  
Despite the lack of change in proportions of Foxp3+ T cells, MeCP2 
deficiency did have a more subtle effect on Foxp3 expression. Within MeCP2-/- 
CD4+Foxp3+ cells Foxp3 expression was enhanced. On average, the geometric mean 
Foxp3 intensity was found to be 1.5-fold higher than in MeCP2+/+ cells (Fig. 5.2 D). 
 One result of increased Foxp3 expression may be upregulation of Treg 
associated markers, such as CD25 and CD103. When expression of these proteins 
was assessed on CD4+Foxp3+ T cells from MeCP2-/- mice no increase was evident 
compared to their MeCP2+/+ counterparts (data not shown).    
 
5.2.3 MBD2 deficiency enhances TGF-β-induced Foxp3 
expression. 
 
5azaC treatment of T cells suggested that the foxp3 locus is heavily controlled by 
DNA methylation (Polansky et al., 2008). With this in mind, the relatively small 
enhancement of Foxp3 expression associated with MeCP2 deficiency implied that 
another MBD family member may be more important in binding to methylated sites, 
and repressing expression of this gene. 
 Based on published data (Su et al., 2004) MeCP2 is predominantly expressed 
in the brain whilst MBD2 is strongly expressed in immune cells (Fig. 5.3). 
Previously, it has been stated that MBD2 deficient animals do not have increased 
numbers of CD4+Foxp3+ cells in their naïve state (Hutchins et al., 2005). However, 
this did not exclude the possibility that induction of Foxp3 in CD4+Foxp3- T cells 
may be altered. Foxp3 induction in WT compared to MBD2-/- CD4+ T cells was 
assessed across a concentration curve of rhTGF-β1 from 0.01 ng/ml – 10 ng/ml (Fig. 
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5.4 A, B) in the same manner as for MeCP2-/- CD4+ T cells (Section 5.2.1). After 72 
hrs, it was apparent that Foxp3 was induced far more frequently in MBD2-/- CD4+ T 
cells than WT. The most dramatic difference was at 1 ng/ml where over twice the 
number of MBD2-/- cells were expressing Foxp3 compared to WT (69% versus 
34%). Interestingly, despite the dramatic changes in induction there was no evidence 
of inappropriate Foxp3 expression in the absence of TGF-β stimulation (Fig. 5.4 A, 
left panel).   
 
 
5.2.4 Temporal expression of Foxp3 is altered in MBD2 deficient 
CD4+ T cells. 
 
In light of the increases in Foxp3 expression observed in MBD2-/- T cells, it seemed 
possible that deficiency in this gene relieves normal restrictions on the foxp3 locus. If 
so, then Foxp3 would be more strongly upregulated in early cell cycles when 
compared to WT. A similar effect on early protein expression has already been 
reported in respect to IL-4 production by MBD2-/- T cells under Th2 polarising 
conditions (Hutchins et al., 2002). CD4+ cells were labelled with the intracellular 
protein binding fluorescein derivative, carboxyfluorescein diacetate succinimidyl 
ester (CFSE), to allow quantitative assessment of cell divisions. Cells were then 
stimulated to divide in the presence of varying amounts of rhTGF-β1, or in the 
absence of this cytokine. After 72 hrs expression of Foxp3 in each round of cell 
division was measured by flow cytometry. 
 Proliferation of the entire CD4+ T cell population was first characterised. In 
the cultures that did not receive rhTGF-β1, very little change to the proliferation 
profile was apparent (Fig. 5.5 A, left panel, C). Upon addition of even low levels of 
rhTGF-β1, clear variations in proliferation were apparent (Fig. 5.5 A, B). At all 
concentrations of rhTGF-β1 there was an approximately 2-fold increase in 
proportion of cells still in generations 0 and 1, whilst there was a concurrent decrease 
in the proportion of cells in generations 3 and 4. A similar proportion of cells were 
found in generation 2 (Fig. 5.5 A, B). 
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  The same analysis was perfomed within the gated Foxp3+ population from 
the same cell cultures (Fig. 5.6). As was observed previously the Foxp3+ population 
is almost doubled in the MBD2-/- cultures (Fig. 5.6 A). When the proliferation within 
this population was analysed a slight trend towards an increased proportion of cells 
within the earlier cell divisions was evident, although very small compared to that 
observed for the whole population (Fig. 5.5 B, Fig. 5.6 B). 
 
 
5.2.5 Aberrant IFN-γ  production, under Foxp3 inducing conditions, 
in MBD2 deficient cultures. 
 
A feature described for MBD2-/- T cells when polarised towards a Th1 or Th2 
phenotype was enhanced production of IFN-γ (Hutchins et al., 2002; Hutchins et al., 
2005). When WT cells were cultured in the presence of TGF-β, IFN-γ production 
was reduced compared to untreated controls (Fig. 5.7, left panel). In contrast to this, 
in MBD2-/- cells IFN-γ was increased in the presence of TGF-β. Levels of IFN-γ 
were also higher in MBD2-/- cells under non-polarising conditions compared to WT. 
 As suggested from previous data, this increase in IFN-γ was not attributable 
to decreased production of the counter-regulatory cytokine IL-10 (Fig. 5.7, right 
panel). MBD2-/- T cells secreted higher levels of IL-10 than WT T cells when TGF-β 
was included in the cultures. However, IL-10 levels were reduced in both WT and 
MBD2-/- T cells in the presence of TGF-β, compared to untreated cultures. 
 
5.2.6 Percentage of CD4+Foxp3+ T cells are increased, in vivo, in 
MBD2-/- mice. 
 
In vitro, MBD2 deficiency has a clear impact on Foxp3 induction and T cell 
proliferation. It seemed likely, therefore, that MBD2-/- mice would have an altered 
Treg compartment, particularly in sites with a high induced Treg component, such as 
the MLNs (Section 5.2.2). Total cell numbers from the MLNs of MBD2-/- mice were 
unaltered compared to WT (Fig. 5.8 A), but, in contrast to previous reports (Hutchins 
et al., 2002), the percentage of CD4+ T cells in the MLNs were found to be decreased 
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by approximately 40% (Fig. 5.8 B). Despite this decrease, when Tregs were 
measured as a percentage of the MLNs they were found to be unchanged (Fig. 5.8 C, 
D). This was due to a dramatic percentage increase of Foxp3+ cells within the CD4+ 
T cell population of approximately 30%.     
 
 
5.2.7 Expression of CD103 is upregulated on CD4+ T cells from 
MBD2-/- mice. 
 
Next the activation state of the CD4+Foxp3+ cells in the MLNs was characterised. 
CD25 expression was reduced by a small but significant percentage in MBD2-/- cells 
compared to WT (Fig 5.9 A). This decrease was limited to the CD4+Foxp3+ 
population as within the CD4+Foxp3- population a small increase in CD25 
expression was evident (Fig. 5.9 B). No significant changes were observed in the 
CD4- cells (Fig. 5.9 C), which represent predominantly CD8 T cells, and B cells.  
Changes in CD103 expression were very different to those observed for 
CD25. CD103 high cells were markedly increased within the CD4+Foxp3+ 
population increasing by around 40% (Fig. 5.10 A). Similarly striking increases in 
CD103 expression also occurred in the CD4+Foxp3- compartment (Fig. 5.10 B). This 
was not a general increase in CD103 expression however, as the CD4- population 
had decreased expression of CD103 (Fig. 5.10 C).   
Despite previous data stating that there was no difference in lymphocyte 
populations in MBD2-/- mice (Hutchins et al., 2002), a deficit in CD4+ cells was also 
apparent in the spleens of these animals (5.11 B). However, while there was a trend 
towards increases in Foxp3 expression, it did not reach significance (Fig. 5.11 C). 
When the CD4+Foxp3+ cells in the spleens were phenotyped for CD25 and CD103 
similar observations were made to these cells in the MLNs (Fig. 5.11 D, E). 





5.2.8 MBD2 deficiency is associated with reduced MLN cell 
numbers but normal percentages of CD4+ T cells in 
response H. polygyrus infection. 
 
The chronic persistence of H. polygyrus is associated with increases in CD4+Foxp3+ 
T cells at day 28 of infection. A possible implication of the increased CD103 
expression and increased numbers of Foxp3+ cells in MBD2-/- mice is that they will 
be more susceptible to infections such as H. polygyrus that are associated with a 
regulatory environment. To assess this, mice were sacrificed 14 days after oral 
inoculation with 200 H. polygyrus L3 larvae, adult worm burdens counted and MLNs 
phenotyped. Although there was a trend towards increased worm burdens in  
MBD2-/- mice this did not reach statistical significance (Fig. 5.12 A).  
MBD2-/- mice infected with T. muris were shown to have IBD-like gut 
pathology (Hutchins et al., 2005), which typically leads to weight loss, so mice were 
weighed at the beginning and end of the experiment to assess whether any weight 
loss occurred during H. polygyrus infection. MBD2-/- mice were slightly smaller than 
age-matched WT mice at the start of the experiment (Fig. 5.12 B) but over the course 
of the H. polygyrus infection there was no difference in weight change (Fig. 5.12 C). 
Surprisingly, although cell numbers in MLNs were similar in naïve MBD2-/- 
and WT mice, at day 14 of H. polygyrus infection MLNs had expanded to a much 
greater extent in WT than MBD2-/- mice (Fig. 5.12 D). The T cell compartment had 
differentially expanded in the MLNs of the MBD2-/- mice during infection as they 
now made up a similar percentage of the LNs to WT (Fig. 5.12 E). There was also no 
longer a difference in the percentage of CD4+ cells expressing Foxp3 (Fig. 5.12 F). 
 
 
5.2.9 Difference in CD103 expression between WT and MBD2-/- 
mice is reduced by day 14 of H. polygyrus infection. 
 
In infected mice CD25 expression on CD4+Foxp3+ cells was much the same as in the 
naïve setting (Fig. 5.13 A) but CD25 expression on the CD4-Foxp3+ cells was no 
longer different between the two groups (Fig. 5.13 B). On the CD4- cells there was 
no change between the very small percentage of CD25+ cells (Fig. 5.13 C). 
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The difference between the percentage of CD103 high cells in both 
CD4+Foxp3+ (Fig. 5.14 A) and CD4+Foxp3- (Fig. 5.14 B) populations was decreased 
between WT and MBD2-/- mice during infection. In the CD4- population CD103 
expression was comparable in both WT and MBD2-/- animals (Fig. 5.14 C). Hence, 
infection appears to promote a similar phenotype in WT mice to that which initially 
exists in naïve MBD2-/- mice. 
 
 
5.2.10 ICCS reveals no evidence of aberrant cytokine expression 
in Th1 or Th2 cells.  
 
A possible explanation for increased antigen-specific IFN-γ observed in the MLNs 
from H. polygyrus infected MBD2-/- mice is that there is an inability to polarise a T 
helper cell response. This could either be due to misexpression of IFN-γ in IL-4 
producing cells (Hutchins et al., 2002) or due to MBD2 playing a role in control of 
IFN-γ expression (Hutchins et al., 2005). ICCS was performed on cells directly ex 
vivo from day 14 H. polygyrus infection. IL-4 production was observed in both 
groups and no significant difference was detectable between them (Fig 5.15 A, B). 
There was also no evidence of incomplete polarisation as there was no change in the 
proportion of IL-4+IFN-γ+ double producing cells (Fig. 5.15 A, B). IFN-γ production, 




Figure 5.1 – MeCP2 deficiency does not affect in vitro Foxp3 induction.  
 
MACS-sorted CD4+ cells from MeCP2-/-, or MeCP2+/+ littermate controls, stimulated 
to proliferate with plate-bound anti-CD3/anti-CD28, were cultured in the presence of 
increasing concentrations of rhTGF-β1 and a constant amount of exogenous IL-2 for 
72 hrs. As a control rhTGF-β1 was excluded from some cultures. (A) Representative 
plots of Foxp3 expression without rhTGF-β1, and selected concentrations of rhTGF-
β1. (B) Graph showing Foxp3 expression in WT and MeCP2-/- cells, as concentration 
of rhTGF-β1 is increased. Data are taken from a single experiment using CD4+ cells 





Figure 5.2 – In vivo, MeCP2 deficiency alters Foxp3 expression on a per cell 
basis.  
 
MLNs were removed from naïve, MeCP2-/- mice, or MeCP2+/+ littermates, and 
phenotyped. (A) Cellularity of MLNs. (B) FACS quantification of CD4+ 
lymphocytes as a proportion of total MLN cells. (C) FACS quantification of Foxp3+ 
cells as a proportion of CD4+ lymphocytes. (D) Representative FACS plots of CD4 
vs Foxp3 on CD4+ population, and histogram showing intensity of Foxp3 geometric 
mean in MeCP2-/- CD4+Foxp3+ T cells compared to MeCP2+/+ cells (left panels). 
Bar chart of mean Foxp3 geometric mean values for CD4+Foxp3+ T cells from 
individual animals (right panel). The experiment shown here is representative of 
two similar experiments.   Five mice were analysed in the MeCP2-/- group and three 
mice in the MeCP2+/+ group. Results of Student’s t test: **, P<0.01. Error bars 







Figure 5.3 – Expression profiles of MeCP2 and MBD2. 
 
Tissue specific mRNA expression profiles of (A) MeCP2 and (B) MBD2. Black 
line, median value calculated across all tissues. Blue line, 3x median value. Regions 
of the brain (Red box) and, lymphocyte populations and thymus (Green Box) are 
highlighted.   Graph is adapted from, Symatlas (Genomics Institute of the Novartis 





Figure 5.4 – MBD2 deficiency enhances TGF-β-induced Foxp3 expression.  
 
MACS sorted CD4+ spleen cells from WT BALB/c, and MBD2-/- mice, stimulated to 
proliferate with plate-bound anti-CD3/anti-CD28, were cultured in the presence of 
increasing concentrations of rhTGF-β1 and a constant amount of exogenous IL-2 for 
72 hrs. As a control rhTGF-β1 was excluded from some cultures. (A) Representative 
plots of Foxp3 expression without rhTGF-β1 (left panel), and selected 
concentrations of rhTGF-β1 (right panel). (B) Graph showing Foxp3 expression in 
WT and MBD2-/- cells, as concentration of rhTGF-β1 is increased. Data shown are 
taken from a single experiment using CD4+ cells isolated from splenocytes of pooled 







Figure 5.5 – Enhanced suppression of proliferation in MBD2-/- CD4+ T cells in 
response to rhTGF-β1.  
 
MACS-sorted CD4+ T cells were labelled with CFSE and cultured under conditions 
favouring Foxp3 induction with increasing concentrations of rhTGF-β1. As a control 
rhTGF-β1 was not added to some cultures. (A) Histogram of cell division, as 
assessed by reduction in CFSE intensity, in both WT and MBD2-/- cultures. Cell 
generation gating calculated by Flow Jo. (B, left panel) Graphic representation of 
percentage of cells in each generation in WT and MBD2-/- cells in the absence of 
rhTGF-β1. (B, right panel) Graphic representation of percentage of cells in each 
generation in WT and MBD2-/- cells in the presence of increasing concentrations of 
rhTGF-β1. White bars = WT, pink bars = MBD2-/- cells. Data shown are from a 







Figure 5.6 – Cell generation associated expression of Foxp3 is unchanged in 
MBD2 deficient CD4+ T cells.  
 
(A) Cells from Fig. 5.5 were costained with Foxp3. (B) Histograms and graphical 
representations of cell generations within Foxp3 expressing population. White bars = 















Figure 5.7 – Foxp3 expressing MBD2-/- CD4+ T cells aberrantly express IFN-γ .  
 
Cytokines were measured by ELISA in supernatants from CD4+ cells cultured under 
non-polarising or Foxp3+ inducing conditions (+ TGF-β). IFN-γ, (left panel). IL-10, 
(right panel). Data shown are triplicate wells from a single experiment but 
representative of two similar experiments. Error bars represent the S.E.M. Results of 




Figure 5.8 – Percentage of CD4+Foxp3+ T cells are increased, in vivo, in naïve 
MBD2-/- mice.  
 
MLNs were removed from naïve, BALB/c WT, or MBD2-/- mice, and phenotyped. 
(A) Cellularity of MLNs. (B) FACS quantification of CD4+ lymphocytes as a 
proportion of total MLN cells. (C) Representative FACS plots of Foxp3 against 
CD4. (D) FACS quantification of CD4+Foxp3+ T cells as a proportion of the total 
MLN cells. (E) FACS quantification of Foxp3+ cells as a proportion of CD4+ 
lymphocytes. The experiment shown here is representative of two similar 
experiments.   Four mice were analysed in the each group. Results of student’s t test: 




Figure 5.9 – Expression of CD25 on CD4+ Foxp3+ T cells from MBD2-/- mice is 
decreased.  
 
CD25 was analysed by FACS on different cell populations from the MLNs of 
BALB/c WT, or MBD2-/- mice. Representative plots and bar charts of data from four 
mice per group showing: (A) CD25 expression on CD4+Foxp3+ T cells. (B) CD25 
expression on CD4+Foxp3- T cells. (C) CD25 expression on the total CD4- cell 
population. The experiment shown here is representative of two similar experiments. 





Figure 5.10 – Expression of CD103 is upregulated on CD4+ T cells from MBD2-/- 
mice.  
 
CD103 expression was analysed by FACS on different cell populations from the 
MLNs of BALB/c WT, or MBD2-/- mice. (A) CD103 expression on CD4+Foxp3+ T 
cells. (B) CD103 expression on CD4+Foxp3- T cells. (C) CD103 expression on the 
total CD4- cell population. The experiment shown here is representative of two 





Figure 5.11 – Phenotypic changes to CD4+ T cells are apparent in the spleen.  
 
Spleen cells were taken from same animals as MLNs. (A) Total spleen cell counts. 
(B) Percentage of CD4+ T cells in spleens. (C) Foxp3+ cell as a percentage of the 
CD4+ population. (D) CD103 expression on different spleen cell populations. (E) 
CD25 expression on different spleen cell populations. The experiment shown here is 
representative of two similar experiments. Results of Student’s t test: *, P<0.05; **, 












Figure 5.12 – MBD2 deficiency is associated with reduced MLN cell numbers 
but normal CD4+ T cells in response to H. polygyrus infection.  
 
BALB/c WT or MBD2-/- mice were infected orally with 200 H. polygyrus L3 larvae 
and then sacrificed 14 days later. (A) Adult worm burden in the lumen of duodenum. 
(B) Initial weight of mice prior to infection. (C) Change in weight after 14 days 
infection with H. polygyrus. (D) Cellularity of MLNs on day 14 of H. polygyrus 
infection. (E) FACS quantification of the proportion of CD4+ T cells in the total 
MLN cells. (F) FACS quantification of the proportion of Foxp3+ cells within the 




Figure 5.13 – Difference in CD25 expression between WT and MBD2-/- mice is 
maintained at day 14 of H. polygyrus infection.  
 
CD25 expression was analysed by FACS on different cell populations from the 
MLNs of day 14 H. polygyrus infected BALB/c WT, or MBD2-/- mice. 
Representative plots and bar charts showing: (A) CD25 expression on CD4+Foxp3+ 
T cells. (B) CD25 expression on CD4+Foxp3- T cells. (C) CD25 expression on the 
total CD4- cell population. The experiment shown here is representative of two 





Figure 5.14 – Difference in CD103 expression between WT and MBD2-/- mice is 
reduced by day 14 of H. polygyrus infection.  
 
CD103 expression was analysed by FACS on different cell populations from the 
MLNs of day 14 H. polygyrus infected BALB/c WT, or MBD2-/- mice. 
Representative plots and bar charts showing: (A) CD103 expression on CD4+Foxp3+ 
T cells. (B) CD103 expression on CD4+Foxp3- T cells. (C) CD103 expression on the 
total CD4- cell population. The experiment shown here is representative of two 






Figure 5.15 – ICCS reveals no evidence of aberrant cytokine expression in IL-4 
or IFN-γ  producing cells.  
 
Ex vivo ICCS of the CD4+ T cell population of MLNs from day 14 H. polygyrus 
infected BALB/c WT and MBD2-/- mice. (A) Sample plots of IL-4 against IFN-γ and 
their respective isotypes. Gates represent IL-4+IFN-γ-, IL-4+IFN-γ+, and IL-4-IFN-γ+ 
populations. (B) Bar charts of data from individual animals. The experiment shown 
here was performed once. The WT group contains six mice and the MBD2-/- group 








DNA methylation-mediated gene regulation plays an essential role in differentiation 
of T cells towards specific effector phenotypes. Whether this form of gene regulation 
is similarly important in differentiation of T regulatory cells, and if it impacts T 
effector : T regulatory cell balance, is less well understood. This chapter has begun to 
address this issue by characterising the role of two MBD family members, MeCP2, 
and MBD2, in control of Foxp3 expression.  
Initially, an in vitro Treg induction assay was used to ascertain whether 
deficiency in either of these genes affected the ability of CD4+ T cells to switch on 
Foxp3 in response to TGF-β. Using MeCP2-/- cells, no change was detected in this 
assay compared to WT. This suggested that if MeCP2 did have a role in repressing 
the foxp3 locus it did not primarily affect regions involved in de novo expression of 
Foxp3 after exposure to TGF-β. In sharp contrast to this, induction of Foxp3 in 
MBD2-/- cultures was markedly increased compared to WT. At this time the 
mechanism behind this increase is not understood, however, two possibilities seem 
likely.  
Firstly, given that the foxp3 locus is methylated, MBD2 may bind directly to 
this site and inhibit TGF-β-activated transcription factor access. Alternatively, 
MBD2 may be acting indirectly, for example repressing components of the TGF-β 
pathway. It has already been shown that in certain situations components of the TGF-
β pathway are controlled by DNA methylation. Breast  (MCF-7L) and colon (GEO) 
cancer cell lines treated with 5azaC upregulated expression of TGF-βRI and TGF-
βRII in a manner that is dependent upon downregulation of the transcription factor 
Sp3 (Ammanamanchi and Brattain, 2001). 
Assessing whether TGF-β responsiveness is accentuated in an alternative 
setting, such as polarisation of Th17 cells, may be one method of distinguishing 
between the options presented above. Of course it is possible that both mechanisms 
are at play, in which case future work will need to focus on taking a genome wide 
approach to identify regions of MBD2 localisation, alongside changes in gene 
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expression patterns, in deficient CD4+ T cells. Transcript analysis, for example by 
SOLEXA sequencing, in tandem with MBD2 ChIP and mRNA extraction would be 
a strategy by which this information could be acquired. 
In concert with this in vitro data, the proportion of Foxp3+ cells within the 
CD4 T cell compartment of the MLNs was unchanged in MeCP2-/-, but significantly 
increased in MBD2-/-, animals, when compared to WT controls. MeCP2 deficiency, 
however, was not without effect in vivo as the level of Foxp3 protein within 
individual Tregs was increased in this setting. The work in this chapter failed to 
address the implications of this finding. One outcome may be that these cells 
overexpress signature Treg genes known to be controlled by Foxp3 (Zheng et al., 
2007), although the classical activation markers CD25 and CD103 were found to be 
unchanged. If this situation occurs then it seems probable that MeCP2-/- Tregs would 
have increased suppressive activity. This could easily be addressed in vitro by 
comparing the capacity of these cells from MeCP2-/- and WT animals to inhibit 
proliferation of a responder population. 
 The same assay should also be performed using MBD2-/- Tregs as evidence 
suggests that they too would have the same phenotype. In vivo, MBD2-/- 
CD4+Foxp3+, and CD4+Foxp3-, T cells had marked elevation of CD103 expression. 
Upregulation of CD103 has been associated with increased suppressive activity in a 
number of settings (Section 1.5.1). Interestingly, this observation regarding CD103 
lends credence to the earlier suggestion that MBD2 may indirectly control Foxp3 
induction by repressing a component of the TGF-β response pathway; CD103 
expression is positively regulated by TGF-β (Section 1.5.1).  
An additional characteristic of MBD2 deficiency was a deficit in CD4+ T 
cells in the MLNs and spleen. It is plausible that this is not only explained by a 
change in the ratio between regulatory and responder cells but also an enhancement 
of the suppressive capacity of each regulatory cell. Alternatively, this could be 
reflective of effects of MBD2 on the non T cell compartment, for example B cells. 
MBD2 is expressed in B cells (Fig. 5.3), but its role in this cell-type has not been 
addressed. 
Previously, it has been reported that MBD2-/- mice have increased 
susceptibility to T. muris (Hutchins et al., 2005). In this setting, an inappropriate 
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Th1-type response developed, although from analysis of IgG1 production, there was 
evidence of Th2 polarisation. To explain this result a competition between MBD2 
and T-bet at the ifn-γ locus was suggested, leading to ‘T-bet-less’ IFN-γ expression 
in Th2 cells. In corroboration of this when T-bet was retrovirally transduced into 
CD4+ cells, cultured under Th2 conditions, IFN-γ expression was increased in the 
MBD2-/- cells.  It was not possible, however, using ChIP, to show direct binding of 
MBD2 at the ifn-γ locus, nor was there any in vivo evidence of the predicted IL-
4+IFN-γ+ Th cells that should have been generated during T. muris infection. 
Fourteen days after initial infection with H. polygyrus MBD2-/- mice, as was 
the case for T. muris, showed a trend towards increased adult worm burden. When 
the CD4+ T helper phenotype in the MLNs was analysed at this time point no 
‘confused’, IL-4+IFN-γ+, double-producing cells were apparent, and no change in the 
percentage of IL-4+IFN-γ- producing cells could be discerned. These data imply that 
in contrast to in vitro reports (Hutchins et al., 2002), a normally differentiated 
effector population can be derived in the presence of a Th2 driving pathogen in vivo. 
The lack of change in these cells could be reflective of the time point chosen but this 
seems unlikely as IL-4+IFN-γ+ cells were still found to be enhanced as late as 6 
weeks when MBD2-/- mice were infected with a Th1-driving pathogen, L. major 
(Hutchins et al., 2005).  
At day 14 of H. polygyrus infection if any trend towards decreased resistance 
is explained by cytokine misexpression, it is due to the increase in IFN-γ single 
positive cells. One source for the increased IFN-γ producing cells could be 
inappropriate expression of this gene by T cell subsets other than Th2 cells, such as 
Treg cells or Th17 cells. The aberrant secretion of IFN-γ by TGF-β induced Foxp3+ 
MBD2-/- T cells in vitro, provides support to the concept that this may well occur in 
vivo. Whether this is the case, could be ascertained by co-staining intracellular IFN-γ 
with Foxp3, or previously uncharacterised lineage specific cytokines.     
Another evident immunological defect in the absence of MBD2 was a failure, 
in the context of H. polygyrus infection, to appropriately expand the entire 
lymphocyte population. A defect in expansion of MBD2-/- CD4+ cells was also 
observed in vitro. It is tempting to speculate that this occurs due to the increased 
proportion, and phenotypically aberrant, Foxp3+ Tregs present in MBD2 deficiency, 
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keeping a tighter hold over proliferation of responder lymphocytes towards the 
pathogen. Both in vitro and in vivo, antibody depletion of CD25+ cells, and hence the 
majority of Foxp3+ cells, would help to assess whether MBD2-/- Tregs do in fact have 
a greater impact on lymphocyte proliferation. However, once again, this lack of 
expansion could be dependent on the non-CD4+ T cell population. B cells are an 
obvious candidate, since they dramatically expand early in H. polygyrus infection 
(Parker and Inchley, 1990).  In future work, it would not only be interesting to better 
phenotype this population but also to look for changes in serum antibody isotypes 
when MBD2 is deficient. 
Clearly, a major limitation to the data regarding H. polygyrus infection 
discussed here is that despite striking immunological differences between WT and 
MBD2-/- animals at day 14 of infection, that are suggestive of decreased resistance, a 
significantly reduced adult worm burden was not recorded. Since worm expulsion 
continues to occur after day 14, if mice were sacrificed at a later stage of infection a 
more marked difference may be observed. 
Overall, the data presented in this chapter, implicate for the first time 
interaction of MBDs with methylated DNA as an important mechanism to control 
Foxp3 expression within the Treg compartment. General understanding of how gene 
expression is controlled by epigenetic modifications, and specifically MBDs, is still 
in its infancy. One particularly interesting question is whether the different MBD 
family members have distinct or overlapping functions in control of gene expression. 
In regard to this it would have been instructive to characterise the response of 
MeCP2-/- mice to infection. The enhanced per cell expression of Foxp3 and the 
reduced MLN size of these mice, described here, suggest that deficiency of this gene 
may, like MBD2, have immunological consequences. 
An important caveat when interpreting any data from both MeCP2-/-, and 
MBD2-/-, mouse models is that these deficiencies lead to non-immunological defects, 
which may impact on the immune system. MeCP2-/- mice have defects in motor 
activity and reduced body weight, whilst MBD2-/- animals have abnormal gut 
formation (Berger et al., 2007), perhaps bringing about changes to their GALT. In 
the long term, problems of this nature could be avoided by generating animals that 
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are deficient in specific MBDs within the Foxp3 compartment, whilst in the short 
term bone marrow chimaeras could also be used. 
Recent work using inhibitors that broadly affect epigenetic mechanisms has 
shown how targeting the immune system at this level can dramatically alter the 
outcome of the final response (Tao et al., 2007). When mice were treated with 
HDAC inhibitors, Foxp3 was increased in vivo leading to suppression of colitis in a 
DSS-induced model. A better understanding of the mechanisms by which Treg cells 
are affected by epigenetic modifications, and the proteins responsible for their 
translation, such as MBDs, may in future allow development of new treatments that 
target very specific components of this network in order to modify the outcome of an 
immune response.   
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6 Helminth secretions induce de novo Foxp3 




Over the course of an immune response to an invading pathogen, Foxp3+ Treg cells 
play a key role in controlling the voracity of the effector response (Section 1.5). The 
host aims to achieve a balance such that potentially harmful immune-mediated 
pathology is limited, whilst sufficient immune pressure is maintained against the 
infectious agent (reviewed by (Belkaid, 2007)). In some infection settings, including 
mycobacteria (Scott-Browne et al., 2007), leishmaniasis (Belkaid et al., 2002), and 
filariasis (Taylor et al., 2005), the Foxp3+ Treg component is favoured and as a result 
the host fails to clear the infection. Currently, it is not clear whether this situation 
represents an intrinsic failure of the host to appropriately balance the regulatory and 
anti-pathogen response, or if pathogens have developed mechanisms to selectively 
enhance Foxp3+ Treg suppression.  
A problem associated with distinguishing between these two possibilities, is 
that in many systems it is difficult to separate Foxp3+ Treg increases that may be due 
to parasite immunomodulation, from those mediated by an ongoing immune 
response. Models of helminth infection are ideally suited to addressing this problem 
as their immunomodulatory factors, ES (Section 1.7), can be screened for Foxp3+ 
Treg enhancing activities in a naïve setting. H. polygyrus is one example of a parasite 
that might be predicted to harbour activity of this kind in its ES, since in vivo over 
the first 28 days of infection, levels of Foxp3 expression within the CD4+ T cell 
population of the MLNs is significantly increased (Section 1.5). 
In this chapter, changes to the Foxp3+ Treg compartment early in H. polygyrus 
infection at sites local to the parasite are characterised. Furthermore, HES treatment 
of naïve T cells, in vitro, is used as a method to assess whether a helminth has 
evolved mechanisms to directly impact this key aspect of the regulatory arm of the 
immune response. 




6.2.1 Foxp3 increases occur at day 7 in lymphocyte populations 
local to the parasite. 
 
Although C57BL/6 mice present a change in Foxp3 expression at day 7 of infection 
in the MLNs, it is unknown whether differences are also observed in lymphocyte 
populations local to the parasite. At this time point, H. polygyrus L4 larvae are 
encysted in the sub-mucosal layer of the small intestine (Section 1.3.3). By 
sectioning and antibody-staining, it has been shown that Foxp3+ cell numbers 
increase in the tissue surrounding the helminth at day 6 of infection (Rausch et al., 
2008). However, these authors made no attempt to compare the frequency of Foxp3+ 
cells in this environment to those in the MLNs, or to characterise differences in the 
specific lymphoid compartments of the small intestine.   
 IELs, LPLs, and Peyer’s patches, were isolated from naïve C57BL/6 mice, or 
mice that had been inoculated 7 days earlier with H. polygyrus L3 larvae. Cells were 
phenotyped by flow cytometry, and compared to MLNs. Naïve levels of CD4+ T 
cells expressing Foxp3 varied depending on compartment. IELs had a lower mean-
percentage, 6.2%, than either LPLs, 15.1%, Peyer’s patches, 11.0%, or MLNs, 
12.8% (Fig. 6.1). Within the IELs a subset of T cells co-express CD4 and CD8; as 
Foxp3+ cells were only apparent in the CD4 single-positive group irrespective of 
infection status, all values were calculated based on this population alone. In the 
presence of H. polygyrus, mean Foxp3 expression increased in all compartments: 
IELs, mean 9.8%, LPLs, mean 17.7%, Peyer’s patches, mean 16.8%, and MLNs, 
mean 15.8%. This confirms that in C57BL/6 mice at sites closest to the infection 




6.2.2 Induced Foxp3+ Tregs are present in the MLNs during H. 
polygyrus infection. 
 
The expansion of Foxp3+ T cells over the course of H. polygyrus infection, could be 
due to, proliferation of natural Foxp3+ Tregs, conversion followed by expansion of 
naïve effector T cells, or a combination of both processes. De novo induction of 
Foxp3 has been described following adoptive transfer of a Foxp3- cell population, 
from Foxp3eGFP reporter mice, into recombination-activating gene 1-deficient (RAG-
1-/-) hosts (Sun et al., 2007), and after OVA-feeding of DO11.10 SCID mice 
(Coombes et al., 2007). There have been no data demonstrating whether Foxp3 
induction occurs in WT animals over the course of any infection. 
One day prior to infection with H. polygyrus, sorted Ly5.2+ CD4+ Foxp3-
GFP- T cells (from Foxp3-GFP knock-in animals (Fontenot et al., 2005)) were 
transferred IV into congenic Ly5.1+ C57BL/6 mice (Fig. 6.2 A). To distinguish GFP+ 
cells from any autofluorescence, at the end of the experiment, the same number of 
MACS sorted WT Ly5.2+ CD4+ cells were transferred at the same time into another 
group of Ly5.1+ C57BL/6 mice (Fig. 6.2 A). 28 days after inoculation with H. 
polygyrus larvae, MLNs were removed from infected mice, alongside naïve controls, 
and peripherally induced Tregs identified by their expression of Ly5.2 and Foxp3-
GFP (Fig. 6.2 B). Due to the extremely low percentages of induced Tregs, prior to 
analysis, samples from each group were pooled, and CD4+ cells pre-enriched by 
MACS sorting (Fig. 6.2 A).  
 Induction of Tregs appeared to have occurred in both naïve and infected 
mice. Foxp3-GFP+ cells made-up 0.54%, and 0.85%, of the CD4 T cell population, 
respectively (Fig. 6.2 B, upper panels). In order to assess whether this represents an 
increase in proportion of induced Foxp3+ Tregs during infection, rather than 
experimental variation, the study will need to be repeated several times. What is 
clear, from these data, is that the absolute number of Foxp3-GFP+ cells from infected 
mice is far greater than from naïve animals, as the MLNs enlarged dramatically in 




6.2.3 HES increases percentage of Foxp3 expressing T cells in, 
naïve, mitogen stimulated splenocyte cultures. 
 
As stated in the introduction to this chapter (Section 6.1), if any of the bias towards 
CD4+ T cell expression of Foxp3 is due to manipulation by H. polygyrus, it is most 
probably mediated by the ES. To begin with, the ability of HES to enhance 
expression of Foxp3 within the CD4+ T cell compartment of naïve C57BL/6 
splenocyte cultures was assessed. Previously, it has been shown that a requirement 
for Foxp3 induction is T cell receptor (TCR) ligation. The T cell mitogen 
Concanavalin (Con) A was, therefore, included in some experimental groups. In 
cultures treated with HES (10 µg/ml) plus Con A, the percentage of Foxp3+ CD25+ 
cells within the CD4+ T cell population was increased more than four-fold over a 48 
hr period compared to Con A alone (Fig. 6.3 A, C). As expected, Con A alone 
strongly up-regulated CD25, consistent with polyclonal activation, but no evidence 
of Foxp3 enhancement was apparent (Fig. 6.3 A, C). HES acted in a dose-dependent 
manner in combination with Con A but failed to have any impact on Foxp3 in its 
absence (Fig. 6.3 C). 
 Although unlikely, it was plausible that the effects of HES were attributable 
to heat-stable contaminants, such as LPS. To address this, cultures were stimulated 
with hiHES plus Con A. In this situation, Foxp3 increases were abrogated, 
suggesting that this phenotype is most probably dependent on a heat-labile parasite 
component rather than a contaminant (Fig. 6.3 A, C). 
This was the first time that a pathogen-associated factor had been 
demonstrated to interact with host cells to increase the percentage of T cells 
expressing Foxp3. There was a possibility that this was a general property of 
pathogen-derived products but had not been observed since they had not been 
assayed in this particular manner. Preparations from the gram-negative bacteria 
Salmonella typhimurium (Sa) and the gram-positive bacteria P. acnes (Pa) were 
found to be devoid of Treg cell-increasing activity. Similarly, the synthetic TLR-2 
ligand PAM-3-CSK4, and the TLR-4 ligand LPS had no effect, along with the other 




6.2.4 HES alters expression of cytokines released in response to 
Con A. 
 
In addition to Foxp3 staining, supernatants from the same cultures were assayed, by 
ELISA, for the presence of IFN-γ, IL-4, and IL-10. When naïve splenocytes were 
stimulated with Con A alone, upregulation of all cytokines occurred (Fig. 6.4). The 
stimulation of IFN-γ secretion was particularly striking, rising from below detection 
limit to 32 ng/ml. Treatment with HES, in the presence of Con A, led to heightened 
IL-4, and IL-10, levels, but inhibition of IFN-γ, in a concentration dependent fashion. 
At 10 µg/ml HES inhibited IFN-γ over two-fold. As was observed in respect to 
Foxp3 percentage change, the effects of HES on cytokine production were heat-
labile. Once again differences were only apparent when cells were co-stimulated 
with Con A; HES alone did not elicit IFN-γ, IL-4, or IL-10 production.      
 
 
6.2.5 Foxp3 increases in response to HES are limited by strong 
TCR stimulation. 
 
Since Con A is a lectin from the jack-bean Canavalia ensiformis, HES-driven 
increases in Foxp3 could be mediated specifically by this mitogen due to its 
interactions with HES glycans. To limit the likelihood of this occurring HES was 
added to splenocyte cultures 30 min prior to Con A. However, to totally exclude this 
possibility anti-CD3 was used as an alternative method to stimulate T cell expansion, 
anti-CD3. At 1 µg/ml anti-CD3, HES was able to increase Foxp3 to a comparable 
extent as with 2 µg/ml of Con A, showing that this effect is independent of the type 
of mitogenic stimulus (Fig. 6.5, upper panels). 
 As already described (Section 1.5.2), addition of exogenous TGF-β to 
proliferating T cell cultures induces Foxp3 expression in vitro. In this setting, Foxp3 
induction is optimal when TCR stimulation is weak, decreasing as mitogen 
concentration increases (Kim and Rudensky, 2006). A similar sensitivity to mitogen 
dose was observed when splenocytes, incubated with HES, were treated with high 
(10 µg/ml), and low (1 µg/ml), concentrations of anti-CD3. At 1 µg/ml, 10% of the 
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CD4+ T cells were Foxp3+, whereas at 10 µg/ml, 4% were in this population, a <1% 
increase over anti-CD3 alone (Fig. 6.5). 
 
 
6.2.6 HES induces de novo expression of Foxp3 in CD4+ T cells. 
 
The change in the proportion of Foxp3+ CD4+ T cells in response to HES may be a 
result of de novo Foxp3 induction, proliferation of natural Foxp3+CD4+ T cells in 
response to parasite antigens, or selective killing of Foxp3-CD4+ T cells. To ascertain 
which of these is the case, initially Foxp3- splenocyte cultures were stimulated with 
HES in the presence of an appropriate concentration of anti-CD3. Foxp3- splenocytes 
were sorted by flow-cytometry, as previously (Section 6.2), from Foxp3-GFP mice. 
After 48 hrs in the presence of HES, Foxp3 expression was evident in CD4+ T cells 
derived from the originally Foxp3- cultures (Fig. 6.6). This demonstrates that HES is 
able to induce de novo Foxp3 expression in activated CD4+ T cells. 
 
 
6.2.7 Foxp3+ T cells, induced by HES, are functionally 
suppressive. 
 
Presence of Foxp3 typically correlates with T cells gaining regulatory activity 
(Fontenot et al., 2003). HES is a complex mixture of helminth products and it is 
feasible that in this situation Foxp3+ cells do not take on a suppressor phenotype as a 
result of these other factors. The functional capacity of HES-induced Foxp3+ CD4+ T 
cells was, therefore, analysed. To test this, Foxp3- CD4+ T cells were first purified 
from Foxp3-GFP mice (Fig. 6.7 A (I, II)), and then stimulated with plate-bound anti-
CD3/anti-CD28 in the presence of either HES, or rhTGF-β1. 72 hrs later, substantial 
numbers of Foxp3+ cells had been induced in both treatment groups (Fig. 6.7 A (III, 
IV). This demonstrated that HES, like TGF-β, acts on CD4+ T cells to induce Foxp3 
without necessity for APCs.  
 Using flow-cytometry, the Foxp3+, and Foxp3-, populations were isolated 
from these cultures, and added to a responder T cell population stained with the 
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quantitative cell division marker CMTMR. The responder T cell population was 
composed of polyclonally-stimulated, freshly isolated, Foxp3-CD4- cells, also sorted 
from Foxp3-GFP mice (Fig. 6.7 A (V)). HES- and rhTGF-β1- induced Foxp3+ cells 
were found to be equally suppressive, and exerted a comparable effect to freshly 
isolated Foxp3-GFP+ natural Tregs (Fig. 6.7 A (V), B). This was in contrast to the 




6.2.8 HES contains a TGF-β-like activity that is not inhibited by a 
pan-vertebrate TGF-β antibody. 
 
Given the phenotypic similarities between HES and TGF-β, and the reported release 
of a TGF-β homologue by the human filarial nematode B. malayi (Section 1.7.8), it 
seemed likely that HES contains a functional mimic of this molecule. To test whether 
HES did contain this activity, MFB-F11 cells were incubated with HES. MFB-F11 is 
a cell line derived from TGF-β1-/- fibroblasts that have been transfected with a TGF-
β responsive alkaline phosphatase (AP) reporter construct. HES at 10 µg/ml was 
found, with batch to batch variation, to activate this assay to the same extent as 
between 0.5 and 5 ng/ml of rhTGF-β1 (Fig. 6.8 A). 
 Several studies of helminth ES products have revealed contamination with 
host material (DeMarco et al., 2007; Hewitson et al., 2008). Since H. polygyrus 
inhabits the TGF-β-rich environment of the duodenum, it is possible that the parasite 
sequesters host TGF-β in vivo and subsequently releases it in vitro. If this were the 
case, the contaminant would be a TGF-β, rather than a superfamily member, such as 
activins, nodals, or BMPs, as the MFB-F11 cell line is specifically responsive to 
TGF-βs (Tesseur et al., 2006). HES was pre-incubated for 1 hr with the pan-
vertebrate monoclonal TGF-β antibody, 1D11, and its subsequent ability to activate 
the assay measured. 1D11 is known to interact with mammalian TGF-β1, 2, and 3, as 
well as amphibian TGF-β5. Even at 100 µg/ml of mAb, HES induction of AP was 
 149 
not inhibited (Fig. 6.8 B, left panel), whereas stimulation by 5 ng/ml of rhTGF-β1 
was abolished with as little as 1 µg/ml of 1D11 (Fig. 6.8 B, right panel). 
      The ability of HES to induce Foxp3 was similarly not inhibited by 1D11 
in mitogenically stimulated splenocyte cultures, whilst the effect of rhTGF-β1 was 
abrogated. As 1D11 is continuously present in these cultures this additionally shows 
that HES does not function by stimulating an accessory cell population to release 
TGF-β (Fig. 6.8 C). 
 
6.2.9 HES TGF-β-like activity is inhibited by H. polygyrus infection 
sera. 
 
If the parasite molecule responsible for the TGF-β-like activity is dissimilar to 
mammalian TGF-β then it may stimulate an antibody response by the host. The 
ability of sera from day 28 H. polygyrus infected mice was tested for its potential to 
neutralise HES stimulation of the MFB-F11 assay. Over two-fold inhibition of TGF-
β-like activity was observed with sera from several parasitised mice (Fig. 6.9 A). 
Naïve sera, used at the same concentration in this assay, was found to have no such 
effect (Fig. 6.9 A). Moreover, sera from infected mice did not alter the ability of 
rhTGF-β1 to stimulate the MFB-F11 cells, confirming that the host and parasite 
ligand are immunologically seperable entities (Fig. 6.9 B). 
 
6.2.10 Other helminth-derived products have TGF-β-like activity. 
 
Although there was no evidence of TGF-β-like activity in the ES from the acute 
rodent nematode N. brasiliensis (Fig. 6.3 B, right panel), it was possible that ES from 
chronic helminth infections may generally harbour this potential. ES was tested from 
the L4 stage of two prominent ovine chronic gastrointestinal nematodes, 
Haemonchus contortus and Teladorsagia circumcincta. Using the MFB-F11 assay 
no detectable activity was present in H. contortus L4 ES, but T. circumcincta L4 ES 
was able to induce AP release (Fig. 6.10 A). Like HES, T. circumcincta L4 ES 
activity was not inhibited by high concentrations of TGF-β antibody. T. circumcincta 
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ES was also able to induce Foxp3 expression in proliferating CD4+ T cells (Fig. 6.10 
B). Hence, it seems that H. polygyrus is not unique in its ability to release an active 
TGF-β mimic. 
 
6.2.11 Foxp3 induction is dependent on TGF-β activity. 
 
Having demonstrated that HES is able to induce Foxp3 in CD4+ T cells, and that 
HES has TGF-β-like activity, experiments were then undertaken to ascertain whether 
these two effects are causally linked. A Foxp3 induction assay was performed, as 
previously, with MACS-sorted CD4+ T cells from mice expressing a dominant 
negative (dn) form of TGF-β receptor (R) II. HES, like rhTGF-β1, was dependent on 
this receptor to induce Foxp3, as no increase in its expression was observed in these 
cultures (Fig. 6.11 A). This also confirmed, as was previously suggested (Section 
6.2.7), that HES directly acts on CD4+ T cells, as the dn construct is restricted to this 
cell type and is normal in other cells populations, such as APCs. 
 TGF-β signalling is dependent on heterodimerisation of TGF-βRII with 
ALK-5/TGF-βRI. If HES does contain a TGF-β mimic then Foxp3 induction would 
be dependent on both of these receptors. CD4 sorted T cells were, therefore, treated 
with an inhibitor of ALK-5 (SB 431542), or DMSO as a control, for 30 min prior to 
addition of HES or rhTGF-β1. After 72 hrs there was no evidence of Foxp3 
induction in either of the cultures containing the inhibitor (Fig. 6.11 B). This data 
formally shows that the Foxp3 inducing activity of HES is dependent on it mediating 









Fig. 6.1 – Percentage increases in CD4+ Foxp3+ cells occur in lymphocyte 
populations local to H. polygyrus.  
 
Intraepithelial lymphocytes (IELs), lamina propria lymphocytes (LPLs), Peyer’s 
patches, and MLNs were isolated from naïve or day 7 H. polygyrus infected 
C57BL/6 mice. Foxp3 expression within the CD4+ T cell population was assessed by 
flow cytometry. Graph represents pooled data from 3 identical experiments. Results 






Figure 6.2 – Converted CD4+ Foxp3+ T cells are present in the MLNs at day 28 
of H. polygyrus infection. 
 
(A) Ly5.2+ CD4+ Foxp3- T cells were sorted from splenocytes of mice expressing a 
knocked-in Foxp3-GFP fusion protein. 5 x 106 of these cells, or the same number of 
WT MACS sorted CD4+ cells, as a non-fluorescent control, were adoptively 
transferred by tail vein injection into congenic Ly5.1+ hosts. 24 hrs later mice were 
inoculated with 200 H. polygyrus L3 larvae, or left as an untreated group. After 28 
days, MLNs were removed from all mice, cells from groups of mice pooled together, 
MACS sorted to enrich for CD4+ cells, and Foxp3-GFP expression assessed by flow-
cytometry. To aid in detection of Foxp3-GFP+ cells, all analysis was performed on 
the gated Ly5.2+ population. (B) Plots of WT non-fluorescent control, and Foxp3-
GFP cells within the Ly5.2+ CD4+ T cell population of pooled MLN cells from naïve 
or day 28 H. polygyrus infected mice. Data are from one experiment in which MLNs 








Figure 6.3 – HES increases the percentage of CD4+ Foxp3+ T cells in mitogen 
stimulated splenocyte cultures.  
 
Sample plots of CD25 versus Foxp3 expression, gated on CD4+ T cells, from 
C57BL/6 splenocyte cultures. Splenocytes were treated with PBS alone, Con A 
(2µg/ml), or combinations of Con A with pathogen products. Con A was added to 
cultures 30 min after pathogen products, and flow-cytometry performed 48 hrs later. 
(A) PBS alone, Con A plus: PBS, HES (10 µg/ml), heat-inactivated HES (hiHES) 
(10 µg/ml). Heat inactivation was carried out for 30 min at 100ºC. (B) Con A plus: 
P. acnes extract (Pa) (10 µg/ml), S. typhimurium extract (Sa) (10 µg/ml), the TLR-2-
ligand Pam-3-CSK4 (1 µg/ml), the TLR-4-ligand LPS (1 µg/ml), S. mansoni soluble 
egg antigen (SEA) (10 µg/ml), or N. brasiliensis ES (NES) (10 µg/ml). (C) 
Percentage of Foxp3+ cells within the CD4+ T cell population of splenocytes exposed 
to indicated stimuli. Data represent the mean ± SD of three replicate cultures from 
individual mice. Results of Student’s t test **, P < 0.005. All data in this figure are 










Figure 6.4 – Inhibition of IFN-γ, but heightened IL-4, secretion is observed in 
HES treated mitogen stimulated splenocyte cultures.  
 
IL-4, IL-10, and IFN-γ (C), present in supernatants, taken from cultures described in 
Fig. 6.4 C, were measured by ELISA. Again, data represent the mean ± SD of three 
replicate cultures from individual mice. These data are representative of at least three 












Figure 6.5 – HES mediated increases in percentage of CD4+ Foxp3+ T cells are 
inhibited by strong stimulation of the TCR. 
 
Sample plots of CD25 versus Foxp3 expression, gated on CD4+ T cells, from naïve 
C57BL/6 mice splenocyte cultures exposed to: Left panels, PBS, or right panels, 
HES (10 µg/ml), in combination with a low (1 µg/ml), or high (10 µg/ml) 
concentration of anti-CD3. Data are representative of two similar experiments using 


















Figure 6.6 – Increases of CD4+ Foxp3+ T cells in response to HES occur by de 
novo induction of Foxp3. 
 
Foxp3 expression in CD4+ T cells, after 48 hrs culture of flow-cytometry sorted GFP- 
splenocytes (from mice expressing a knocked-in Foxp3-GFP fusion protein) 




Figure 6.7 – HES generated CD4+ Foxp3+ T cells have regulatory activity. 
 
(A) Flow-cytometric analysis of, pre- (A I) and post- (A II) sort samples to obtain 
CD4+ Foxp3- T cells from a Foxp3-GFP mouse. These cells were subsequently 
expanded for 72 hrs, in an APC-free system, with plate-bound anti-CD3/anti-CD28, 
in the presence of HES (10 µg/ml) (A III), or rhTGF-β1 (2 ng/ml) (A IV). Cells from 
these cultures were sorted into CD4+ Foxp3+ and CD4+ Foxp3- populations (gates 
shown A III, IV), and their suppressive capacity assessed (see B). The responder 
population, used for this assessment, of CD4+ Foxp3- T cells, along with ex vivo 
CD4+ Foxp3+ T cells, was sorted from naïve Foxp3-GFP spleen and pLN cells (A 
V). (B) The proliferation of CD4+ Foxp3-, CMTMR-loaded, index responder T cells, 
stimulated with soluble anti-CD3 (1 µg/ml) in the presence of irradiated APCs for 4 
days, and co-cultured with the different populations of ‘suppressor’ cells, was 
measured by flow-cytometry. Left panel, CD4+ Foxp3-, CMTMR-loaded, index 
responder T cells alone.  Right upper panel, CMTMR-loaded responder cells mixed 
with equal numbers of induced Foxp3+ T cells from HES, or rhTGF-β1 treated 
cultures, or ex vivo, Foxp3+ T cells from a naïve Foxp3-GFP mouse. Right lower 
panel, CMTMR-loaded responder cells mixed with CD4+ T cells that did not express 







Figure 6.8 – HES contains a TGF-β-like activity, which is not blocked by a pan-
vertebrate anti-TGF-β monoclonal antibody. 
 
(A) HES activates the TGF-β responsive reporter cell-line, MFB-F11, inducing 
expression of alkaline phosphatase. (B) Left panel, HES TGF-β-like activity, as 
compared to a rhTGF-β1 standard curve, is not diminished when pre-incubated with 
up to 100 µg/ml of the pan-vertebrate TGF-β mAb, 1D11. Right panel, in contrast to 
HES, 5 ng/ml of rhTGF-β1 activity is abrogated by as little as 1 µg/ml of 1D11. (C) 
HES (10 µg/ml) induced Foxp3 expression in soluble anti-CD3 (1 µg/ml) stimulated 
splenocyte cultures is unchanged when pre-incubated with 1D11 when compared to 
isotype control. Foxp3 induction by 2 ng/ml rhTGF-β1 is, however, markedly 
inhibited. Sample plots of CD25 versus Foxp3, gated on CD4+ T cells are shown. 
 Data shown in figure is representative of two similar experiments. Error bars 






Figure 6.9 – Infection sera neutralises the TGF-β-like activity in HES, but has 
no effect on the efficacy of rhTGF-β1. 
 
(A) Pre-incubation with sera (1:50) from day 28 H. polygyrus infected, but not naïve, 
mice blocks the ability of HES to induce reporter activity in the MFB-F11 cell line. 
(B) Activity of rhTGF-β1 is unaffected by treatment with the infection sera.
 Data shown in figure is representative of two similar experiments. Error bars 









Figure 6.10 – Teladorsagia circumcincta L4 ES, has TGF-β-like activity and is 
able to increase percentage of CD4+ Foxp3+ T cells. 
 
(A) T. circumcincta (Tc)L4 ES (30 µg/ml), but not H. contortus (Hc)L4ES (30 
µg/ml), stimulates alkaline phosphatase release by the MFB-F11 reporter assay. This 
activity is unaltered by high levels (100 µg/ml) of anti-TGF-β (1D11). Error bars 
represent SEM of triplicate wells of MFB-F11 cells stimulated with each treatment. 
(B) TcL4ES (30 µg/ml) induces significant Foxp3 expression, after 72 hrs, in MACS 
purified CD4+ cultures stimulated to expand with plate-bound anti-CD3/anti-CD28 
and exogenous IL-2 (10 ng/ml). In contrast, HcL4ES (30 µg/ml) had no effect. 




Figure 6.11 – HES induced Foxp3 expression is dependent on intact TGF-β- 
receptor signalling. 
 
(A) MACS sorted CD4+ cells were purified from WT C57BL/6, or dnTGF-βRII 
mice, and stimulated with plate-bound anti-CD3/anti-CD28, in the presence of IL-2 
(10 ng/ml), with either 10 µg/ml HES, or 5 ng/ml rhTGF-β1. After 72 hrs Foxp3 
expression was assessed. (B) CD4+ cells were cultured as in A, but were treated with 
5 µM of the ALK-5/THG-βRI inhibitor SB 431542, or DMSO as a control, along 
with HES or rhTGF-β1. Again, 72 hrs later expression of Foxp3 was analysed. 




Increased prevalence of Foxp3 expression within the CD4+ T cell population is a 
common feature observed over the course of an infection (Section 1.5). If H. 
polygyrus is able to directly affect the Foxp3+ Treg population, in vivo, it is probable 
that this would be most apparent within the tissue infiltrating lymphocytes, and 
Peyers patches, which are the local lymphoid structures. The proportion of CD4+ 
Foxp3+ cells was elevated, in all local populations analysed: IELs, LPLs, and Peyer’s 
patches.  
 Production of ES is one method helminths are thought to use to modulate the 
host’s immune response (Section 1.7). HES was found to have a component(s) that 
enhanced the Foxp3+ Treg population when T cells were stimulated to proliferate, in 
vitro. As shown by stimulating an initially Foxp3-GFP- population, HES was able to 
induce Foxp3 expression in naïve peripheral T cells. This is the first report of a 
parasite product that is able to act in a direct fashion on the Foxp3+ Treg component 
of the immune response. Despite HES being a complex mixture of products, perhaps 
with competing T effector and T regulatory activities (Section 1.7), the Foxp3+ cells 
were functionally suppressive. Moreover, induction of Foxp3 was still favoured in 
whole splenocyte cultures, even though HES concurrently increased expression of 
IL-4, which has been shown to counteract this process (Wei et al., 2007). This 
implies that, in vivo, local to the parasite (where HES concentrations are highest) it 
would be possible for the immunological balance to be swayed such that Foxp3+ 
Tregs are generated. As there is a requirement for TCR-ligation and subsequent 
expansion of T cells to switch on Foxp3 (Section 1.5.2), it seems probable, that these 
induced Tregs would have come from a naïve pool preferentially recognising HES 
antigens. Expansion of such HES-specific Tregs could ultimately lead to a 
preponderance of worm-responsive suppressor cells within the T cell pool, limiting 
development of Th2-cells, and hence Th2-type protective effector mechanisms. By 
this mechanism, H. polygyrus would eventually come to be recognised more like self 
than an invading pathogen.     
Agreeing with this hypothesis, de novo expression of Foxp3 seems to occur 
during infection, as demonstrated by the conversion of a transferred Foxp3-GFP- cell 
population in this setting. Interestingly, a similar percentage of Foxp3-GFP+ T cells 
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were found in the MLNs of naïve and infected mice, after 28 days, perhaps 
suggesting there is a homeostatic mechanism maintaining proportions of induced 
Tregs. There were, however, dramatic increases in the number of cells present in the 
infected LNs. This means that when responding to the parasite either more 
conversion to a Foxp3+ phenotype occurs, or else there is greater expansion of 
converted cells. A major caveat to this experiment is that a small number of Foxp3-
GFP+ cells could have contaminated the original sample. If contaminants were 
present then over the relatively long time period of this study they may have 
expanded to become the GFP+ population described. Shortening the length of the 
experiment would be one way to avoid this problem, perhaps looking for evidence of 
induction at 7 days post-infection. Alternatively, a population of cells that do not 
contain natural Foxp3+ Tregs, such as those from DO11.10 SCID mice (in 
combination with OVA-feeding), could be transferred in the same setting and 
conversion assessed. 
The activity in HES was defined as TGF-β-like since, using either genetic, or 
pharmaceutical, techniques to block TGF-β signalling, induction of Foxp3 could be 
abrogated. Additionally, HES was able to activate the TGF-β-specific-reporter cell-
line, MFB-F11. Recently, in our lab, a TGF-β homologue has been identified from 
H. polygyrus, termed Hp-TGH-2 (McSorley et al., in submission). It has not been 
possible, at this time, to correlate the TGF-β-like activity in HES with the presence 
of this molecule, but given the high degree of structural similarity between TGF-βs 
from diverse organisms it would seem a plausible candidate. If a TGF-β homologue 
is responsible for the effects of HES on T cells, then its identification could prove to 
be difficult. This is because, it is likely be a minor component of the mixture, given 
the extremely low levels at which TGF-β is biologically active. A possible method to 
identify the molecule would to enrich using gel-filtration, perhaps followed by ion-
exchange, chromatography, and then to use mass spectrometry to assign an identity 
to the active component. However, due to the very limited amount of sequence data 
available for H. polygyrus, unless this is a previously characterised protein, for 
example Hp-TGH, the approach could ultimately prove to be inconclusive.  
 Even in the absence of a defined parasite-product it was still possible to 
demonstrate that sera, derived from day 28 infected animals, were able to inhibit the 
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ability of HES to stimulate the MFB-F11 assay. This effect is specifically against 
HES, not altering recognition of rhTGF-β1, implicating antibodies as the likely 
mediators of suppression. To attempt to confirm this, the Ig component of the sera 
could be purified on a Protein A, or G, column and used in the same kind of blocking 
experiments. If antibodies do target this protein, in vivo, then it would be of interest 
to establish whether there is a correlation between its neutralisation and parasite 
expulsion. One obvious way of studying this would be simply to measure serum 
inhibition of TGF-β-like activity versus worm burden. This could be done for a 
single strain, but also between differently resistant strains. 
 There may of course be no role in protection for antibody-mediated inhibition 
of this molecule in resistant strains of mice, since the parasite is targeted whilst still 
in the sub-mucosa (Chapter 4), and it is unclear whether the TGF-β-like molecule(s) 
is released at this time. Although culture techniques would need to be optimised, ES 
from, exsheathed L3, and L4 stages of H. polygyrus could likely be obtained and 
TGF-β-like activity measured. Supporting the prospect that they would have this 
activity, L4 ES from the ovine helminth T. circumcincta, which also dwell at this 
stage in the gut-mucosa was able to increase percentages of Foxp3+ T cells. Indeed, it 
can be envisaged that excretion-secretion of products with this function early during 
infection, such as the L3/L4 stages, may be extremely important at a time when the 
parasite is potentially directly in contact with immune cells. A further question raised 
by the presence of TGF-β-like activity in TcL4ES is: how common is this potentially 
immunomodulatory strategy amongst helminth species? In this chapter a number of 
helminth-derived products were found to be negative including, H. contortus ES, 
NES, and SEA. N. brasiliensis, unlike H. polygyrus, is unable to establish a chronic 
infection in the mouse, being expelled after 5-7 days. One intriguing possibility, is 
that the lack of TGF-β-like activity in NES is key to the rapid expulsion of the 
parasite. Better characterisation of TGF-β-like activity across a wide-variety of 
helminths is needed to ascertain both the prevalence of this feature, and whether it is 
related to chronicity of infection.  
Until the molecule(s) has been identified it will be difficult to assess whether 
its primary role in vivo is to induce Foxp3+ Tregs. TGF-β has been found to have 
anti-inflammatory effects on many different cell-types, including DCs, macrophages, 
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and mast cells, that could also aid worm persistence (in Section 1.6.2). Although 
poorly understood, feeding by H. polygyrus is thought to cause damage to the IEC 
barrier, an additional role for TGF-β-like activity, therefore, could be aiding in repair 
of this. Its breakdown could lead to systemic bacterial infiltration, negatively 
affecting host survival. 
Although not parasite-derived, host TGF-β depletion, by mAb, reversed some 
of the immune suppression observed in H. polygyrus infection (Doligalska et al., 
2006). Additionally, in work by our own lab, in vivo treatment of C57BL/6 mice 
with TGFβRI/ALK-5 inhibitor (SB 431542) at day 28 of H. polygyrus infection 
promoted worm expulsion (K. Smith, unpublished observation). This issue could be 
addressed further, specifically in respect to the effects of TGF-β on T cells, by 
comparing the response to infection of CD4dnTGFβRII mice. Other genetically-
deficient mouse strains, that may be useful to shed light on any parasite-derived 
TGF-β-activity during the course of disease, are those which have deficiencies in 
TGF-β processing genes, such as furin (Pesu et al., 2008), or the integrin αvβ8 
(Travis et al., 2007). If a pre-processed TGF-β-like molecule is released by H. 
polygyrus a predicted outcome of the infection would be a lessening of the severity 
of the colitic phenotype of these animals. It is worth note, at this point, that the 
benefits of TGF-β-like expression for H. polygyrus could be highly dependent on its 
appropriate temporal and spatial deployment. Recent work has revealed that in 
situations where IL-4 and TGF-β are co-expressed IL-9 producing T cells, Th9-cells, 
differentiate (Dardalhon et al., 2008; Veldhoen et al., 2008b). Generation of Th9-
cells would plausibly be detrimental to the parasite, as IL-9 production has been 
linked to worm expulsion in other models (Section 1.3.6). 
 When considered in a broader context, an ES product with TGF-β-like 
activity could potentially be both a vaccine candidate, and/or a novel 
immunosuppressant. Again, identification of the molecule(s) is essential to assess 
whether either of these are the case, but preliminary studies could be undertaken 
using whole HES. No work has as yet been undertaken to ascertain whether HES is 
able to modulate autoimmune or allergic diseases. H. polygyrus is known to suppress 
a mouse model of allergy (Wilson et al., 2005), via expansion of the CD4+ CD25+ T 
cell compartment. This system would be an ideal candidate for any initial 
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characterisation of the abilities of HES to bias towards the regulatory arm of the 
immune response in the face of an ongoing inflammatory setting. 
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7 Final discussion 
 
In order to establish a long-term infection, parasitic helminths must limit the host’s 
immune response to favour their own persistence whilst preventing the development 
of unnecessary immunopathology. If Th1/Th17-type responses are generated towards 
helminths then pathology often ensues (Rutitzky and Stadecker, 2006), whilst Th2-
type responses are more frequently associated with the relatively minor symptoms 
typical of these parasites. Driving a Th2-type response, however, although favouring 
host survival might lead to expulsion of the helminth. This means that the parasite 
must walk a dangerous line, allowing a Th2-type response to be generated against it 
but at the same time suppressing this response to such an extent that it will not be 
expelled. In the case of H. polygyrus infection, the precise mechanisms of expulsion 
are poorly understood, although generation of Th2 cells is clearly integral to the 
process (Urban et al., 1991a; Urban et al., 1991b). An important dimension which 
has yet to be fully explored is whether H. polygyrus and other helminths can 
selectively interfere with the Th2 response to neutralise only those components to 
which they are most vulnerable. 
The work in this thesis has attempted to better describe how susceptibility to 
H. polygyrus is defined in a primary response to the parasite, both in terms of type 
and voracity of response, and in relation to how the ES products released by the 
parasite contribute to this process.  
DCs are thought to be the main cell-type involved in initially presenting 
antigen to, and driving expansion of, the T cell pool during the initiation of an 
immune response to a helminth infection. Chapter 3 of this thesis examined this 
critical early phase of the immune response by characterising the effects of HES on 
BMDCs and their ability to drive Th2-type responses when transferred in vivo.  
Chapter 4 then moved on to consider how primary resistance to H. polygyrus was 
mediated in different strains of mice to elucidate general mechanisms of protection. 
Formation of granuloma-like structures in the duodenal wall, which have been 
reported to occur in secondary infection, seem to be related to early rejection of the 
parasite. Furthermore, the cytokine IL-23, plays a key role in counteracting this 
process in susceptible C57BL/6 mice. 
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A level at which polarisation and strength of the immune response is critically 
regulated, but often not considered, is the epigenetic level. Chapter 5 characterised 
the effects of genetic deficiency in a protein that binds to, and ultimately leads to 
repression of transcription in, regions of CpG methylation. Interestingly, despite 
having been reported as primarily affecting Th2 polarisation, it was found that 
MBD2 also regulated Foxp3 induction, altering the balance between Teff and Treg 
cells.  
 Finally, in Chapter 6 components of HES were identified which, rather than 
generating a Th2 response, are potentially important in downregulating the immune 
response against the parasite. It was found that H. polygyrus contains a TGF-β-like 
activity that is able to induce Foxp3+ Tregs, thus providing a means to directly 
enhance the regulatory arm of the immune response. In this discussion the 
implications of the results from each chapter will be considered in more detail, along 
with potential links between them (Fig. 7.1). 
 
7.1 Recognition of HES and induction of Th2-type 
responses. 
 
DCs are thought to be the primary cell-type involved in initiating immune responses 
to helminth infections. In the gut these cells are located in the gut mucosa and 
Peyer’s patches. When infected with H. polygyrus, due to the damage caused to the 
epithelial layer, gut DCs will be concurrently exposed to parasite, and commensal 
bacterial, products. Inflammatory responses driven by the bacterial products could 
potentially lead to Th1/Th17-mediated immune pathology. Additionally, damage to 
the gut wall needs to be rapidly repaired to limit the risk of systemic bacterial 
infection, a process which Th2-type responses aid. 
It is, therefore, of benefit to both host and parasite for a Th2-type response to 
balance Th1/Th17 responses. When BMDCs were co-treated with HES and LPS, as a 
bacterial stimulus, they were inhibited in their ability to release the pro-inflammatory 
cytokine IL-12p70, whilst maintaining production of the anti-inflammatory cytokine, 
IL-10. Previously, this phenotype has been suggested to be an immunosuppressive 
tactic used by the helminth to limit development of a response towards it (Segura et 
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al., 2007). DCs pulsed with HES were found to be competent to induce a Th2-type 
response, characterised by IL-4, and IL-13, production, with little IFN-γ, and no 
evidence of an IL-17 response. Additionally, HES pulsed DCs were able to drive 
production of the immunoregulatory cytokine IL-10. The ability of HES to generate 
a Th2-type response, however, was not related to its pro-inflammatory suppressive 
properties. DCs incubated with heat-inactivated (hi)HES still drove a comparable 
Th2-type response to HES-treated DCs. Moreover, the Th2-type response towards 
hiHES was no different to HES when DCs were co-treated with the Th1/Th17-
driving stimulus, Pa. These data suggest that the role of the cytokine inhibition is not 
to directly induce a Th2-response.  
 One possibility is that its role is actually to locally suppress cytokine release 
to favour Th2-type effector responses (Fig. 7.1). This could include alternative 
activation of macrophages, which, as demonstrated in Chapter 4, may correlate with 
resistance to H. polygyrus in some strains of mice. Of course it is possible that if 
HES inhibits inflammatory cytokine production from DCs it could also act directly 
on Mφs and might be another route to favour their alternative activation. Although 
not tested it is possible that if HES is able to inhibit IL-12p70 production it could 
also inhibit IL-23 production (Fig. 7.1). 
 If the role of HES described here is to suppress cytokine production local to 
the helminth, then this could represent on appropriate response of the host to enhance 
parasite clearance, rather than a helminth immunosuppressive tactic. Of course, as 
described in the introduction, Th2-type polarisation could be thought of as an 
immunomodulatory response in itself. In Chapter 3 of this thesis no attempt was 
made to elucidate the mechanisms by which HES acts to inhibit pro-inflammatory 
cytokine production. A possibility is that the TGF-β-like activity described in 
Chapter 6 is responsible for this suppression (Fig. 7.1). Murine TGF-β has been 
reported to limit pro-inflammatory cytokine production from DCs (Fainaru et al., 
2007). To further address whether this is the case Western-blotting could be used to 
study pathways typically associated with TGF-β-stimulation, such as SMAD-2/3-
phosphorylation. Alternatively, DCs could be treated with the TGF-βRI inhibitor 





7.2 Protection against primary infection with H. polygyrus. 
 
In experimental infections of mice with T. muris, much work has focussed on the 
factors that affect the balance between Th1, and Th2, reponses towards the parasite. 
No such studies had been undertaken with H. polygyrus. The small and large 
intestine are very different immunological environments, particularly in regard to 
colonisation with bacteria. The data presented in Chapter 4 suggest that the factors 
counteracting protective immune responses in H. polygyrus infection may be very 
different to those in T. muris infection. In particular IFN-γ deficiency had no effect 
on primary susceptibility to H. polygyrus infection, but its depletion has previously 
been shown to have dramatic effects on susceptibility to T. muris (Else et al., 1994).  
It was found that IL-23 deficiency is able to reduce susceptibility to primary 
H. polygyrus infection in C57BL/6 mice. It is not currently clear whether this is due 
to the actions of IL-23 directly, or whether this is mediated by its ability to stabilise 
IL-17 expression. This contrasts with the role of the IL-23/IL-17 axis in the lung 
where it promotes Th2-type responses in a mouse model of allergic airway 
hypersensitivity (Schnyder-Candrian et al., 2006; Wakashin et al., 2008). Whether 
IL-23 is specifically important to protection against helminth infection in the small 
intestine is not yet known as no studies have addressed the role of this cytokine in 
large intestinal dwelling helminths.  
 Additionally, it seems that resistance to H. polygyrus, even in primary 
infection, may be largely mediated against the tissue-dwelling larval stage of the 
parasite. Although, it was not clear whether this was associated with alternative 
activation of macrophages (as is the case for secondary infection), it did appear to be 
associated with granuloma formation. The importance of IL-23 in H. polygyrus 
infection could be due to the need for rapid effector cell activity at this early stage.  
 Once the worms emerge into the gut lumen, other mechanisms may become 
more important in clearance, but it is possible that damage sustained during the tissue 
phase shortens adult lifespan, and may account for reduced fecundity in the more 
resistant strains. Future, work should focus on better identifying these mechanisms 
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and in particular if the same balances are important. For example IL-23, IL-17, IFN-
γ, depletion at later time points during the course of infection. Indeed, if bacterial 
status rather than just initial bacterial status of the host is important then perhaps 
antibiotic treatment may provide a novel therapeutic approach to favour the Th2 
response, thus enhancing parasite expulsion. 
 
 
7.3 Epigenetic regulation of Teff and Treg balance. 
 
The importance of methyl-CpG binding domain proteins (MBDs) in maintenance of 
gene silencing during Teff polarisation has been described (Hutchins et al., 2002; 
Hutchins et al., 2005). Since MeCP2 has previously been found to bind to an intronic 
region of the Foxp3 gene, in Chapter 5, the role of MBDs in control of Foxp3 
expression was assessed. It was found that genetic deficiency in MBD2, rather than 
MeCP2, enhanced Foxp3 induction, in vitro, in naïve T cells. When the CD4+ T cell 
compartment was phenotyped, ex vivo, from these mice it was found that the 
percentage of Foxp3+ cells was increased. MBD2-/- animals did, however, have 
reduced numbers of CD4+ T cells, perhaps due to the increased ratio of Tregs to 
Teffs. When infected with H. polygyrus MBD2-/- animals had reduced MLN 
expansion, and hence a reduced number of CD4+ IL-4 producing T cells. There was 
also a trend towards reduced expulsion of the parasite, although this did not reach 
statistical significance.   
Specific polymorphisms in MBD proteins have been found to modify the risk 
of developing breast (Zhu et al., 2005), and lung cancer (Liu et al., 2008). The data 
from Chapter 5, gives further support to the possibility polymorphisms in these 
proteins might also alter susceptibility to certain types of infection. Future human 
studies should perhaps consider the role of these genes in affecting response to 




7.4 Immune suppression by helminth derived products. 
 
Enhancement of the CD4+ Foxp3+ Treg compartment has been considered a likely 
mechanism by which parasites might manipulate the immune system to favour their 
persistence (Belkaid, 2007). Whether this is the case, has been of particular interest 
in helminth infections, since CD4+ Foxp3+ Tregs in these settings have been 
associated with the ability of these pathogens to abrogate allergic disease (Wilson et 
al., 2005). If the CD4+ Foxp3+ Treg increases are due to manipulation by helminth 
products, then it may be possible to derive novel therapeutics from these organisms. 
However, if the increases represent the host trying to return to a new homeostatic 
balance in the face of an infection that it cannot clear, then infection itself may be the 
only effective therapy. Infection with parasitic helminths as a treatment for allergic, 
or autoimmune, diseases, is far from ideal. There is a risk that the helminths 
themselves may cause pathology in some patients, whilst depending on the species 
used there is the possibility of transfer to other individuals. The work in Chapter 6 of 
this thesis demonstrates that, at least in some helminth infections, ES can contain 
activities that act to directly induce CD4+ Foxp3+ Tregs (Fig. 7.1). The identification 
of such an activity implies that at least some of the Treg enhancing capacity of these 
parasites could be recapitulated without the need for helminth infection. 
 Ultimately, in order to develop effective therapeutics from helminth products, 
it may be necessary to combine several different molecules identified from them. 
This concept is exemplified by the TGF-β-like activity characterised in Chapter 6 
that could drive naïve T cells to take on a pathogenic Th17, rather than CD4+ Foxp3+ 
Treg, phenotype, in the presence of IL-6 (Bettelli et al., 2006). To prevent this 
unwanted result from occurring this TGF-β-like activity might need to be 
administered in the presence of IL-25 driving factors. IL-25 has been demonstrated 
to suppress Th17 generation (Zaph et al., 2008). Activities of this kind are likely 
present in ES, as IL-25 upregulation is associated with Th2-driving infections 
(Owyang et al., 2006). 
 Future work will be required to conclusively identify not only the TGF-β-like 
activity, but also additional helminth-derived products which (as the example of Treg 
induction illustrates) may be able to mimic the features of live helminth infections; 
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through this route, it is hoped that new and effective treatments of human and animal 




Figure 7.1 – Immune modulation by HES. 
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